Mead Johnson Nutrition 8-K 24 Apr 14 Other Events Financial data

Document_and_Entity_Informatio

Document and Entity Information	12 Months Ended
	Dec. 31, 2013
Entity Information [Line Items]	'
Entity Registrant Name	'Mead Johnson Nutrition Co
Entity Central Index Key	'0001452575
Document Type	'8-K
Document Period End Date	31-Dec-13
Amendment Flag	'false

CONSOLIDATED_STATEMENTS_OF_EAR

CONSOLIDATED STATEMENTS OF EARNINGS (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
NET SALES	$4,200.70	$3,901.30	$3,677
Cost of Goods Sold	1,528.50	1,503.80	1,391
GROSS PROFIT	2,672.20	2,397.50	2,286
Expenses:	'	'	'
Selling, General and Administrative Expense	903.5	904.5	975.4
Advertising and Promotion	645.1	552.8	501.7
Research and Development Expense	100.2	100.1	100.8
Other Expenses—net	48.5	4.8	9.9
EARNINGS BEFORE INTEREST AND INCOME TAXES	974.9	835.3	698.2
Interest Expense-net	50.6	65	52.2
EARNINGS BEFORE INCOME TAXES	924.3	770.3	646
Provision for Income Taxes	235.1	182	178.8
NET EARNINGS	689.2	588.3	467.2
Less Net Earnings Attributable to Noncontrolling Interests	5.4	7.9	10.5
Net earnings attributable to shareholders	$683.80	$580.40	$456.70
Earnings per Share-Basic	'	'	'
Net Earnings Attributable to Shareholders (in dollars per share)	$3.37	$2.84	$2.23
Earnings per Share-Diluted	'	'	'
Net Earnings Attributable to Shareholders (in dollars per share - diluted)	$3.36	$2.83	$2.22
Weighted Average Number of Shares Outstanding, Basic [Abstract]	'	'	'
Weighted Average Number of Shares Issued, Basic	202.4	203.6	204.3
Weighted Average Number of Shares Outstanding, Basic	203.1	204.3	205

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
NET EARNINGS	$689.20	$588.30	$467.20
Foreign Currency Translation Adjustments	'	'	'
Translation Adjustments	-90.5	-8.4	-27.2
Tax Benefit/(Expense)	9.2	-13	4.7
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges	'	'	'
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges for the Period	24.2	-12.7	5.8
Reclassification Adjustment for Losses Included in Net Earnings	5.4	0.8	2.9
Tax Benefit/(Expense)	-10.1	3.5	-2.6
Pension and Other Post Retirement Benefits	'	'	'
Deferred Gains/(Losses) on Pension and Other Postemployment Benefits	-1.1	0	0
Reclassification Adjustment for Losses Included in Net Earnings	-0.2	0	-0.2
Tax Benefit/(Expense)	0	0	0
OTHER COMPREHENSIVE INCOME/(LOSS)	-63.1	-29.8	-16.6
COMPREHENSIVE INCOME	626.1	558.5	450.6
Less Comprehensive Income Attributable to Noncontrolling Interests	-6.9	7.9	10.6
COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREHOLDERS	$633	$550.60	$440

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
CURRENT ASSETS:	'	'
Cash and Cash Equivalents	$1,050.80	$1,042.10
Receivables-net of allowances of $6.5 and $7.6, respectively	384.4	364.6
Inventories	534.8	435.9
Deferred Income Taxes-net of valuation allowance	75.3	86.4
Income Taxes Receivable	15.9	26
Prepaid Expenses and Other Assets	56.9	60
Total Current Assets	2,118.10	2,015
Property, Plant, and Equipment-net	867.5	689.9
Goodwill	196.8	270.6
Other Intangible Assets-net	97.5	129.9
Deferred Income Taxes-net of valuation allowance	37	24.5
Other Assets	157.2	128.3
TOTAL	3,474.10	3,258.20
CURRENT LIABILITIES:	'	'
Short-term Borrowings	2	161
Accounts Payable	566.8	508.5
Dividends Payable	69.3	61.3
Long-term Debt, Current Maturities	505.6	0
Note Payable	0	26
Accrued Expenses	220	220.4
Accrued Rebates and Returns	314.9	314.8
Deferred Income-current	46.6	36.1
Income Taxes-payable and deferred	56.1	41.8
Total Current Liabilities	1,781.30	1,369.90
Long-Term Debt	1,009.10	1,523.20
Deferred Income Taxes-noncurrent	15.3	15.9
Pension, Post Retirement and Post Employment Liabilities	161.8	188.8
Other Liabilities	156.4	95.1
Total Liabilities	3,123.90	3,192.90
COMMITMENTS AND CONTINGENCIES	'	'
REDEEMABLE NONCONTROLLING INTEREST	49.7	36.3
Shareholders' Equity	'	'
Common Stock, $0.01 par value: 3,000 authorized, 206.8 and 206.0 issued, respectively	2.1	2.1
AdditionalPaidinDistributedCapital	-721.5	-772.8
Retained Earnings	1,432.30	1,052.40
Treasury Stock-at cost	-351.9	-244.6
Accumulated Other Comprehensive Loss	-69.2	-18.4
Total Shareholders' Equity/(Deficit)	291.8	18.7
Noncontrolling Interests	8.7	10.3
Total Equity/(Deficit)	300.5	29
TOTAL	$3,474.10	$3,258.20

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, except Per Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Receivables, allowances (in dollars)	$6.50	$7.60
Common Stock, par value (in dollars per share)	$0.01	$0.01
Common Stock, authorized	3,000	3,000
Common Stock, issued	206.8	206

CONSOLIDATED_STATEMENTS_OF_EQU

CONSOLIDATED STATEMENTS OF EQUITY/(DEFICIT) AND REDEEMABLE NONCONTROLLING INTEREST (USD $)	Total	Redeemable Noncontrolling Interest	Common Stock	Additional Paid-in (Distributed) Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss	Noncontrolling Interests
In Millions, unless otherwise specified
Redeemable Noncontrolling Interest, BALANCE at Dec. 31, 2010	$0	'	'	'	'	'	'	'
BALANCE at Dec. 31, 2010	-358.3	'	2	-871.8	477.5	-3.2	28.1	9.1
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'
Stock-based Compensation Awards	42.4	'	0.1	47.2	'	-4.9	'	'
Treasury Stock Acquired	-81.6	'	'	'	'	-81.6	'	'
Distributions to Noncontrolling Interests	-8.6	'	'	'	'	'	'	-8.6
Cash Dividends Declared	-212.5	'	'	'	-212.5	'	'	'
Net Earnings	467.2	'	'	'	456.7	'	'	10.5
Other Comprehensive Income/(Loss)	-16.6	'	'	'	'	'	-16.7	0.1
Increase (Decrease) in Temporary Equity	'	'	'	'	'	'	'	'
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	8.6	'	'	'	'	'	'	8.6
Redeemable Noncontrolling Interest, BALANCE at Dec. 31, 2011	0	'	'	'	'	'	'	'
BALANCE at Dec. 31, 2011	-168	'	2.1	-824.6	721.7	-89.7	11.4	11.1
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'
Stock-based Compensation Awards	36.6	'	0	51.8	'	-15.2	'	'
Treasury Stock Acquired	-139.7	'	'	'	'	-139.7	'	'
Distributions to Noncontrolling Interests	-7.6	'	'	'	'	'	'	-7.6
Cash Dividends Declared	-244.7	'	'	'	-244.7	'	'	'
Net Earnings	587.2	'	'	'	580.4	'	'	6.8
Equity Impact of Redeemable Noncontrolling Interest Accretion	-5	'	'	'	-5	'	'	'
Other Comprehensive Income/(Loss)	-29.8	'	'	'	'	'	-29.8	0
Increase (Decrease) in Temporary Equity	'	'	'	'	'	'	'	'
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	7.6	'	'	'	'	'	'	7.6
Acquisition	'	30.2	'	'	'	'	'	'
Net earnings of redeemable noncontrolling interest	'	1.1	'	'	'	'	'	'
Redeemable Noncontrolling Interest Accretion	'	5	'	'	'	'	'	'
Redeemable Noncontrolling Interest, BALANCE at Dec. 31, 2012	36.3	'	'	'	'	'	'	'
BALANCE at Dec. 31, 2012	29	'	2.1	-772.8	1,052.40	-244.6	-18.4	10.3
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'
Stock-based Compensation Awards	37.7	'	'	56.6	'	-18.9	'	'
Treasury Stock Acquired	-88.4	'	'	'	'	-88.4	'	'
Distributions to Noncontrolling Interests	-8.3	-1.2	'	'	'	'	'	-8.3
Cash Dividends Declared	-275.7	'	'	'	-275.7	'	'	'
Net Earnings	688.4	'	'	'	683.8	'	'	4.6
Equity Impact of Redeemable Noncontrolling Interest Accretion	-28.2	'	'	'	-28.2	'	'	'
Other Comprehensive Income/(Loss)	-63.1	-14.4	'	'	'	'	-50.8	2.1
Other Comprehensive Income Loss net of tax excl RNCI	-48.7	'	'	'	'	'	'	'
OtherComprehensiveIncomeLossOther	-5.3	'	'	-5.3	'	'	'	'
Increase (Decrease) in Temporary Equity	'	'	'	'	'	'	'	'
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	8.3	1.2	'	'	'	'	'	8.3
Net earnings of redeemable noncontrolling interest	'	0.8	'	'	'	'	'	'
Redeemable Noncontrolling Interest Accretion	'	28.2	'	'	'	'	'	'
Redeemable Noncontrolling Interest, BALANCE at Dec. 31, 2013	49.7	49.7	'	'	'	'	'	'
BALANCE at Dec. 31, 2013	$300.50	'	$2.10	($721.50)	$1,432.30	($351.90)	($69.20)	$8.70

CONSOLIDATED_STATEMENTS_OF_EQU1

CONSOLIDATED STATEMENTS OF EQUITY/ AND REDEEMABLE NONCONTROLLING INTEREST Consolidated Statements of Equity/ and Redeemable Noncontrolling Interest (parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Consolidated Statements Of Equity deficit And Redeemable Noncontrolling Interest Parenthetical [Abstract]	'	'	'
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	$9.50	$11.80	$2.80

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Earnings	$689.20	$588.30	$467.20
Adjustments to Reconcile Net Earnings to Net Cash Provided by Operating Activities:	'	'	'
Depreciation and Amortization	83.1	76.9	75.3
Stock-Based Compensation Expense	32.6	32.2	39.9
Deferred Income Tax	23	6.5	-57.4
Gain on Sale of Intangible Assets	0	-6.5	0
Exchange Loss from Devaluation	2.2	0	0
Pension and Other Post Retirement Benefits Expense	-7.2	62.6	95
Other	2.8	1.8	2.3
Receivables	-37.7	-8.5	-7.9
Inventories	-108.2	109.8	-183.3
Accounts Payable	56	-30.9	114.7
Accrued Expense, Rebates and Returns	14.8	-6.3	50
Income Taxes Payable	27	-62.2	53.2
Other Assets and Liabilities	48.4	-42.7	-6.5
Pension and Other Post Retirement Benefits Contributions	-19.4	-28.3	-9.7
Net Cash Provided by Operating Activities	806.6	692.7	632.8
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'	'
Payments for Capital Expenditures	-240.4	-124.4	-109.5
Proceeds from Sale of Property, Plant and Equipment	2.6	1.5	1.6
Proceeds from Sale of Intangible Assets	0	6.5	0
Investment in Other Companies	-2.7	-6.3	-4.7
Payment for Acquisition	0	-106.1	0
Net Cash Used in Investing Activities	-240.5	-228.8	-112.6
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'	'
Proceeds from Short-term Borrowings	6.9	391.2	72
Repayments of Short-term Borrowings	-165.4	-230.2	-73.2
Repayments of Notes Payable	-27.6	-52.6	0
Payments of Dividends	-267.7	-236.7	-205.7
Stock-based-compensation-related Proceeds and Excess Tax Benefits	23.6	23.3	4.5
Purchases of Treasury Stock	-106	-154.9	-87.7
Proceeds from Termination of Interest Rate Swaps	0	0	23.5
Distributions to Noncontrolling Interests	-9.5	-7.6	-8.6
Net Cash Used in Financing Activities	-545.7	-267.5	-275.2
Effects of Changes in Exchange Rates on Cash and Cash Equivalents	-11.7	5.4	-0.3
NET INCREASE IN CASH AND CASH EQUIVALENTS	8.7	201.8	244.7
CASH AND CASH EQUIVALENTS:	'	'	'
Beginning of Period	1,042.10	840.3	595.6
End of Period	$1,050.80	$1,042.10	$840.30

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
ORGANIZATION	'
	ORGANIZATION
	Mead Johnson Nutrition Company (“MJN” or the “Company”) manufactures, distributes and sells infant formula, children’s nutrition and other nutritional products. MJN has a broad product portfolio, which extends across routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. These products are generally sold to wholesalers, retailers and distributors and are promoted to healthcare professionals, and, where permitted by regulation and policy, directly to consumers.

ACCOUNTING_POLICIES

ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
ACCOUNTING POLICIES	'
	ACCOUNTING POLICIES
	Basis of Presentation—The financial statements present the results of operations, financial position, and cash flows of MJN and its majority-owned and controlled subsidiaries. Intercompany balances and transactions have been eliminated. The Company prepared the accompanying consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). These financial statements consider subsequent events through the date of filing with the Securities and Exchange Commission.
	In the Consolidated Statements of Cash Flows for the years ended December 31, 2012 and 2011, operating cash flow amounts reflected as pension and other post-employment benefit expense have been reclassified to conform to the presentation for the year ended December 31, 2013. These amounts were previously classified as a component of the change in other assets and liabilities.
	Use of Estimates—The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used in revenue recognition, including sales rebate and return accruals, impairment testing of goodwill and other indefinite-lived intangible assets, income tax assets and liabilities, income tax expense, and legal liabilities, as well as the accounting for stock-based compensation and retirement and post-employment benefits, including the actuarial assumptions. Actual results may or may not differ from estimated results.
	Fair Value Measurements—The fair value of financial assets and liabilities are classified in the fair value hierarchy as follows: Level 1—unadjusted quoted prices in active markets for identical assets or liabilities, Level 2—observable prices that are based on inputs not quoted on active markets, and Level 3—unobservable inputs that reflect estimates about the assumptions market participants would use in pricing the asset or liability.
	Revenue Recognition—MJN recognizes revenue when substantially all the risks and rewards of ownership have transferred to the customer. Revenue is recognized on the date MJN’s products are received by the purchaser. Revenues are reduced at the time of recognition to reflect expected returns that are estimated based on historical experience and business trends. Additionally, provisions are made at the time of revenue recognition for discounts, Women, Infants and Children (“WIC”) rebates and estimated sales allowances based on historical experience, updated for changes in facts and circumstances, as appropriate. Such provisions are recorded as a reduction of revenue. The Company offers sales incentives to customers and consumers through various programs consisting primarily of customer pricing allowances, merchandising funds and consumer coupons. Provisions are made at the time of revenue recognition for these items based on historical experience, updated for changes in facts and circumstances, as appropriate. Such provisions are recorded as a reduction of revenue.
	WIC rebate accruals were $199.7 million and $206.5 million at December 31, 2013 and 2012, respectively, and are included in accrued rebates and returns on the Company’s balance sheet. MJN participates on a competitive bidding basis in nutrition programs sponsored by states, tribal governments, the Commonwealth of Puerto Rico, and U.S. territories for WIC. Under these programs, MJN reimburses these entities for the difference between wholesaler list price and the contract price on eligible products. The Company accounts for WIC rebates by establishing an accrual in an amount equal to the Company’s estimate of WIC rebate claims attributable to a sale. MJN determines its estimate of the WIC rebate accrual primarily based on historical experience regarding WIC rebates and current contract prices under the WIC programs. The Company considers levels of inventory in the distribution channel, new WIC contracts, terminated WIC contracts, changes in existing WIC contracts and WIC participation, and adjusts the accrual periodically throughout the year to reflect actual expense. Rebates under the WIC program reduced revenues by $702.3 million, $730.0 million, and $700.7 million in the years ended December 31, 2013, 2012, and 2011, respectively.
	Sales return accruals were $44.8 million and $46.4 million at December 31, 2013 and 2012, respectively, and are included in accrued rebates and returns on the Company’s balance sheet. The Company accounts for sales returns by establishing an accrual in an amount equal to its estimate of sales recorded for which the related products are expected to be returned. The Company determines its estimate of the sales return accrual primarily based on historical experience regarding sales returns, but also considers other factors that could impact sales returns such as discontinuations and new product introductions. Returns reduced sales by $81.0 million, $82.5 million, and $81.8 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Income Taxes—The provision for income taxes has been determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax basis of the Company’s assets and liabilities. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable earnings in effect for the years in which those tax attributes are expected to be recovered or paid, and are adjusted for changes in tax rates and tax laws when changes are enacted. The ultimate liability incurred by the Company may differ from the provision estimates based on a number of factors, including interpretations of tax laws and the resolution of examinations by the taxing authorities.
	Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment including the long-range forecast of future taxable earnings and the evaluation of tax planning initiatives. Adjustments to the deferred tax valuation allowances are made to earnings in the period when such assessments are made.
	Uncertain tax positions that relate to deferred tax assets are recorded against deferred tax assets; otherwise, uncertain tax positions are recorded as either a current or noncurrent liability.
	Cash and Cash Equivalents—Cash and cash equivalents consist of bank deposits, time deposits and money market funds. The Company maintains cash and cash equivalent balances in U.S. dollars and foreign currencies, which are subject to currency rate risk. Cash equivalents are primarily highly liquid investments with original maturities of 3 months or less at the time of purchase and are recorded at cost, which approximates fair value. Money market funds, which totaled $447.8 million and $520.7 million at December 31, 2013 and 2012, respectively, are classified as Level 2 in the fair value hierarchy.
	Inventory Valuation—Inventories are valued at the lower of cost or market. The Company determines cost on the basis of the average cost or first-in, first-out methods.
	Property, Plant and Equipment—Expenditures for additions and improvements, including capitalized interest, are recorded at cost. Depreciation is computed on a straight-line method based on the estimated useful lives of the related assets. The estimated useful lives of the major classes of depreciable assets are up to 50 years for buildings and 3 to 40 years for machinery, equipment, and fixtures. Maintenance and repair costs are expensed as incurred.
	Capitalized Software—Certain costs to obtain internal-use software for significant systems projects are capitalized and amortized on a straight-line basis over the estimated useful life of the software, which ranges from 3 to 7 years. Costs to obtain software for projects that are not significant are expensed as incurred.
	Impairment of Long-Lived Assets—The Company periodically evaluates whether current facts or circumstances indicate that the carrying value of its depreciable assets to be held and used may not be recoverable. If such circumstances are determined to exist, an estimate of undiscounted future cash flows produced by the long-lived asset, or the appropriate grouping of assets, is compared to the carrying value to determine whether impairment exists. If an asset is determined to be impaired, the loss is measured based on the difference between the asset’s fair value and its carrying value. An estimate of the asset’s fair value is based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. The Company reports an asset to be disposed of at the lower of its cost less accumulated depreciation or its estimated net realizable value.
	Goodwill and Other Intangible Assets—During the third quarter of 2013 the Company changed its annual impairment testing date from January 1 to July 1, which did not result in any delay, acceleration or avoidance of an impairment charge. The Company believes that moving the goodwill impairment testing date to the third quarter is preferable because it better aligns with MJN’s annual and long-term planning timeline, which is a significant element in the testing process. The Company completed impairment testing in both the first and third quarters of 2013 and concluded that no impairment of goodwill exists (see Note 14).
	The Company’s policy is to test Goodwill for impairment on an annual basis or when current facts or circumstances indicate that a potential impairment may exist. The Company compares the carrying value of a reporting unit, including goodwill, to the fair value of the unit. If the carrying amount of a reporting unit exceeds its fair value, the Company revalues all assets and liabilities of the reporting unit, excluding goodwill, to determine if the fair value of the net assets is greater than the net assets including goodwill. If the fair value of the net assets is less than the carrying amount of net assets including goodwill, impairment has occurred. The Company’s estimates of fair value are primarily determined based on a discounted cash flow model. Growth rates for sales and profits are determined using inputs from the Company’s annual long-range planning process. The Company also makes estimates of discount rates, perpetuity growth assumptions, market comparables, and other factors. The Company completed its most recent goodwill impairment assessment during the third quarter and monitored for any potential impairment during the remainder of 2013. No impairment of goodwill was required in 2013, 2012 or 2011.
	The Company evaluates the useful lives of its other intangible assets to determine if they are finite or indefinite-lived. Reaching a determination on useful life requires significant judgments and assumptions regarding the future effects of obsolescence, demand, competition, other economic factors (such as the stability of the industry, known technological advances, legislative action that results in an uncertain or changing regulatory environment, and expected changes in distribution channels), the level of required maintenance expenditures, and the expected lives of other related groups of assets. Intangible assets that are deemed to have definite lives are amortized on a straight-line basis, over their useful lives.
	The Company’s indefinite-lived intangible assets are also tested for impairment annually and whenever events or changes in circumstances indicate that their carrying value may not be recoverable. Estimates of the fair value of indefinite-lived intangible assets is based on a discounted cash flow model using inputs which included projected revenues from the Company’s annual long-range plan, assumed royalty rates that could be payable if MJN did not own the brands, and a discount rate. The Company completed its most recent indefinite-lived intangible asset impairment assessment during the third quarter and monitored for any potential impairment during the remainder of 2013, determining that no impairment was required.
	Contingencies—In the ordinary course of business, the Company is subject to loss contingencies, such as lawsuits, investigations, government inquiries and claims, including, but not limited to, product liability claims, advertising disputes and inquiries, consumer fraud suits, other commercial disputes, premises claims and employment and environmental, health, and safety matters. The Company records accruals for such loss contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated. The Company does not recognize gain contingencies until realized. Legal costs are expensed as incurred.
	Derivatives—Derivatives are used by the Company principally in the management of its foreign currency, interest rate and commodity pricing exposures. The Company records all derivatives on the balance sheet at fair value. The Company does not hold or issue derivatives for speculative purposes.
	The Company designates and assigns derivatives as hedges of forecasted transactions, specific assets or specific liabilities. When the hedged assets or liabilities are sold, extinguished or the forecasted transactions being hedged are no longer expected to occur, the Company immediately recognizes the gain or loss on the designated hedging financial instruments in the consolidated statements of earnings.
	If derivatives are designated as a cash flow hedge, the effective portion of changes in the fair value is temporarily reported in accumulated other comprehensive loss and is recognized in earnings when the hedged item affects earnings or is deemed ineffective; cash flows are classified consistent with the underlying hedged item. The Company assesses hedge effectiveness at inception and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of the change in fair value is included in current period earnings. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date, or 60 days thereafter, or when the hedge is no longer effective.
	If derivatives are designated as a fair value hedge, both the changes in the fair value of the derivatives and of the hedged item attributable to the hedged risk are recognized in the consolidated statements of earnings; cash flows are classified consistent with the underlying hedged item.
	Pension and Other Post-employment Benefits—The funded status of the Company’s defined benefit pension and other post-employment benefit plans is measured as the difference between the fair value of the plan assets and the benefit obligation. For the defined benefit plans, the benefit obligation is the projected benefit obligation; for any other defined benefit post-employment plans, the benefit obligation is the accumulated post-employment benefit obligation. The net over- or under-funded status is recognized separately as an asset or a liability on the balance sheet.
	During the first quarter of 2014, the Company changed its accounting principles for the recognition of actuarial gains and losses for all of its defined benefit pension and other post-employment benefit plans and the calculation of expected return on pension plan assets.  Historically, the Company recognized actuarial gains and losses as a component of accumulated other comprehensive loss in its Consolidated Balance Sheets and amortized them into the Consolidated Statements of Earnings over the average future service period of the active employees of these plans to the extent such gains and losses were outside of a corridor.  Starting in the first quarter of 2014, the Company elected to immediately recognize actuarial gains and losses in its Consolidated Statements of Earnings on the basis that it is preferable to accelerate the recognition of such gains and losses into earnings rather than to delay them over time.  Additionally, for purposes of calculating the expected return on pension plan assets, the Company previously used a calculated value for the market-related valuation of pension plan assets. With this change in accounting principle, the Company now uses the actual fair value of pension plan assets. These changes will improve transparency in operating results by immediately recognizing the effects of external conditions on plan obligations, investments and assumptions.
	Under these new accounting principles, actuarial gains and losses from these plans are recognized upon plan remeasurement in the fourth quarter of each year, or more frequently if a remeasurement occurs. The remaining components of net periodic benefit cost, primarily interest on projected benefit obligation and the expected return on pension plan assets, continue to be recorded on a quarterly basis. Actuarial gains and losses are recognized within Corporate and Other and the remaining components of net periodic benefit costs are recognized in the respective reportable segments.
	The Company has applied both of these accounting changes, immediate recognition of actuarial gains or losses and use of actual fair value to calculate expected return on pension plan assets, retrospectively to all periods presented.  The cumulative effect of these changes on additional-paid-in/(distributed) capital and retained earnings on the Company’s opening balance sheet as of January 1, 2011 was a decrease of $96.2 million and an increase of $3.5 million, respectively, with an offsetting adjustment to accumulated other comprehensive loss. The annual recognition of actuarial gains was $12.0 million on a pre-tax basis for the year ended December 31, 2013 and the recognition of actuarial losses was $58.9 million and $91.5 million on a pre-tax basis for the years ended December 31, 2012 and 2011, respectively. These changes had no impact on cash flows for any period presented.
	The following tables present the effects of retrospectively applying these accounting changes for the periods presented:
		as at December 31, 2013 and for the year then ended
	(in millions except per share data)	Previously Reported			Impact of Change			Recast
	Consolidated Statements of Earnings
	Cost of Products Sold	$	1,532.80		$	(4.3	)	$	1,528.50
	Selling, General and Administrative	918			(14.5		)	903.5
	Research and Development	102.4			(2.2		)	100.2
	Other Expenses – net	77.8			(29.3		)	48.5
	EARNINGS BEFORE INTEREST AND INCOME TAXES	924.6			50.3			974.9
	EARNINGS BEFORE INCOME TAXES	874			50.3			924.3
	Provision for Income Taxes	219.1			16			235.1
	NET EARNINGS	654.9			34.3			689.2
	NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	649.5			34.3			683.8
	Earnings per Share – Basic	3.2			0.17			3.37
	Earnings per Share – Diluted	3.19			0.17			3.36
	Consolidated Statements of Comprehensive Income
	Deferred Gains/(Losses) on Pension and Other Post-Employment Benefits	11.6			(12.7		)	(1.1		)
	Reclassification Adjustment for Losses Included in Net Earnings	37.5			(37.7		)	(0.2		)
	Tax Benefit/(Expense)	(16.1		)	16.1			—
	Consolidated Balance Sheets
	Additional Paid-in/(Distributed) Capital	(625.3		)	(96.2		)	(721.5		)
	Retained Earnings	1,470.40			(38.1		)	1,432.30
	Accumulated Other Comprehensive Loss	(203.5		)	134.3			(69.2		)
	Consolidated Statements of Cash Flows
	Deferred Income Tax	7			16			23
	Pension and Other Post-Employment Benefits Expense	43.1			(50.3		)	(7.2		)
		as at December 31, 2012 and for the year then ended
	(in millions except per share data)	Previously Reported			Impact of Change			Recast
	Consolidated Statements of Earnings
	Cost of Products Sold	$	1,485.30		$	18.5		$	1,503.80
	Selling, General and Administrative	877.8			26.7			904.5
	Research and Development	95.4			4.7			100.1
	Other Expenses – net	20			(15.2		)	4.8
	EARNINGS BEFORE INTEREST AND INCOME TAXES	870			(34.7		)	835.3
EARNINGS BEFORE INCOME TAXES	805			(34.7		)	770.3
Provision for Income Taxes	192.6			(10.6		)	182
NET EARNINGS	612.4			(24.1		)	588.3
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	604.5			(24.1		)	580.4
Earnings per Share – Basic	2.96			(0.12		)	2.84
Earnings per Share – Diluted	2.95			(0.12		)	2.83
Consolidated Statements of Comprehensive Income
Deferred Gains/(Losses) on Pension and Other Post-Employment Benefits	(58.5		)	58.5			—
Reclassification Adjustment for Losses Included in Net Earnings	23.8			(23.8		)	—
Tax Benefit/(Expense)	10.6			(10.6		)	—
Consolidated Balance Sheets
Additional Paid-in/(Distributed) Capital	(676.6		)	(96.2		)	(772.8		)
Retained Earnings	1,124.80			(72.4		)	1,052.40
Accumulated Other Comprehensive Loss	(187.0		)	168.6			(18.4		)
Consolidated Statements of Cash Flows
Deferred Income Tax	17.1			(10.6		)	6.5
Pension and Other Post-Employment Benefits Expense	27.9			34.7			62.6
	For the year ended December 31, 2011
(in millions except per share data)	Previously Reported			Impact of Change			Recast
Consolidated Statements of Earnings
Cost of Products Sold	$	1,362.30		$	28.7		$	1,391.00
Selling, General and Administrative	926.8			48.6			975.4
Research and Development	92.5			8.3			100.8
Other Expenses – net	19.6			(9.7		)	9.9
EARNINGS BEFORE INTEREST AND INCOME TAXES	774.1			(75.9		)	698.2
EARNINGS BEFORE INCOME TAXES	721.9			(75.9		)	646
Provision for Income Taxes	202.9			(24.1		)	178.8
NET EARNINGS	519			(51.8		)	467.2
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	508.5			(51.8		)	456.7
Earnings per Share – Basic	2.48			(0.25		)	2.23
Earnings per Share – Diluted	2.47			(0.25		)	2.22
Consolidated Statements of Comprehensive Income
Deferred Gains/(Losses) on Pension and Other Post-Employment Benefits	(90.7		)	90.7			—
Reclassification Adjustment for Losses Included in Net Earnings	14.6			(14.8		)	(0.2		)
Tax Benefit/(Expense)	24.1			(24.1		)	—
Consolidated Statements of Cash Flows
Deferred Income Tax	(33.3		)	(24.1		)	(57.4		)
Pension and Other Post-Employment Benefits Expense	19.1			75.9			95
Shipping and Handling Costs—The Company typically does not charge customers for shipping and handling costs. Shipping and handling costs, including warehousing expenses, were $119.1 million, $115.6 million, and $104.3 million in the years ended December 31, 2013, 2012, and 2011, respectively, and are included in selling, general and administrative expenses.
Advertising Costs—Advertising costs are expensed as incurred and were $226.7 million, $180.3 million, and $180.6 million in the years ended December 31, 2013, 2012, and 2011, respectively.
Research and Development—Research and development costs are expensed as incurred.
Foreign Currency Translation—The statements of earnings of the Company’s foreign subsidiaries whose functional currencies are other than the U.S. dollar are translated into U.S. dollars using average exchange rates for the period. The net assets of the Company’s foreign subsidiaries whose functional currencies are other than the U.S. dollar are translated into U.S. dollars using exchange rates as of the balance sheet date. The U.S. dollar effects that arise from translating the net assets of these subsidiaries at changing rates are recorded in the foreign currency translation adjustment account, which is included in accumulated other comprehensive income (loss).
Recently Adopted Accounting Standards—In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, requiring entities to provide information about the amounts reclassified out of accumulated other comprehensive income by component. For significant reclassifications related to net income, the ASU required disclosure in the consolidated statement of earnings or within the footnotes. For other amounts, the ASU required a cross-reference to other disclosures that provide additional detail about those amounts. This ASU did not change the current requirements for reporting the consolidated statement of earnings or other comprehensive income in the financial statements. The Company adopted the required financial reporting presentation effective January 1, 2013.
Recently Issued Accounting Standards—In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830), clarifying the applicable guidance for the release of the cumulative translation adjustment. ASU 2013-05 is effective for the Company in the period beginning January 1, 2014. The Company does not expect the adoption of this update to have a material impact on the consolidated financial statements.
In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or Tax Credit Carryforward Exists. ASU 2013-11 requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. ASU 2013-11 is effective for the Company in the period beginning January 1, 2014 and the Company does not anticipate that the adoption of this standard to have a material impact on its consolidated financial statements.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	EARNINGS PER SHARE
	The numerator for basic and diluted earnings per share is net earnings attributable to shareholders reduced by dividends and undistributed earnings attributable to unvested shares. The denominator for basic earnings per share is the weighted-average number of shares outstanding during the period. The denominator for diluted earnings per share is the weighted-average shares outstanding adjusted for the effect of dilutive stock options and performance share awards.
	The following table presents the calculation of basic and diluted earnings per share:
		Years Ended December 31,
	(In millions, except per share data)	2013			2012			2011
	Basic earnings per share:
	Weighted-average shares outstanding	202.4			203.6			204.3
	Net earnings attributable to shareholders	$	683.8		$	580.4		$	456.7
	Dividends and undistributed earnings attributable to unvested shares	(1.3		)	(1.3		)	(1.3		)
	Net earnings attributable to shareholders used for basic earnings per share calculation	$	682.5		$	579.1		$	455.4
	Net earnings attributable to shareholders per share	$	3.37		$	2.84		$	2.23
	Diluted earnings per share:
	Weighted-average shares outstanding	202.4			203.6			204.3
	Incremental shares outstanding assuming the exercise/vesting of dilutive stock options/performance shares	0.7			0.7			0.7
	Weighted-average shares — diluted	203.1			204.3			205
	Net earnings attributable to shareholders	$	683.8		$	580.4		$	456.7
	Dividends and undistributed earnings attributable to unvested shares	(1.3		)	(1.3		)	(1.3		)
	Net earnings attributable to shareholders used for diluted earnings per share calculation	$	682.5		$	579.1		$	455.4
	Net earnings attributable to shareholders per share	$	3.36		$	2.83		$	2.22
	Potential shares outstanding from all stock-based awards were 2.8 million, 2.7 million and 2.9 million as of December 31, 2013, 2012 and 2011, respectively, of which 2.1 million, 2.0 million and 2.2 million were not included in the diluted earnings per share calculation for the years ended December 31, 2013, 2012 and 2011, respectively.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	The components of earnings before income taxes were:
		Years Ended December 31,
	(In millions)	2013			2012				2011
	U.S.	$	141.9		$	105.9			$	85
	Non-U.S.	782.4			664.4				561
	Total	$	924.3		$	770.3			$	646
	The above amounts are categorized based on the applicable taxing authorities.
	The provision (benefit) for income taxes consisted of:
		Years Ended December 31,
	(In millions)	2013			2012				2011
	Current:
	U.S. federal	$	79.1		$	37.1			$	81.3
	U.S. states	2.4			(1.3		)		10.7
	Non-U.S.	130.6			139.7				144.2
	Total current income tax expense	212.1			175.5				236.2
	Deferred:
	U.S. federal	(6.4		)	7.9				(27.3		)
	U.S. states	1.9			(4.0		)		(6.2		)
	Non-U.S.	27.5			2.6				(23.9		)
	Total deferred income tax expense	23			6.5				(57.4		)
	Total	$	235.1		$	182			$	178.8
	Effective Tax Rate—MJN’s provision for income taxes in the years ended December 31, 2013, 2012 and 2011 was different from the amount computed by applying the statutory U.S. federal income tax rate to earnings before income taxes as a result of the following:
	(Dollars in millions)	2013						2012						2011
	U.S. statutory rate	$	323.5		35	%		$	269.6			35	%	$	226.1		35	%
	State and local taxes	1.3			0.1			0.8				0.1		3.7			0.6
	Foreign income taxed at different rates	(25.6		)	(2.8	)		(67.7		)		(8.8	)	(42.1		)	(6.5	)
	Repatriation of foreign income	9.4			1			21.6				2.8		21.8			3.4
	Tax rulings and agreements	(121.9		)	(13.2	)		(46.4		)		(6.0	)	(51.9		)	(8.0	)
	Reversal of deferred tax on prior years' unremitted foreign earnings due to a permanent reinvestment assertion	(8.2		)	(0.9	)		(8.7		)		(1.1	)	—			—
	Administrative penalty related to China antitrust review	8.3			0.9			—				—		—			—
	Unrecognized tax benefits and related interest/penalties	38.1			4.1			13.1				1.7		7.3			1.1
	Other	10.2			1.2			(0.3		)		(0.1	)	13.9			2.1
	Total provision / effective tax rate	$	235.1		25.4	%		$	182			23.6	%	$	178.8		27.7	%
	The Company negotiated a tax ruling effective from January 1, 2010, under which certain profits in the Netherlands are exempt from taxation through the year ending December 31, 2019. This ruling was superseded by a subsequent tax agreement effective July 26, 2012, whereby the Company and the Dutch tax authorities agreed to the appropriate remuneration attributable to Dutch manufacturing activities through the year ending December 31, 2019.
	In addition, the Company negotiated a tax ruling effective from January 1, 2013, under which certain profits in Singapore are eligible for favorable taxation through the year ending December 31, 2027.
	Deferred Taxes and Valuation Allowance—The components of current and noncurrent deferred income tax assets (liabilities) were:
		December 31,
	(In millions)	2013			2012
	Deferred tax assets:
	Accrued expenses	$	33.5		$	28
	Accrued rebates and returns	42.2			44.5
	Pension, post-retirement and post employment liabilities	58.1			65.3
	Stock-based compensation	20.2			18.3
	Obsolescence reserves and other inventory items	7.9			6.3
	Net operating loss carryforwards	13.5			17.2
	Other—net	6.7			23.2
	Valuation allowance	(7.3		)	(6.1		)
	Total deferred tax assets	174.8			196.7
	Deferred tax liabilities:
	Depreciation and amortization	(68.5		)	(76.5		)
	Unremitted earnings and cumulative foreign currency translation adjustments	(9.7		)	(26.1		)
	Total deferred tax liabilities	(78.2		)	(102.6		)
	Deferred tax assets—net	$	96.6		$	94.1
	Recognized as:
	Net deferred income taxes—current	74.9			85.5
	Net deferred income taxes—noncurrent	21.7			8.6
	Total	$	96.6		$	94.1
	As of December 31, 2013, the Company had definite-lived and indefinite-lived gross foreign net operating loss (“NOL”) carryforwards of $49.0 million. Indefinite-lived NOL carryforwards totaled $22.3 million with the remainder being definite-lived. An immaterial amount of these definite-lived NOL carryforwards will begin to expire in 2014, with the remainder of the definite-lived NOL carryforwards to expire no later than 2031. The valuation allowance recorded for NOL carryforwards is $5.0 million as of December 31, 2013.
	As of December 31, 2013, the Company had various definite-lived U.S. state tax credit carryforwards of $6.9 million net of federal benefit. An immaterial amount of these state tax credit carryforwards will begin to expire in 2016, with the remainder of the state tax credit carryforwards to expire no later than 2023. The valuation allowance recorded for state tax credit carryforwards is $2.3 million, net of federal benefit as of December 31, 2013.
	Income taxes paid net of refunds were $159.3 million, $226.8 million, and $174.3 million in the years ended December 31, 2013, 2012, and 2011, respectively. The income taxes were paid to federal, state and foreign taxing authorities and BMS pursuant to the terms of the Amended and Restated Tax Matters Agreement.
	As of December 31, 2013, U.S. taxes have not been provided on approximately $1.4 billion of foreign earnings as these undistributed earnings have been permanently invested offshore. If, in the future, these earnings were to be repatriated to the U.S. additional tax provisions would be required. It is impracticable to determine a precise estimate of the additional provision required. However, the maximum potential estimated U.S. tax liability would be $494 million if these earnings were to be repatriated to the United States in such a manner that the entire amount of foreign earnings would be subject to the U.S. statutory tax rate with no U.S. tax relief for foreign taxes already paid.  However, the Company has no plans to repatriate these foreign earnings.
	The Company’s tax returns are routinely audited by federal, state and foreign tax authorities and these tax audits are at various stages of completion at any given time. The Internal Revenue Service (“IRS”) has completed examinations of the Company’s U.S. income tax filings through December 31, 2007. At December 31, 2013, the Company’s 2011 income tax return was under IRS examination. At December 31, 2013, tax years remaining open to examination outside the U.S. include 2003 and forward.
A reconciliation of the Company’s changes in gross uncertain tax positions is as follows:
	Years Ended
	December 31,
(In millions)	2013			2012				2011
Balance at January 1:	$	64.7		$	29.7			$	13.6
Increases based on current year tax positions	23.8			17.8				14.6
Decreases based on current year tax positions	—			—				—
Increases based on prior year tax positions	18.9			21.4				1.7
Decreases based on prior year tax positions	—			—				(0.3		)
Settlements	—			—				(0.1		)
Lapse of statute of limitations	(3.8		)	(5.2		)		—
Cumulative translation adjustment	(1.0		)	1				0.2
Balance at December 31:	$	102.6		$	64.7			$	29.7
Uncertain tax positions have been recorded as part of other liabilities with a reversal of up to $10 million reasonably possible in the next 12 months due to the expiration of statutes of limitations. The amounts of uncertain tax positions that, if recognized, would impact the effective tax rate were $48.6 million, $18.9 million, and $10.9 million as of December 31, 2013, 2012 and 2011, respectively. The Company believes that it has provided adequately for all uncertain tax positions. It is reasonably possible that new issues may be raised by tax authorities and that these issues may require increases in the balance of uncertain tax positions.
Interest and penalties related to uncertain tax positions were $14.8 million and $11.2 million, as of December 31, 2013, and 2012, respectively, and are included as a component of other liabilities. The Company classifies interest and penalties related to uncertain tax positions as a component of provision for income taxes. The amount of interest and penalties included as a component of provision for income taxes was $3.0 million, $5.0 million and $0.6 million for the years ended December 31, 2013, 2012 and 2011, respectively.
On December 18, 2009, the Company and Bristol-Myers Squibb Company (“BMS”) entered into an Amended and Restated Tax Matters Agreement in anticipation of the separation from BMS. Under the Amended and Restated Tax Matters Agreement, BMS agreed to indemnify the Company for (i) any tax attributable to a MJN legal entity for any taxable period ending on or before December 31, 2008, (ii) any tax arising solely as a result of MJN’s 2009 initial public offering (“IPO”) and the restructuring preceding the IPO, and (iii) any transaction tax associated with the separation transaction. The Company agreed to indemnify BMS for (i) any tax payable with respect to any separate return that the Company is required to file or cause to be filed, (ii) any tax incurred as a result of any gain which may be recognized by a member of the BMS affiliated group with respect to a transfer of certain foreign affiliates by the Company in preparation for the IPO, and (iii) any tax arising from the failure or breach of any representation or covenant made by the Company which failure or breach results in the intended tax consequences of the separation transaction not being achieved. Additionally, under the Amended and Restated Tax Matters Agreement, the Company continues to maintain responsibility for any tax positions which may exist for any taxable period ending after December 31, 2008.

SEGMENT_INFORMATION

SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
SEGMENT INFORMATION	'
	SEGMENT INFORMATION
	MJN operates in four geographic operating segments: Asia, Europe, Latin America and North America. In the fourth quarter of 2013, the Company revised its reportable segments. Previously the Company presented two reportable segments: Asia/Latin America and North America/Europe. In the fourth quarter of 2013, the Company expanded the number of reportable segments to three as it separated the Asia/Latin America segment into two reportable segments: Asia and Latin America. The North America/Europe reportable segment remains unchanged. This change in segment reporting presentation does not change any consolidated totals. The Company made this segment reporting change because it believes that the new presentation will provide investors with greater insight into the Company's consolidated results and operating performance. Prior year comparative information has been revised to conform to the current reportable segment presentation.
	Corporate and Other consists of net actuarial gains and losses related to defined benefit pension and other post-employment benefit plans; unallocated general and administrative expenses; global business support activities, including research and development, marketing, and supply chain costs; and income or expenses incurred within the operating segments that are not reflective of ongoing operations and affect the comparability of the operating segments’ results. The Company’s products are sold principally to wholesalers, retailers and distributors. One customer in the North America/Europe and Latin America segments accounted for 10%, 11% and 12% of the Company’s gross sales for each year ended December 31, 2013, 2012, and 2011; a second customer in the Asia segment accounted for 16%, 15%, and 14% of the Company’s gross sales for the years ended December 31, 2013, 2012, and 2011, respectively.
	The Company's segment, product and geographic results consisted of:
	(In millions)	Net Sales		Earnings			Year-End		Payments for				Depreciation
				Before			Assets		Capital				and
				Interest and					Expenditures				Amortization
				Income Taxes
	Year ended December 31, 2013
	Asia	$	2,179.30	$	796.2		$	1,390.70	$	168.1			$	19.4
	Latin America	861.4		207.2			716.9		33.3				10.5
	North America/Europe	1,160.00		255			798.5		31.6				29.1
	Total operating segments	4,200.70		1,258.40			2,906.10		233				59
	Corporate and Other	—		(283.5		)	568		7.4				24.1
	Total	$	4,200.70	$	974.9		$	3,474.10	$	240.4			$	83.1
	Year ended December 31, 2012
	Asia	$	1,967.00	$	725.4		$	1,097.30	$	87.4			$	16.9
	Latin America	752.5		177.2			712.8		10.7				8.9
	North America/Europe	1,181.80		251.9			740.5		22.3				27.4
	Total operating segments	3,901.30		1,154.50			2,550.60		120.4				53.2
	Corporate and Other	—		(319.2		)	707.6		4				23.7
	Total	$	3,901.30	$	835.3		$	3,258.20	$	124.4			$	76.9
	Year ended December 31, 2011
	Asia	$	1,827.80	$	672.5		$	1,008.60	$	34			$	17.2
	Latin America	619.4		139.2			467.4		12				7.6
	North America/Europe	1,229.80		312.7			764		33.4				30.7
	Total operating segments	3,677.00		1,124.40			2,240.00		79.4				55.5
	Corporate and Other	—		(426.2		)	526.8		30.1				19.8
	Total	$	3,677.00	$	698.2		$	2,766.80	$	109.5			$	75.3
	Net Sales (in millions)	Infant		Children’s			Other		Total
		Formula		Nutrition
	Year ended December 31, 2013	$	2,459.70	$	1,653.30		$	87.7	$	4,200.70
	Year ended December 31, 2012	$	2,295.50	$	1,487.00		$	118.8	$	3,901.30
	Year ended December 31, 2011	$	2,188.70	$	1,394.40		$	93.9	$	3,677.00
	Geographic (in millions)	United		China/			Mexico		Singapore		Other				Total
		States		Hong Kong
	Year ended December 31, 2013
	Net Sales	$	948.2	$	1,315.80		$	328.2	28		$	1,580.50			$	4,200.70
	Long-Lived Assets	446.6		64.7			134.8		245.9		427				1,319.00
	Year ended December 31, 2012
	Net Sales	$	990.1	$	1,160.10		$	317.2	22.5		$	1,411.40			$	3,901.30
	Long-Lived Assets	456		65.1			180.1		104.9		437.1				1,243.20
	Year ended December 31, 2011
	Net Sales	$	1,019.70	$	1,083.50		$	321	20.8		$	1,232.00			$	3,677.00
	Long-Lived Assets	457.3		60.7			171.6		1.3		169.7				860.6

EMPLOYEE_STOCK_BENEFIT_PLANS

EMPLOYEE STOCK BENEFIT PLANS	12 Months Ended
	Dec. 31, 2013
EMPLOYEE STOCK BENEFIT PLANS [Abstract]	'
EMPLOYEE STOCK BENEFIT PLANS	'
	EMPLOYEE STOCK BENEFIT PLANS
	MJN 2009 Stock Award and Incentive Plan—The MJN 2009 Amended and Restated Stock Award and Incentive Plan (“Award and Incentive Plan”) provides for the grant of stock options, performance share awards, restricted stock units and other stock-based awards. Executive officers and other key employees of MJN, and non-employee directors and others who provide substantial services to MJN, are eligible to be granted awards under the Award and Incentive Plan. Twenty-five million shares of stock were approved and registered with the Securities and Exchange Commission (the “SEC”) for grants to participants under the Award and Incentive Plan. Shares used for awards assumed in an acquisition or combination will not count against the shares reserved under the Award and Incentive Plan. The shares reserved may be used for any type of award under the Award and Incentive Plan. Stock-based compensation expense is based on awards ultimately expected to vest. Forfeitures are estimated based on the historical experience of participants in the Award and Incentive Plan since its inception in February of 2009.
	MJN may grant options to purchase common stock at no less than 100% of the closing market price on the date the option is granted. Stock options generally become exercisable in installments of either 25% per year on each of the first through the fourth anniversaries of the grant date or 33% per year on each of the first through the third anniversaries of the grant date. Stock options have a maximum term of 10 years. Generally, MJN will issue shares for the stock option exercises from treasury stock, if available, or will issue new shares.
	MJN may also grant performance share awards, which are granted in the form of a target number of performance shares to be earned and have a three-year performance cycle consisting of three one-year performance periods. The performance share awards have annual goals set at the beginning of each performance period, at which time the awards are considered granted. The maximum payout is 200%. If targets are not met for a performance period, no payment is made under the plan for that annual period.
	MJN may also grant restricted stock units under the Award and Incentive Plan. Restrictions generally expire over a 1- to 5-year period from the date of grant. Stock-based compensation expense is recognized over the restricted period. A restricted stock unit is a right to receive stock at the end of the specified vesting period. A restricted stock unit has non-forfeitable rights to dividend equivalent payments and has no voting rights.
	MJN Stock Options—The fair value of stock options granted in 2013, 2012, and 2011 was estimated on the date of grant using the Black-Scholes option pricing model. No stock options with market conditions were granted in 2013, 2012 or 2011. The following assumptions were used in the valuations:
			2013			2012			2011
			Black-Scholes			Black-Scholes			Black-Scholes
			Model			Model			Model
	Expected volatility		27	%		26.9	%		26.7	%
	Risk-free interest rate		0.9	%		1.2	%		2.6	%
	Dividend yield		1.9	%		1.6	%		1.7	%
	Expected life		5.3 years			6.0 years			6.0 years
	The 2013 and 2012 expected volatility assumption required in the Black-Scholes model was calculated based principally on the Company’s historical volatility, and to a lesser extent, on implied volatility from publicly-traded options on the Company’s stock. As MJN has not yet accumulated six years of historical stock trading data, the full history of MJN over the period of February 2009 through December 2013 is used to calculate the expected volatility assumption required in the Black-Scholes model. The 2011 expected volatility assumption required in the Black-Scholes model was calculated based on an equal weighting between the Company’s historical volatility and implied volatility from publicly-traded options on the Company’s stock.
	The risk-free interest rate assumption in the Black-Scholes model is based upon the U.S. Treasury yield curve in effect at the time of grant. The dividend yield assumption is based on MJN’s expectation of dividend payouts. The expected life is based on the vesting period and the contractual term for each grant, or for each vesting tranche for awards with graded vesting. The selection of this approach was based on MJN’s assessment that this simplified method is appropriate given the terms of the stock option granted and given that there is not sufficient historical stock option exercise experience upon which to estimate expected terms.
	Stock option activities were as follows:
		Shares		Weighted				Average		Aggregate
		(in thousands)		Average				Remaining		Intrinsic
				Exercise				Contractual		Value
				Price of				Term		(in millions)
				Shares				(in years)
	Balance—January 1, 2011	1,404		$	34.36			8.6		$	48.2
	Granted	558		59.18
	Exercised	-140		31.65						$	5.2
	Forfeited or expired	-33		45.03
	Balance—December 31, 2011	1,789		42.12				8.1		$	47.6
	Granted	491		78.12
	Exercised	-325		35.6						$	11.6
	Forfeited or expired	-53		57.5
	Balance—December 31, 2012	1,902		52.11				7.7		$	99.2
	Granted	485		74.76
	Exercised	-377		36.06						$	17.6
	Forfeited or expired	-51		73.57
	Balance—December 31, 2013	1,959		60.12				7.4		$	46.3
	Vested—December 31, 2013	1,119		50.24				6.5		$	37.5
	Vested and expected to vest—December 31, 2013	1,940		59.98				7.4		$	46.1
	The weighted-average grant date fair value of stock options granted is $15.08, $17.55 and $14.73 for 2013, 2012 and 2011 respectively.
	Cash proceeds received from options exercised during the years ended December 31, 2013, 2012 and 2011 were $13.6 million, $11.6 million and $4.5 million, respectively. The tax benefit realized from stock options exercised was $5.9 million in 2013, $4.8 million in 2012 and $1.8 million in 2011.
	At December 31, 2013, total unrecognized compensation cost related to stock options of $7.4 million is expected to be recognized over a weighted average period of 1.8 years.
	MJN Performance Share Awards—The fair value of performance share awards is based on the closing trading price of MJN’s stock on the date of the grant, discounted using the risk-free interest rate as the awards do not participate in dividends. Information related to performance share awards activity is summarized as follows:
	Grant Date		Performance Cycle		Shares Granted		Weighted-				Performance
			Measurement Date		and Earned		Average Grant-				Shares
					(in thousands)		Date Fair				Outstanding at
							Value				December 31, 2013
	27-Feb-13		Annually on 12/31		203		$	72.3			143
	March 2, 2012		Annually on 12/31		418		$	67.22			197
	March 2, 2011		Annually on 12/31		275		$	57.03			79
	Shares granted and earned in the table above assumes 100% plan performance adjusted for the actual plan achievement level for completed performance periods. At December 31, 2013, total unrecognized compensation cost related to the performance share awards granted of $6.5 million is expected to be recognized over a weighted average period of 1.5 years.
	MJN Restricted Stock Units—The fair value of restricted stock units is determined based on the closing trading price of MJN’s common stock on the grant date. A summary of restricted stock unit activity is as follows:
		Shares			Weighted-
		(in thousands)			Average Grant
					Date Fair
					Value
	Nonvested restricted stock units—January 1, 2011	588			$	35.15
	Granted	134			59.4
	Vested	(170	)		44.44
	Forfeited	(19	)		40.39
	Nonvested restricted stock units—December 31, 2011	533			38.09
	Granted	146			76.98
	Vested	(146	)		32.28
	Forfeited	(19	)		47.57
	Nonvested restricted stock units—December 31, 2012	514			50.24
	Granted	133			74.85
Vested	(189	)		39.14
Forfeited	(35	)		62.68
Nonvested restricted stock units—December 31, 2013	423			61.59
At December 31, 2013, total unrecognized compensation cost related to nonvested restricted stock units was $12.8 million and is expected to be recognized over a weighted average period of 2.5 years.
Stock-Based Compensation Expense—The following table summarizes stock-based compensation expense related to MJN stock options, MJN performance share awards and MJN restricted stock units for the years ended December 31, 2013, 2012, and 2011:
	Years Ended December 31,
(In millions)	2013				2012				2011
Stock options	$	6.5			$	7.5			$	5.9
Performance share awards	16.1				16.1				22.8
Restricted stock units	10				8.6				11.2
Total pre-tax stock-based compensation expense	$	32.6			$	32.2			$	39.9
Net tax benefit related to stock-based compensation expense	$	(11.4	)		$	(9.8	)		$	(14.1	)
Stock-based compensation expense was recognized in the consolidated statements of earnings as follows:
	Years Ended December 31,
(Dollars in millions)	2013				2012				2011
Cost of products sold	$	3			$	3			$	4
Selling, general and administrative	26.6				26.2				31.9
Research and development	3				3				4
Total stock-based compensation expense	$	32.6			$	32.2			$	39.9
There were no costs related to stock-based compensation that were capitalized.

PENSION_AND_OTHER_POSTEMPLOYME

PENSION AND OTHER POST-EMPLOYMENT BENEFIT PLANS	12 Months Ended
	Dec. 31, 2013
General Discussion of Pension and Other Postretirement Benefits [Abstract]	'
PENSION AND OTHER POST RETIREMENT BENEFIT PLANS	'
	EMPLOYEE BENEFITS
	Pension and Other Post-Employment Benefits
	During the first quarter of 2014, the Company changed its accounting principles for the recognition of actuarial gains and losses for all of its defined benefit pension and other post-employment benefit plans and the calculation of expected return on pension plan assets.  Historically, the Company recognized actuarial gains and losses as a component of accumulated other comprehensive loss in its Consolidated Balance Sheets and amortized them into the Consolidated Statements of Earnings over the average future service period of the active employees of these plans to the extent such gains and losses were outside of a corridor.  Starting in the first quarter of 2014, the Company elected to immediately recognize actuarial gains and losses in its Consolidated Statements of Earnings on the basis that it is preferable to accelerate the recognition of such gains and losses into earnings rather than to delay them over time.  Additionally, for purposes of calculating the expected return on pension plan assets, the Company previously used a calculated value for the market-related valuation of pension plan assets. With this change in accounting principle, the Company now uses the actual fair value of pension plan assets. These changes will improve transparency in operating results by immediately recognizing the effects of external conditions on plan obligations, investments and assumptions.
	Under these new accounting principles, actuarial gains and losses from these plans are recognized upon plan remeasurement in the fourth quarter of each year, or more frequently if a remeasurement occurs. The Company has applied these changes retrospectively, adjusting the comparative periods presented (see Note 2 for discussion of the change in accounting principles).
	Pension—The principal pension plan is the Mead Johnson & Company Retirement Plan in the United States (U.S. Pension Plan) which represents approximately 75% of the Company’s total pension assets and obligations. The benefits of this plan are frozen as of February 9, 2014 and benefits are no longer accrued for service.
	Other post-employment benefits—The Company also provides comprehensive medical and group life benefits for substantially all U.S. and Canadian retirees who elect to participate in its comprehensive medical and group life plans. The retiree medical plan is contributory and participation is limited to those employees who participate in the U.S. Pension Plan. Contributions are adjusted periodically and vary by date of retirement. The retiree life insurance plan is non-contributory.
	Changes in benefit obligations, plan assets, funded status and amounts recognized in the balance sheet were as follows:
		Pension Benefits								Other Benefits
	(In millions)	2013				2012				2013			2012
	Beginning benefit obligations	$	463.6			$	402.7			$	35.1		$	30.2
	Service cost—benefits earned during the year	5.2				3.9				1.1			1
	Interest cost on projected benefit obligations	14.4				15.6				1.3			1.3
	Actuarial assumptions (gains) losses	(25.7		)		72.2				(3.8		)	2.6
	Settlements and curtailments	(50.4		)		(30.9		)		—			—
	Benefits paid	(2.8		)		(2.2		)		(1.3		)	(0.1		)
	Exchange rate changes	(0.3		)		2.3				0.2			0.1
	Benefit obligations at end of year	$	404			$	463.6			$	32.6		$	35.1
	Beginning fair value of plan assets	$	312.1			$	280.7			$	—		$	—
	Actual return on plan assets	(1.4		)		32.8				—			—
	Employer contributions	18.5				28.2				0.9			0.1
	Settlements	(50.4		)		(29.3		)		—			—
	Benefits paid	(2.8		)		(2.2		)		(1.3		)	(0.1		)
	Exchange rate changes	0.1				1.9				0.4			—
	Fair value of plan assets at end of year	$	276.1			$	312.1			$	—		$	—
	Underfunded status at end of year	$	(127.9	)		$	(151.5	)		$	(32.6	)	$	(35.1	)
	Amounts in the consolidated balance sheets include:
	Other assets	$	1.3			$	2.2			$	—		$	—
	Pension, post-retirement and post employment liabilities	(129.2		)		(153.7		)		(32.6		)	(35.1		)
	Balance in the consolidated balance sheet at end of year	$	(127.9	)		$	(151.5	)		$	(32.6	)	$	(35.1	)
	Amounts in accumulated other comprehensive loss include:
	Prior service (benefit)	1.2				—				(0.3		)	(0.5		)
	Transition obligation	0.1				0.2				—			—
	Balance in accumulated other comprehensive loss at end of year	$	1.3			$	0.2			$	(0.3	)	$	(0.5	)
	Accumulated benefit obligation	$	375.7			$	428			$	32.6		$	35.1
	The Company’s defined benefit pension and other post-employment benefit plans with an accumulated benefit obligation in excess of plan assets were as follows:
		Years Ended
		December 31,
	(In millions)	2013				2012
	Projected benefit obligation	$	366.3			$	449.3
	Accumulated benefit obligation	356.1				430.2
	Fair value of pension plan assets	210.8				263.1
	The net periodic benefit cost of the Company’s defined benefit pension and other post-employment benefit plans includes:
		Pension Benefits											Other Benefits
		Years Ended											Years Ended
		December 31,											December 31,
	(In millions)	2013				2012				2011			2013				2012			2011
	Service cost — benefits earned during the period	$	5.2			$	3.9			$	3.5		$	1.1			$	1		$	0.9
	Interest cost on projected benefit obligations	14.4				15.6				17			1.3				1.3			1.3
	Expected return on pension plan assets	$	(17.1	)		$	(16.6	)		$	(19.1	)	$	—			$	—		$	—
	Amortization of prior service (benefit)	—				—				—			(0.2		)		(0.2		)	(0.2		)
	Amortization of transition cost	0.1				0.1				0.1			—				—			—
	Sub-total	$	2.6			$	3			$	1.5		$	2.2			$	2.1		$	2
	Net actuarial (gains) losses	(8.2		)		56.3				87.5			(3.8		)		2.6			4
	Curtailments	—				(1.4		)		—			—				—			—
	Total Pension and Other Post-Employment Benefit costs:	$	(5.6	)		$	57.9			$	89		$	(1.6	)		$	4.7		$	6
	The estimated prior service and transition costs that will be amortized from accumulated other comprehensive loss into net periodic benefit cost in 2014 are not material.
	Actuarial assumptions
	Weighted-average assumptions used to determine benefit obligations are established as of the balance sheet date and were as follows:
		Pension Benefits						Other Benefits
		December 31,						December 31,
		2013			2012			2013			2012
	Discount rate	4.08	%		3.21	%		4.98	%		3.75	%
	Rate of compensation increase	3.22	%		3.58	%		3.08	%		3.48	%
The discount rate was determined based on the yield to maturity of high-quality corporate bonds and considering the duration of the pension plan obligations. The Citigroup Pension Discount Curve is used in developing the discount rate for the U.S. Pension Plan.
Weighted-average assumptions used to determine net periodic benefit cost are established at the beginning of the plan year and were as follows:
	Pension Benefits									Other Benefits
	Years Ended									Years Ended
	December 31,									December 31,
	2013			2012			2011			2013		2012			2011
Discount rate	3.26	%		4.03	%		5.59	%		3.75	%	4.29	%		5.28	%
Expected long term return on pension plan assets	5.22	%		5.65	%		6.91	%		—	%	—	%		—	%
Rate of compensation increase	3.59	%		4	%		4.02	%		3.48	%	3.94	%		3.94	%
The yield on high-quality corporate bonds that matches the duration of the benefit obligations was used in determining the discount rate. The Citigroup Pension Discount Curve is used in developing the discount rate for the U.S. plans. The expected long-term return on plan assets was determined based on the target asset allocation, expected rate of return by each asset class, and estimated future inflation.
For the U.S. Pension Plan, the expected long-term return on plan assets assumption to be used to determine net periodic benefit cost for the year ending December 31, 2014 is 7.00%. The expected long-term return on plan assets was determined based on the Company’s target asset allocation, expected rate of return by each asset class, and estimated future inflation. The Company anticipates moving towards an asset mix that is more heavily focused on equity securities in 2014. Any difference between the expected rate of return and actual returns will be included with actuarial gains or losses recorded during the fourth quarter.
Assumed health care cost trend rates were as follows:
	December 31,
	2013			2012			2011
Health care cost trend rate assumed for next year	6.9	%		7.8	%		7.4	%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	4.9	%		4.9	%		5	%
Year that the rate reaches the ultimate trend rate	2023			2023			2017
Assumed health care cost trend rates affect the amounts reported for the retiree medical plans. A one-percentage-point change in assumed health care cost trend rates would have the following effects:
(In millions)	1-Percentage-Point				1-Percentage-Point
	Increase				Decrease
Effect on total of service and interest cost	$	—			$	—
Increase/(decrease) in post-employment benefit obligation	0.2				0.3
Pension Plan assets
The Company’s investment strategy for the U.S. Pension Plan assets consists of a mix of equities and fixed income in order to achieve returns over a market cycle which reduces contribution and expense at an acceptable level of risk. The target asset allocation as of December 31, 2013 was 40% public equity and 60% fixed income. Cash flow (i.e., cash contributions, benefit payments) was used to rebalance back to the targets as necessary. Investments are well diversified within each of the two major asset categories. All of the U.S. equity investments are actively managed. Investment strategies for international pension plans are typically similar, although the asset allocations are usually more conservative.
The fair values of the Company’s pension plan assets by asset category were as follows:
	December 31, 2013											December 31, 2012
(In millions)	Total				Level 1				Level 2			Total				Level 1			Level 2
Cash and cash equivalents	$	13			$	13			$	—		$	11.4			$	11.4		$	—
Equity securities:
U.S. large-cap	16.3				—				16.3			13.6				—			13.6
U.S. mid-cap growth	3.1				—				3.1			2.8				—			2.8
U.S. small-cap growth	0.1				—				0.1			1.5				—			1.5
Emerging markets	2.8				—				2.8			3.1				—			3.1
Real estate investment trusts	5.6				—				5.6			13.4				—			13.4
International large-cap value	37				8.5				28.5			28.3				—			28.3
Hedge fund	17.4				—				17.4			15.7				—			15.7
Fixed income securities:
Government bonds	72.8				—				72.8			83.5				—			83.5
Corporate bonds	101.7				—				101.7			138.8				—			138.8
Emerging markets	6.3				—				6.3			—				—			—
Total	$	276.1			$	21.5			$	254.6		$	312.1			$	11.4		$	300.7
Level 1 cash and cash equivalents, which excluded money market funds, are recorded at closing prices in active markets. Level 2 money market, equity, and fixed income funds are recorded at the net asset values per share, which were determined based on quoted market prices of the underlying assets contained within the funds. The Level 2 hedge fund is recorded at the net asset value per share, which was derived from the underlying funds’ net asset values per share; this diversified hedge fund may be redeemed quarterly with 60 days notice.
Contributions
In 2014, the funding policy for the pension plans is to contribute amounts to provide for current service and to fund past service liability. MJN contributed $18.5 million, $28.2 million and $9.5 million to the pension plans in 2013, 2012 and 2011, respectively. The Company is not required to make any contributions to its pension plans in 2014 and does not foresee making a discretionary contribution. There will be no cash funding for other post-employment benefits in 2014, except funding to cover benefit payments.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid:
(In millions)	Pension				Other
	Benefits				Benefits
2014	$	29.3			$	0.8
2015	29.5				1
2016	29.5				1.1
2017	30.8				1.1
2018	29.7				1.3
Years 2019 - 2023	147.8				6.5
Defined Contribution Benefits
Employees who meet certain eligibility requirements may participate in various defined contribution plans. Total cost recognized for all defined contribution benefit plans were $19.9 million, $21.3 million and $19.3 million for the years ended December 31, 2013, 2012, and 2011, respectively.

REDEEMABLE_NONCONTROLLING_INTE

REDEEMABLE NONCONTROLLING INTEREST (Notes)	12 Months Ended
	Dec. 31, 2013
Business Acquisition [Line Items]	'
Business Combination Disclosure [Text Block]	'
	REDEEMABLE NONCONTROLLING INTEREST
	On March 15, 2012, the Company acquired 80% of the outstanding capital stock of Nutricion para el Conosur S.A. which manufactures, distributes and sells infant formula and children’s nutrition products in Argentina under the SanCor Bebé and Bebé Plus brands (the “Argentine Acquisition”). Under the terms of an agreement related to the Argentine Acquisition, the noncontrolling interest owner has the right to require MJN to purchase (the “Put Right”) its remaining 20% interest or to sell (the “Call Right”) up to an additional 20% of the outstanding capital stock of Nutricion para el Conosur S.A. The Put Right is exercisable from September 15, 2015 to September 15, 2018 and the decision to exercise is not within the control of MJN. The price paid upon exercise will be determined based on established multiples of sales and earnings of the acquired business and is currently estimated to equate to fair value at the earliest exercise date. As a result of the Put Right, the noncontrolling interest is presented as redeemable noncontrolling interest outside of equity on the balance sheet. Accretion to the redemption value of the Put Right is being recognized through equity using an interest method over the period from March 15, 2012 to September 15, 2015.

NONCONTROLLING_INTERESTS

NONCONTROLLING INTERESTS	12 Months Ended
	Dec. 31, 2013
Noncontrolling Interest [Abstract]	'
NONCONTROLLING INTERESTS	'
	NONCONTROLLING INTERESTS
	Net earnings attributable to noncontrolling interests consists of approximately 20%, 11% and 10% interests held by third parties in operating entities in Argentina, China and Indonesia, respectively.

OTHER_EXPENSESNET

OTHER EXPENSES-NET	12 Months Ended
	Dec. 31, 2013
Other Income and Expenses [Abstract]	'
Other Expense/(Income)-Net	'
	OTHER EXPENSES—NET
	The components of other expenses—net were:
		Years Ended December 31,
	(In millions)	2013			2012			2011
	Foreign exchange (gains)/losses—net	$	9.3		$	(3.1	)	$	(9.7	)
	Administrative penalty (China)	33.4			—			—
	Severance and other costs	2.2			8			9.9
	Gain on sale of non-core intangible assets	—			(6.5		)	—
	Legal settlements	7			—			—
	Other—net	(3.4		)	6.4			9.7
	Other expenses—net	$	48.5		$	4.8		$	9.9

RECEIVABLES

RECEIVABLES	12 Months Ended
	Dec. 31, 2013
us gaap loans notes trade and other receivables disclosure text block [Abstract]	'
Receivables	'
	RECEIVABLES
	The major categories of receivables were as follows:
		December 31,
	(In millions)	2013			2012
	Trade receivables	$	335.7		$	330
	Miscellaneous receivables	55.2			42.2
	Less allowances	(6.5		)	(7.6		)
	Receivables—net	$	384.4		$	364.6

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
INVENTORIES	'
	INVENTORIES
	The major categories of inventories were as follows:
	(In millions)	December 31, 2013		December 31, 2012
	Finished goods	$	312.7	$	264.6
	Work in process	82.5		56.9
	Raw and packaging materials	139.6		114.4
	Inventories	$	534.8	$	435.9

LONG_LIVED_ASSETS

LONG LIVED ASSETS	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Long-lived Assets	'
	LONG-LIVED ASSETS
	Property, Plant, and Equipment
	The major categories of property, plant, and equipment were as follows:
	(In millions)	December 31, 2013			December 31, 2012
	Land	$	12.6		$	6
	Buildings	550.8			506
	Machinery, equipment, and fixtures	650.3			595.7
	Construction in progress	260.9			150.4
	Accumulated depreciation	(607.1		)	(568.2		)
	Property, plant, and equipment—net	$	867.5		$	689.9
	Depreciation expense was $63.7 million, $55.8 million and $57.2 million for the years ended December 31, 2013, 2012 and 2011, respectively, and is primarily included in costs of products sold. Interest capitalized during the year was $5.7 million, $0.6 million and $0.2 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	The Company’s liability for asset retirement obligations was $3.6 million and $3.3 million at December 31, 2013 and 2012.
	Other Intangible Assets
	The gross carrying value and accumulated amortization by class of intangible assets were as follows:
		As of December 31, 2013								As of December 31, 2012
	(In millions)	Gross			Accumulated			Net Book		Gross		Accumulated			Net Book
		Carrying			Amortization			Value		Carrying		Amortization			Value
		Amount								Amount
	Indefinite-lived intangible assets
	Trademark(1) .	$	34.5		$	—		$	34.5	$	45.3	$	—		$	45.3
	Non-compete agreement(1) .	6.8			—			6.8		8.9		—			8.9
	Total	41.3			—			41.3		54.2		—			54.2
	Amortizable intangible assets
	Computer software	132.8			(79.3		)	53.5		132.2		(60.2		)	72
	Distributor-customer relationship(2) 10 year life	3.3			(0.6		)	2.7		4.4		(0.7		)	3.7
	Total	136.1			(79.9		)	56.2		136.6		(60.9		)	75.7
	Total other intangible assets	$	177.4		$	(79.9	)	$	97.5	$	190.8	$	(60.9	)	$	129.9
	(1) Changes in balances result from currency translation.
	(2) Changes in balances result from currency translation and amortization.
	Amortization expense for other intangible assets was $19.4 million, $21.1 million and $18.1 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	Expected amortization expense related to intangible assets is as follows:
	(In millions)
	Years Ending December 31,
	2014	$	16
	2015	15
	2016	12.3
	2017	9.4
	2018	1.8
	Later years	1.7
	Non-Cash Activity
	Additions to long-lived assets not yet paid were $89.5 million, $78.7 million and $32.8 million for the years ended December 31, 2013, 2012 and 2011, respectively.

GOODWILL

GOODWILL	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
GOODWILL	'
	GOODWILL
	The Company tests goodwill for impairment on an annual basis and whenever an event occurs or circumstances change that would, more likely than not, reduce the fair value of a reporting unit below its carrying amount. Historically, the Company’s policy was to perform the annual impairment test for goodwill as of January 1 of each year. The Company completed its annual impairment test in the first quarter of 2013 in accordance with this policy and concluded that no impairment existed. During the third quarter of 2013 the Company changed its annual impairment testing date from January 1 to July 1 of each fiscal year to better align with the timing of its annual and long-term planning process, which is a significant input in the testing process. Accordingly, the Company believes this change is preferable. This change did not delay, accelerate or avoid an impairment charge. As a result of this change, impairment testing was completed during the third quarter of 2013 and the Company concluded that no impairment existed. This change was applied prospectively beginning July 1, 2013 and had no impact on the consolidated financial statements. The change was not applied retrospectively as it is impracticable to do so because retrospective application would have required the application of significant estimates and assumptions without the use of hindsight.
	For the year ended December 31, 2013, the change in the carrying amount of goodwill by reportable segment, was primarily driven by the cumulative impact due to a correction of the currency denomination of the goodwill related to two reporting units. The revision had the impact of decreasing the Company’s total value of goodwill and decreasing the total currency translation adjustment included in the accumulated other comprehensive loss section of shareholders’ equity and other comprehensive income.
	For the year ended December 31, 2013 and 2012, the change in the carrying amount of goodwill by reportable segment, including the cumulative impact of the revisions described above, was as follows:
	(In millions)	Asia		Latin America			North America/			Total
							Europe
	Balance as of January 1, 2012	$	—	$	115.8		$	1.7		$	117.5
	Acquisition	—		155.5			17.3			172.8
	Translation adjustments	—		(17.7		)	(2.0		)	(19.7		)
	Balance as of December 31, 2012	—		253.6			17			270.6
	Redenomination	—		(42.5		)	2			(40.5		)
	Translation adjustments	—		(33.3		)	—			(33.3		)
	Balance as of December 31, 2013	$	—	$	177.8		$	19		$	196.8
	A portion of the goodwill from the acquisition of Nutricion para el Conosur S.A. was attributed to the North America/Europe segment in consideration of expected benefits to be derived from the acquisition. As of December 31, 2013, the Company had no accumulated impairment loss.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
DEBT	'
	DEBT
	Short-Term Borrowings
	Outstanding Borrowings
	As of December 31, 2013, the Company’s short-term borrowings were $2.0 million and consisted of borrowings made by the Company’s subsidiary in Argentina. These short-term borrowings had a weighted-average interest rate of 22.00% as of December 31, 2013. The Company intends to repay these borrowings within 12 months and has the ability to do so.
	As of December 31, 2012, the Company’s short-term borrowings totaled $161.0 million and were primarily from its 5-year revolving credit facility agreement (“Credit Facility”).
	Five-Year Revolving Credit Facility Agreement
	Borrowings from the Credit Facility are used for working capital and other general corporate purposes. The Credit Facility is unsecured, repayable at maturity in June 2016 and can be extended annually if a sufficient number of lenders agree. The maximum amount of outstanding borrowings and letters of credit permitted at any one time under the Credit Facility is $500.0 million, which may be increased from time to time up to $750.0 million at the Company’s request and with the consent of the lenders, subject to satisfaction of customary conditions. The Credit Facility contains financial covenants, whereby the ratio of consolidated total debt to consolidated Earnings Before Interest, Income Taxes, Depreciation and Amortization (“EBITDA”) cannot exceed 3.25 to 1.0, and the ratio of consolidated EBITDA to consolidated interest expense cannot be less than 3.0 to 1.0. The Company was in compliance with these covenants as of December 31, 2013.
	Borrowings under the Credit Facility bear interest at a rate that is determined as a base rate plus a margin. The base rate is either (a) LIBOR for a specified interest period, or (b) a floating rate based upon JPMorgan Chase Bank’s prime rate, the Federal Funds rate or LIBOR. The margin is determined by reference to the Company’s credit rating. The margin can range from 0.075% to 1.45% over the base rate. In addition, the Company incurs an annual 0.2% facility fee on the entire facility commitment of $500.0 million.
	As of December 31, 2013, the Company did not have any borrowings outstanding from the Credit Facility. For the year ended December 31, 2013, borrowings from the Credit Facility had a weighted-average interest rate of 1.52%.
	Note Payable
	On March 15, 2012, the Company acquired 80% of the outstanding capital stock of Nutricion para el Conosur S.A. See Note 8 for discussion of the acquisition. Of the ARS850.7 million purchase price, ARS377.6 million was financed through a note payable. The remaining balance of the note payable was paid on July 10, 2013.
	Long-Term Debt
	The components of long-term debt were as follows:
	(Dollars in millions)		December 31, 2013				December 31, 2012
	Principal Value:
	3.50% Notes due 2014		$	500			$	500
	4.90% Notes due 2019		700				700
	5.90% Notes due 2039		300				300
	Subtotal		1,500.00				1,500.00
	Adjustments to Principal Value:
	Unamortized basis adjustment for terminated interest rate swaps		16.7				26
	Unamortized bond discount		(2.0		)		(2.8		)
	Less amount due within one year		505.6				—
	Long-term debt		$	1,009.10			$	1,523.20
	The notes may be prepaid at any time, in whole or in part, at a redemption price equal to the greater of par value or an amount calculated based upon the sum of the present values of the remaining scheduled payments. Upon a change of control, the Company may be required to repurchase the notes in an amount equal to 101% of the then outstanding principal amount plus accrued and unpaid interest. Interest on the notes are due semi-annually, and the notes are not subject to amortization.
	The Company’s long-term debt has a principal value of $1,500 million, of which $500 million is considered short-term as it matures on November 1, 2014. MJN plans to refinance a portion of these notes in 2014. The Company determined the fair value of its long-term debt based on current market yields in the secondary market, classified as Level 2. As of December 31, 2013 fair value of the Company's long-term debt was $1,611.1 million.
	The components of interest expense-net were as follows:
		Years Ended December 31,
	(In millions)	2013				2012				2011
	Interest expense	$59.20				$70.90				$	60.2
	Interest income	(8.6		)		(5.9		)		(8.0		)
	Interest expense-net	$50.60				$65.00				$	52.2
	Interest payments, net of amounts related to interest rate swaps	$	72			$	74.9			$	61.4
	See Note 16 for discussion on the Company’s derivatives.

DERIVATIVES_AND_OTHER_FINANCIA

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS	'
	DERIVATIVES
	The Company is exposed to market risk due to changes in foreign currency exchange rates, commodities pricing and interest rates. To manage that risk, the Company enters into certain derivative financial instruments, when available on a cost-effective basis, to hedge its underlying economic exposure. The Company does not enter into derivatives for speculative purposes. These financial instruments are classified as Level 2 of the fair value hierarchy at December 31, 2013 and 2012, and there were no transfers between levels in the fair value hierarchy during the periods then ended.
	The following table summarizes the fair value of the Company's outstanding derivatives, all of which are cash flow hedges:
				December 31,
	(In millions)	Balance Sheet Location		2013				2012
	Cash flow hedges:
	Foreign exchange contracts	Other assets		$	4.2			$	—
	Interest rate forward swaps	Other assets		19.9				—
	Foreign exchange contracts	Accrued expenses		(0.5		)		(5.1		)
	Net asset/(liability) of derivatives designated as hedging items			$	23.6			$	(5.1	)
	The Company’s derivative financial instruments present certain market and counterparty risks; however, concentration of counterparty risk is mitigated as the Company deals with a variety of major banks worldwide whose long-term debt is rated A- or higher by Standard & Poor’s Rating Service, Fitch Ratings, or Moody’s Investors Service, Inc. In addition, only conventional derivative financial instruments are used. The Company would not be materially impacted if any of the counterparties to the derivative financial instruments outstanding at December 31, 2013 failed to perform according to the terms of its agreement. Based upon the risk profile of the Company's portfolio, MJN does not require collateral or any other form of securitization to be furnished by the counterparties to its derivative financial instruments.
	Cash Flow Hedges
	As of December 31, 2013 and 2012 all of the Company’s cash flow hedges qualify as hedges of forecasted cash flows and the effective portion of changes in fair value are temporarily reported in accumulated other comprehensive income (loss). During the period that the underlying hedged transaction impacts earnings, the effective portion of the changes in the fair value of the cash flow hedges are recognized within earnings. The Company assesses effectiveness at inception and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of the change in fair value is included in current period earnings.
	The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date, or 60 days thereafter, or when the hedge is no longer effective. For the years ended December 31, 2013, 2012, and 2011, the Company did not discontinue any cash flow hedges.
	Foreign Exchange Contracts
	The Company uses foreign exchange contracts to hedge forecasted transactions, primarily foreign currency denominated intercompany purchases anticipated in the next 1.5 years and designates these derivative instruments as foreign currency cash flow hedges when appropriate. When the underlying intercompany purchases impact the Company’s consolidated earnings, the effective portion of the hedge is recognized within cost of products sold. For the years ended December 31, 2013, 2012 and 2011, ineffectiveness related to the Company’s foreign exchange hedges on earnings was insignificant.
	The table below summarizes the Company’s outstanding foreign exchange forward contracts at December 31, 2013. The fair value of foreign exchange forward contracts should be viewed in relation to the fair value of the underlying hedged transactions and the overall reduction in exposure to fluctuations in foreign currency exchange rates.
	(Dollars in millions)		Weighted-average		Notional				Fair Value				Maturity
			Forward Rate		Amount				Asset
	Foreign exchange contracts:
	Cash flow hedges:
	Mexican peso		13.07		84				0.7				2014
	Malaysian ringgit		3.18		55				2				2014
	Philippine peso		43.48		62.4				1				2014
	Total foreign exchange contracts				$	201.4			$	3.7
	The change in accumulated other comprehensive income (loss) and the impact on earnings from foreign exchange contracts that qualified as cash flow hedges for the years ended December 31, 2013 and 2012, were as follows:
	(In millions)	2013				2012
	Balance—January 1	$	(4.1	)		$	4.3
	Derivatives qualifying as cash flow hedges deferred in other comprehensive income	4.8				(12.7		)
	Derivatives qualifying as cash flow hedges reclassified to cost of products sold (effective portion)	5.4				0.8
	Change in deferred taxes	(2.9		)		3.5
	Balance—December 31	$	3.2			$	(4.1	)
	At December 31, 2013, the portion of changes in cash flow hedges deferred into other comprehensive income that is expected to be reclassified into earnings within the next 12 months was $3.2 million.
	Interest Rate Forward Swaps
	During the fourth quarter of 2013 the Company entered into interest rate forward starting swaps with a combined notional value of $500.0 million. The forward starting rates of the swaps range from 3.79% to 3.94% and have an effective date of October 31, 2014. The forward starting swaps effectively mitigate the interest rate exposure associated with the Company’s planned refinancing of a portion of long-term debt in 2014, which is an anticipated transaction as a portion of MJN’s existing long-term debt will mature in 2014. These derivative instruments were designated as cash flow hedges at inception and were highly effective in offsetting fluctuations in the benchmark interest rate. As of December 31, 2013, all forward swaps were outstanding and had a fair value of $19.4 million, recognized in accumulated other comprehensive income. When the forward swaps are settled, which would be on or about the time of the issuance of long-term debt, any gain or loss on the settlement will be recorded to accumulated other comprehensive income (loss) and will be amortized over the life of the notes. There was an immaterial amount of ineffectiveness related to the forward swaps which was recognized as a benefit within other expenses-net.
	Commodity Hedge
	During the fourth quarter of 2013, the Company began utilizing commodity hedges to minimize the variability in cash flows due to fluctuations in market prices of the Company’s non-fat dry milk purchases. The maturities of the commodity contracts are scheduled to match the pricing terms of the Company’s existing bulk purchase agreements. When the underlying non-fat dry milk purchases impact the Company’s consolidated earnings, the effective portion of the hedge is recognized within cost of products sold.
	As of December 31, 2013, the Company had commodity contracts outstanding with a notional of 0.2 million pounds of forecasted non-fat dry milk purchases, representing a value of $0.3 million and an insignificant portion of the Company’s total forecasted volume. The effective portion of the hedge, which was recorded at fair value as a component of accumulated other comprehensive income, as well as the ineffective portion recognized within other income and expense were immaterial as of December 31, 2013 and for the period then ended.
	Fair Value Hedges
	Interest Rate Swaps
	In November 2009, the Company executed several interest rate swaps to convert $700.0 million of the Company’s newly-issued fixed rate debt to be paid in 2014 and 2019 to variable rate debt. In November 2010, the Company terminated $200.0 million notional amount of fixed-to-floating interest rate swaps for cash of $15.6 million. In July 2011, the Company terminated the remaining $500.0 million notional amount of fixed-to-floating interest rate swaps for cash of $23.5 million. The related basis adjustments of the underlying hedged items are being recognized as a reduction of interest expense over the remaining life of the underlying debt. The Company had no interest rate swaps outstanding at December 31, 2013.
	(Gain) loss on marked to market of fair value hedges during the years ended December 31, 2013, 2012, and 2011 was as follows:
		(Gain) Loss on Marked												(Gain) Loss on Marked
		to Market Swaps												to Market of
														Hedged Items
	(In millions)	2013				2012				2011				2013		2012		2011
	Interest expense—net	$	—			$	—			$	(4.2	)		$	—	$	—	$	4.2
	The impact on earnings from interest rate swaps that qualified as fair value hedges was as follows:
	(In millions)	2013				2012				2011
	Recognized in interest expense	$	—			$	—			$	(6.3	)
	Amortization of basis adjustment for terminated interest rate swaps recognized in interest expense	(9.2		)		(9.3		)		(5.5		)
	Total	$	(9.2	)		$	(9.3	)		$	(11.8	)
	See Note 15 for discussion on the Company’s debt.
	Other Financial Instruments
	The Company does not hedge the interest rate risk associated with money market funds, which totaled $447.8 million and $520.7 million as of December 31, 2013 and 2012, respectively. Money market funds are classified as Level 2 in the fair value hierarchy and are included in cash and cash equivalents on the balance sheet.  The money market funds have quoted market prices that are generally equivalent to par.

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
EQUITY	'
	EQUITY
	Changes in common shares and treasury stock were as follows:
	(In millions)	Common Shares			Treasury Stock		Cost of Treasury
		Issued					Stock
	Balance as of January 1, 2011	204.8			0.1		$	3.2
	Stock-based compensation	0.3			—		4.9
	Treasury stock purchases	—			1.3		81.6
	Balance as of December 31, 2011	205.1			1.4		$	89.7
	Stock-based compensation	0.9			0.2		15.2
	Treasury stock purchases	—			1.9		139.7
	Balance as of December 31, 2012	206			3.5		$	244.6
	Stock-based compensation	0.8			0.2		18.9
	Treasury stock purchases	—			1.1		88.4
	Balance as of December 31, 2013	206.8			4.8		$	351.9
	The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and vesting of performance share awards and restricted stock units. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized using the first-in first-out method.
	On March 16, 2010, MJN’s board of directors approved the repurchase of up to $300.0 million of the Company’s common stock. From the date of such authorization through December 31, 2013, 4.2 million shares were repurchased at an average cost per share of $71.21. As of December 31, 2013, the Company has completed all purchases remaining under this authorization.
	On September 10, 2013, MJN’s board of directors approved a new share repurchase authorization of up to an additional $500.0 million of the Company’s common stock. From the date of such authorization through December 31, 2013, 0.1 million shares were repurchased at an average cost of $84.06. As of December 31, 2013, the Company had $490.3 million available under this authorization.
	Changes in accumulated other comprehensive loss by component were as follows:
	(In millions)		Foreign Currency Translation Adjustments			Deferred Gains/(Losses) on Derivatives Qualifying as Hedges			Pension and Other Post-employment Benefits			Total			Noncontrolling Interest					Redeemable Noncontrolling Interest
	Balance as of January 1, 2013		$	(14.6	)	$	(4.1	)	$	0.3		$	(18.4	)	$	(0.2	)			$	—
	Deferred Gains/(Losses)		(79.4		)	24.2			(1.1		)	(56.3		)	3.3			1		(14.4		)	1
	Reclassification Adjustment for		—			5.4			(0.2		)	5.2			—					—
	(Gains)/Losses Included in Net
	Earnings
	Tax Benefit/(Expense)		10.4			(10.1		)	—			0.3			(1.2		)			—
	Balance as of December 31, 2013		$	(83.6	)	$	15.4		$	(1.0	)	$	(69.2	)	$	1.9				$	(14.4	)
	1 Represents foreign currency translation adjustments.
	Reclassification adjustments out of accumulated other comprehensive loss were as follows:
			31-Dec-13
			Affected Statement of Earnings Lines
	(In millions)		Cost of Products Sold			Selling, General and Administrative			Research and Development			Other Expenses/ (Income) - Net			Tax Benefit/(Expense)				Net
	Deferred Gains/(Losses) on Derivatives Qualifying as Hedges:
	Forward Exchange Contracts		$	(5.4	)										$	1.6			$	(3.8	)
	Pension and Other Post-employment Benefit Plans:
	Prior Service Benefits		0.1			0.1													0.2
	Total Reclassifications		$	(5.3	)	$	0.1		$	—		$	—		$	1.6			$	(3.6	)
	Dividends declared per share were $1.36, $1.20 and $1.04 for the years ended December 31, 2013, 2012 and 2011, respectively.

LEASES

LEASES	12 Months Ended
	Dec. 31, 2013
Leases [Abstract]	'
Leases of Lessee Disclosure [Text Block]	'
	LEASES
	Minimum rental commitments under all non-cancelable operating leases, primarily real estate leases for offices, manufacturing-related leases and vehicle leases, in effect at December 31, 2013, are:
	(In millions)
	Years Ending December 31,
	2014	$	36.4
	2015	29.5
	2016	20.8
	2017	15.5
	2018	14.3
	Later Years	22.3
	Total Minimum Payments	$	138.8
	Operating lease rental expenses were $39.7 million, $37.4 million and $35.5 million in the years ended December 31, 2013, 2012, and 2011, respectively. At December 31, 2013 and 2012, MJN had capital lease obligations outstanding in the amount of $2.9 million and $2.7 million, respectively.

CONTINGENCIES

CONTINGENCIES	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
CONTINGENCIES	'
	CONTINGENCIES
	In the ordinary course of business, the Company is subject to lawsuits, investigations, government inquiries and claims, including, but not limited to, product liability claims, advertising disputes and inquiries, consumer fraud suits, other commercial disputes, premises claims and employment and environmental, health, and safety matters.
	The Company was served with a lawsuit filed on October 16, 2012 in St. Clair County (Illinois) Circuit Court under the caption Shelby Schrack, et al. v. Mead Johnson Nutrition Company and Mead Johnson & Company, which lawsuit alleges that certain bacteria in powdered formula were responsible for the death of one infant and serious illness in two others and seeks unspecified monetary damages. These events were widely publicized in December 2011 and January 2012. The infants allegedly consumed formula from batches that were extensively tested by the Company, the Centers for Disease Control (“CDC”) and the U.S. FDA. These tests detected no bacteria in our infant formula. The CDC further noted that while these bacteria have sometimes been found in formula, they also exist in the environment and may potentially cause illness through person to person contact or through contamination of infant feedings at the point of use. The Company believes that the claims in this matter are without merit. Nevertheless, in November 2013, the Company and the plaintiffs agreed to settle the disputed claims asserted in this litigation, and on December 12, 2013, the Company obtained court approval of the proposed settlement and release of all such claims. The settlement did not materially affect the Company’s consolidated financial position, results of operations or cash flows.
	The Company records accruals for contingencies when it is probable that a liability will be incurred and the loss can be reasonably estimated. Although the Company cannot predict with certainty the final resolution of lawsuits, investigations and claims asserted against the Company, MJN does not believe any currently pending legal proceeding to which the Company is a party will have a material effect on the Company’s business or financial condition, although an unfavorable outcome in excess of amounts recognized as of December 31, 2013, with respect to one or more of these proceedings could have a material effect on the Company’s results of operations and cash flows for the periods in which a loss is recognized.
	The Company incurred costs for an administrative penalty assessed by China's National Development and Reform Commission ("NDRC") in connection with the NDRC’s antitrust review of the infant formula industry’s resale pricing practices (the “China Antitrust Review”) and was resolved during the third quarter of 2013. In connection with the China Antitrust Review, the NDRC assessed an administrative penalty of $33.4 million against the Company, which penalty was paid during the third quarter and is non-deductible for tax purposes.
	Following an SEC request for documents relating to certain business activities of the Company’s local subsidiary in China, the Company is continuing an internal investigation of such business activities. The Company’s investigation is focused on certain expenditures that were made in connection with the promotion of the Company’s products or may have otherwise been made. Certain of such expenditures were made in violation of Company policies and may have been made in violation of applicable U.S. and/or local laws, including the U.S. Foreign Corrupt Practices Act (the “FCPA”).  The investigation is being conducted by outside legal counsel and overseen by a committee of independent members of the Company’s board of directors. The status and results of the investigation are being discussed with the SEC and other governmental authorities.  At this time, the Company is unable to predict the scope, timing or outcome of this ongoing matter or any regulatory or legal actions that may be commenced related to this matter.  If a violation of the FCPA or other laws is determined to have occurred, the Company could become subject to monetary penalties as well as civil and criminal sanctions.

SELECTED_QUARTERLY_FINANCIAL_D

SELECTED QUARTERLY FINANCIAL DATA(UNAUDITED)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Information [Text Block]	'
	SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)
	Dollars in Millions, Except Per Share Data	First		Second		Third		Fourth		Year
		Quarter		Quarter		Quarter		Quarter
	2013:00:00
	Net sales	$	1,037.90	$	1,055.30	$	1,046.80	$	1,060.70	$	4,200.70
	Gross profit	$	652.9	$	673.3	$	684.5	$	661.5	$	2,672.20
	Net earnings	$	190	$	173.4	$	169.7	$	156.1	$	689.2
	Net earnings attributable to shareholders	$	188	$	172	$	171.3	$	152.5	$	683.8
	Basic earnings per share	$	0.93	$	0.85	$	0.85	$	0.75	$	3.37
	Diluted earnings per share	$	0.92	$	0.84	$	0.84	$	0.75	$	3.36
	2012:00:00
	Net sales	$	986.6	$	1,012.30	$	921.3	$	981.1	$	3,901.30
	Gross profit	$	613.8	$	635.6	$	565.6	$	582.5	$	2,397.50
	Net earnings	$	172.6	$	168.9	$	145.2	$	101.6	$	588.3
	Net earnings attributable to shareholders	$	167	$	163.6	$	146.3	$	103.5	$	580.4
	Basic earnings per share	$	0.82	$	0.8	$	0.72	$	0.51	$	2.84
	Diluted earnings per share	$	0.81	$	0.8	$	0.71	$	0.51	$	2.83

Schedule_II_Valuation_and_Qual

Schedule II Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]	'
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	'
	SCHEDULE II
	MEAD JOHNSON NUTRITION COMPANY
	VALUATION AND QUALIFYING ACCOUNTS
	Description	Balance at		Provisions		Bad			Other			Balance
		beginning		for bad		debts						at end of
		of period		debts		written off						period
	(In millions)
	Allowances for Doubtful Accounts
	For the year ended December 31, 2013	$	7.6	$	0.6	$	(0.2	)	$	(1.5	)	$	6.5
	For the year ended December 31, 2012	6.3		1.5		(0.4		)	0.2			7.6
	For the year ended December 31, 2011	8.3		0.2		—			(2.2		)	6.3
	Description	Balance at		Provision for		Release of			Balance
		beginning		valuation		valuation			at end of
		of period		allowance		allowance/			period
						other
	(In millions)
	Valuation Allowance on Deferred Tax Assets
	For the year ended December 31, 2013	$	6.1	$	3.8	$	(2.6	)	$	7.3
	For the year ended December 31, 2012	7		1.1		(2.0		)	6.1
	For the year ended December 31, 2011	3.3		3.7		—			7

ACCOUNTING_POLICIES_Policies

ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation—The financial statements present the results of operations, financial position, and cash flows of MJN and its majority-owned and controlled subsidiaries. Intercompany balances and transactions have been eliminated. The Company prepared the accompanying consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). These financial statements consider subsequent events through the date of filing with the Securities and Exchange Commission.
Reclassification, Policy [Policy Text Block]	'
	In the Consolidated Statements of Cash Flows for the years ended December 31, 2012 and 2011, operating cash flow amounts reflected as pension and other post-employment benefit expense have been reclassified to conform to the presentation for the year ended December 31, 2013. These amounts were previously classified as a component of the change in other assets and liabilities.
Use of Estimates	'
	Use of Estimates—The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used in revenue recognition, including sales rebate and return accruals, impairment testing of goodwill and other indefinite-lived intangible assets, income tax assets and liabilities, income tax expense, and legal liabilities, as well as the accounting for stock-based compensation and retirement and post-employment benefits, including the actuarial assumptions. Actual results may or may not differ from estimated results.
Fair Value Measurements	'
	Fair Value Measurements—The fair value of financial assets and liabilities are classified in the fair value hierarchy as follows: Level 1—unadjusted quoted prices in active markets for identical assets or liabilities, Level 2—observable prices that are based on inputs not quoted on active markets, and Level 3—unobservable inputs that reflect estimates about the assumptions market participants would use in pricing the asset or liability.
Revenue Recognition	'
	Revenue Recognition—MJN recognizes revenue when substantially all the risks and rewards of ownership have transferred to the customer. Revenue is recognized on the date MJN’s products are received by the purchaser. Revenues are reduced at the time of recognition to reflect expected returns that are estimated based on historical experience and business trends. Additionally, provisions are made at the time of revenue recognition for discounts, Women, Infants and Children (“WIC”) rebates and estimated sales allowances based on historical experience, updated for changes in facts and circumstances, as appropriate. Such provisions are recorded as a reduction of revenue. The Company offers sales incentives to customers and consumers through various programs consisting primarily of customer pricing allowances, merchandising funds and consumer coupons. Provisions are made at the time of revenue recognition for these items based on historical experience, updated for changes in facts and circumstances, as appropriate. Such provisions are recorded as a reduction of revenue.
	WIC rebate accruals were $199.7 million and $206.5 million at December 31, 2013 and 2012, respectively, and are included in accrued rebates and returns on the Company’s balance sheet. MJN participates on a competitive bidding basis in nutrition programs sponsored by states, tribal governments, the Commonwealth of Puerto Rico, and U.S. territories for WIC. Under these programs, MJN reimburses these entities for the difference between wholesaler list price and the contract price on eligible products. The Company accounts for WIC rebates by establishing an accrual in an amount equal to the Company’s estimate of WIC rebate claims attributable to a sale. MJN determines its estimate of the WIC rebate accrual primarily based on historical experience regarding WIC rebates and current contract prices under the WIC programs. The Company considers levels of inventory in the distribution channel, new WIC contracts, terminated WIC contracts, changes in existing WIC contracts and WIC participation, and adjusts the accrual periodically throughout the year to reflect actual expense. Rebates under the WIC program reduced revenues by $702.3 million, $730.0 million, and $700.7 million in the years ended December 31, 2013, 2012, and 2011, respectively.
	Sales return accruals were $44.8 million and $46.4 million at December 31, 2013 and 2012, respectively, and are included in accrued rebates and returns on the Company’s balance sheet. The Company accounts for sales returns by establishing an accrual in an amount equal to its estimate of sales recorded for which the related products are expected to be returned. The Company determines its estimate of the sales return accrual primarily based on historical experience regarding sales returns, but also considers other factors that could impact sales returns such as discontinuations and new product introductions. Returns reduced sales by $81.0 million, $82.5 million, and $81.8 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Income Taxes	'
	Income Taxes—The provision for income taxes has been determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax basis of the Company’s assets and liabilities. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable earnings in effect for the years in which those tax attributes are expected to be recovered or paid, and are adjusted for changes in tax rates and tax laws when changes are enacted. The ultimate liability incurred by the Company may differ from the provision estimates based on a number of factors, including interpretations of tax laws and the resolution of examinations by the taxing authorities.
	Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment including the long-range forecast of future taxable earnings and the evaluation of tax planning initiatives. Adjustments to the deferred tax valuation allowances are made to earnings in the period when such assessments are made.
	Uncertain tax positions that relate to deferred tax assets are recorded against deferred tax assets; otherwise, uncertain tax positions are recorded as either a current or noncurrent liability.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents—Cash and cash equivalents consist of bank deposits, time deposits and money market funds. The Company maintains cash and cash equivalent balances in U.S. dollars and foreign currencies, which are subject to currency rate risk. Cash equivalents are primarily highly liquid investments with original maturities of 3 months or less at the time of purchase and are recorded at cost, which approximates fair value. Money market funds, which totaled $447.8 million and $520.7 million at December 31, 2013 and 2012, respectively, are classified as Level 2 in the fair value hierarchy.
Inventory Valuation	'
	Inventory Valuation—Inventories are valued at the lower of cost or market. The Company determines cost on the basis of the average cost or first-in, first-out methods.
Property, Plant and Equipment	'
	Property, Plant and Equipment—Expenditures for additions and improvements, including capitalized interest, are recorded at cost. Depreciation is computed on a straight-line method based on the estimated useful lives of the related assets. The estimated useful lives of the major classes of depreciable assets are up to 50 years for buildings and 3 to 40 years for machinery, equipment, and fixtures. Maintenance and repair costs are expensed as incurred.
Capitalized Software	'
	Capitalized Software—Certain costs to obtain internal-use software for significant systems projects are capitalized and amortized on a straight-line basis over the estimated useful life of the software, which ranges from 3 to 7 years. Costs to obtain software for projects that are not significant are expensed as incurred.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets—The Company periodically evaluates whether current facts or circumstances indicate that the carrying value of its depreciable assets to be held and used may not be recoverable. If such circumstances are determined to exist, an estimate of undiscounted future cash flows produced by the long-lived asset, or the appropriate grouping of assets, is compared to the carrying value to determine whether impairment exists. If an asset is determined to be impaired, the loss is measured based on the difference between the asset’s fair value and its carrying value. An estimate of the asset’s fair value is based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. The Company reports an asset to be disposed of at the lower of its cost less accumulated depreciation or its estimated net realizable value.
Goodwill	'
	Goodwill and Other Intangible Assets—During the third quarter of 2013 the Company changed its annual impairment testing date from January 1 to July 1, which did not result in any delay, acceleration or avoidance of an impairment charge. The Company believes that moving the goodwill impairment testing date to the third quarter is preferable because it better aligns with MJN’s annual and long-term planning timeline, which is a significant element in the testing process. The Company completed impairment testing in both the first and third quarters of 2013 and concluded that no impairment of goodwill exists (see Note 14).
	The Company’s policy is to test Goodwill for impairment on an annual basis or when current facts or circumstances indicate that a potential impairment may exist. The Company compares the carrying value of a reporting unit, including goodwill, to the fair value of the unit. If the carrying amount of a reporting unit exceeds its fair value, the Company revalues all assets and liabilities of the reporting unit, excluding goodwill, to determine if the fair value of the net assets is greater than the net assets including goodwill. If the fair value of the net assets is less than the carrying amount of net assets including goodwill, impairment has occurred. The Company’s estimates of fair value are primarily determined based on a discounted cash flow model. Growth rates for sales and profits are determined using inputs from the Company’s annual long-range planning process. The Company also makes estimates of discount rates, perpetuity growth assumptions, market comparables, and other factors. The Company completed its most recent goodwill impairment assessment during the third quarter and monitored for any potential impairment during the remainder of 2013. No impairment of goodwill was required in 2013, 2012 or 2011.
	The Company evaluates the useful lives of its other intangible assets to determine if they are finite or indefinite-lived. Reaching a determination on useful life requires significant judgments and assumptions regarding the future effects of obsolescence, demand, competition, other economic factors (such as the stability of the industry, known technological advances, legislative action that results in an uncertain or changing regulatory environment, and expected changes in distribution channels), the level of required maintenance expenditures, and the expected lives of other related groups of assets. Intangible assets that are deemed to have definite lives are amortized on a straight-line basis, over their useful lives.
	The Company’s indefinite-lived intangible assets are also tested for impairment annually and whenever events or changes in circumstances indicate that their carrying value may not be recoverable. Estimates of the fair value of indefinite-lived intangible assets is based on a discounted cash flow model using inputs which included projected revenues from the Company’s annual long-range plan, assumed royalty rates that could be payable if MJN did not own the brands, and a discount rate. The Company completed its most recent indefinite-lived intangible asset impairment assessment during the third quarter and monitored for any potential impairment during the remainder of 2013, determining that no impairment was required.
Contingencies	'
	Contingencies—In the ordinary course of business, the Company is subject to loss contingencies, such as lawsuits, investigations, government inquiries and claims, including, but not limited to, product liability claims, advertising disputes and inquiries, consumer fraud suits, other commercial disputes, premises claims and employment and environmental, health, and safety matters. The Company records accruals for such loss contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated. The Company does not recognize gain contingencies until realized. Legal costs are expensed as incurred.
Derivatives	'
	Derivatives—Derivatives are used by the Company principally in the management of its foreign currency, interest rate and commodity pricing exposures. The Company records all derivatives on the balance sheet at fair value. The Company does not hold or issue derivatives for speculative purposes.
	The Company designates and assigns derivatives as hedges of forecasted transactions, specific assets or specific liabilities. When the hedged assets or liabilities are sold, extinguished or the forecasted transactions being hedged are no longer expected to occur, the Company immediately recognizes the gain or loss on the designated hedging financial instruments in the consolidated statements of earnings.
	If derivatives are designated as a cash flow hedge, the effective portion of changes in the fair value is temporarily reported in accumulated other comprehensive loss and is recognized in earnings when the hedged item affects earnings or is deemed ineffective; cash flows are classified consistent with the underlying hedged item. The Company assesses hedge effectiveness at inception and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of the change in fair value is included in current period earnings. The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable of occurring on the originally forecasted date, or 60 days thereafter, or when the hedge is no longer effective.
	If derivatives are designated as a fair value hedge, both the changes in the fair value of the derivatives and of the hedged item attributable to the hedged risk are recognized in the consolidated statements of earnings; cash flows are classified consistent with the underlying hedged item.
Pension and Other Post Retirement Benefits	'
	Pension and Other Post-employment Benefits—The funded status of the Company’s defined benefit pension and other post-employment benefit plans is measured as the difference between the fair value of the plan assets and the benefit obligation. For the defined benefit plans, the benefit obligation is the projected benefit obligation; for any other defined benefit post-employment plans, the benefit obligation is the accumulated post-employment benefit obligation. The net over- or under-funded status is recognized separately as an asset or a liability on the balance sheet.
	During the first quarter of 2014, the Company changed its accounting principles for the recognition of actuarial gains and losses for all of its defined benefit pension and other post-employment benefit plans and the calculation of expected return on pension plan assets.  Historically, the Company recognized actuarial gains and losses as a component of accumulated other comprehensive loss in its Consolidated Balance Sheets and amortized them into the Consolidated Statements of Earnings over the average future service period of the active employees of these plans to the extent such gains and losses were outside of a corridor.  Starting in the first quarter of 2014, the Company elected to immediately recognize actuarial gains and losses in its Consolidated Statements of Earnings on the basis that it is preferable to accelerate the recognition of such gains and losses into earnings rather than to delay them over time.  Additionally, for purposes of calculating the expected return on pension plan assets, the Company previously used a calculated value for the market-related valuation of pension plan assets. With this change in accounting principle, the Company now uses the actual fair value of pension plan assets. These changes will improve transparency in operating results by immediately recognizing the effects of external conditions on plan obligations, investments and assumptions.
	Under these new accounting principles, actuarial gains and losses from these plans are recognized upon plan remeasurement in the fourth quarter of each year, or more frequently if a remeasurement occurs. The remaining components of net periodic benefit cost, primarily interest on projected benefit obligation and the expected return on pension plan assets, continue to be recorded on a quarterly basis. Actuarial gains and losses are recognized within Corporate and Other and the remaining components of net periodic benefit costs are recognized in the respective reportable segments.
	The Company has applied both of these accounting changes, immediate recognition of actuarial gains or losses and use of actual fair value to calculate expected return on pension plan assets, retrospectively to all periods presented.  The cumulative effect of these changes on additional-paid-in/(distributed) capital and retained earnings on the Company’s opening balance sheet as of January 1, 2011 was a decrease of $96.2 million and an increase of $3.5 million, respectively, with an offsetting adjustment to accumulated other comprehensive loss. The annual recognition of actuarial gains was $12.0 million on a pre-tax basis for the year ended December 31, 2013 and the recognition of actuarial losses was $58.9 million and $91.5 million on a pre-tax basis for the years ended December 31, 2012 and 2011, respectively. These changes had no impact on cash flows for any period presented.
	The following tables present the effects of retrospectively applying these accounting changes for the periods presented:
		as at December 31, 2013 and for the year then ended
	(in millions except per share data)	Previously Reported			Impact of Change			Recast
	Consolidated Statements of Earnings
	Cost of Products Sold	$	1,532.80		$	(4.3	)	$	1,528.50
	Selling, General and Administrative	918			(14.5		)	903.5
	Research and Development	102.4			(2.2		)	100.2
	Other Expenses – net	77.8			(29.3		)	48.5
	EARNINGS BEFORE INTEREST AND INCOME TAXES	924.6			50.3			974.9
	EARNINGS BEFORE INCOME TAXES	874			50.3			924.3
	Provision for Income Taxes	219.1			16			235.1
	NET EARNINGS	654.9			34.3			689.2
	NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	649.5			34.3			683.8
	Earnings per Share – Basic	3.2			0.17			3.37
	Earnings per Share – Diluted	3.19			0.17			3.36
	Consolidated Statements of Comprehensive Income
	Deferred Gains/(Losses) on Pension and Other Post-Employment Benefits	11.6			(12.7		)	(1.1		)
	Reclassification Adjustment for Losses Included in Net Earnings	37.5			(37.7		)	(0.2		)
	Tax Benefit/(Expense)	(16.1		)	16.1			—
	Consolidated Balance Sheets
	Additional Paid-in/(Distributed) Capital	(625.3		)	(96.2		)	(721.5		)
	Retained Earnings	1,470.40			(38.1		)	1,432.30
	Accumulated Other Comprehensive Loss	(203.5		)	134.3			(69.2		)
	Consolidated Statements of Cash Flows
	Deferred Income Tax	7			16			23
	Pension and Other Post-Employment Benefits Expense	43.1			(50.3		)	(7.2		)
		as at December 31, 2012 and for the year then ended
	(in millions except per share data)	Previously Reported			Impact of Change			Recast
	Consolidated Statements of Earnings
	Cost of Products Sold	$	1,485.30		$	18.5		$	1,503.80
	Selling, General and Administrative	877.8			26.7			904.5
	Research and Development	95.4			4.7			100.1
	Other Expenses – net	20			(15.2		)	4.8
	EARNINGS BEFORE INTEREST AND INCOME TAXES	870			(34.7		)	835.3
	EARNINGS BEFORE INCOME TAXES	805			(34.7		)	770.3
	Provision for Income Taxes	192.6			(10.6		)	182
	NET EARNINGS	612.4			(24.1		)	588.3
	NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	604.5			(24.1		)	580.4
	Earnings per Share – Basic	2.96			(0.12		)	2.84
	Earnings per Share – Diluted	2.95			(0.12		)	2.83
	Consolidated Statements of Comprehensive Income
	Deferred Gains/(Losses) on Pension and Other Post-Employment Benefits	(58.5		)	58.5			—
	Reclassification Adjustment for Losses Included in Net Earnings	23.8			(23.8		)	—
	Tax Benefit/(Expense)	10.6			(10.6		)	—
	Consolidated Balance Sheets
	Additional Paid-in/(Distributed) Capital	(676.6		)	(96.2		)	(772.8		)
	Retained Earnings	1,124.80			(72.4		)	1,052.40
	Accumulated Other Comprehensive Loss	(187.0		)	168.6			(18.4		)
	Consolidated Statements of Cash Flows
	Deferred Income Tax	17.1			(10.6		)	6.5
	Pension and Other Post-Employment Benefits Expense	27.9			34.7			62.6
		For the year ended December 31, 2011
	(in millions except per share data)	Previously Reported			Impact of Change			Recast
	Consolidated Statements of Earnings
	Cost of Products Sold	$	1,362.30		$	28.7		$	1,391.00
	Selling, General and Administrative	926.8			48.6			975.4
	Research and Development	92.5			8.3			100.8
	Other Expenses – net	19.6			(9.7		)	9.9
	EARNINGS BEFORE INTEREST AND INCOME TAXES	774.1			(75.9		)	698.2
EARNINGS BEFORE INCOME TAXES	721.9			(75.9		)	646
Provision for Income Taxes	202.9			(24.1		)	178.8
NET EARNINGS	519			(51.8		)	467.2
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	508.5			(51.8		)	456.7
Earnings per Share – Basic	2.48			(0.25		)	2.23
Earnings per Share – Diluted	2.47			(0.25		)	2.22
Consolidated Statements of Comprehensive Income
Deferred Gains/(Losses) on Pension and Other Post-Employment Benefits	(90.7		)	90.7			—
Reclassification Adjustment for Losses Included in Net Earnings	14.6			(14.8		)	(0.2		)
Tax Benefit/(Expense)	24.1			(24.1		)	—
Consolidated Statements of Cash Flows
Deferred Income Tax	(33.3		)	(24.1		)	(57.4		)
Pension and Other Post-Employment Benefits Expense	19.1			75.9			95
Shipping and Handling Costs	'
	Shipping and Handling Costs—The Company typically does not charge customers for shipping and handling costs. Shipping and handling costs, including warehousing expenses, were $119.1 million, $115.6 million, and $104.3 million in the years ended December 31, 2013, 2012, and 2011, respectively, and are included in selling, general and administrative expenses.
Advertising Costs	'
	Advertising Costs—Advertising costs are expensed as incurred and were $226.7 million, $180.3 million, and $180.6 million in the years ended December 31, 2013, 2012, and 2011, respectively.
Research and Development	'
	Research and Development—Research and development costs are expensed as incurred.
Foreign Currency Translation	'
	Foreign Currency Translation—The statements of earnings of the Company’s foreign subsidiaries whose functional currencies are other than the U.S. dollar are translated into U.S. dollars using average exchange rates for the period. The net assets of the Company’s foreign subsidiaries whose functional currencies are other than the U.S. dollar are translated into U.S. dollars using exchange rates as of the balance sheet date. The U.S. dollar effects that arise from translating the net assets of these subsidiaries at changing rates are recorded in the foreign currency translation adjustment account, which is included in accumulated other comprehensive income (loss).
Recently Adopted Accounting Standards and Recently Issued Accounting Standards	'
	Recently Adopted Accounting Standards—In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, requiring entities to provide information about the amounts reclassified out of accumulated other comprehensive income by component. For significant reclassifications related to net income, the ASU required disclosure in the consolidated statement of earnings or within the footnotes. For other amounts, the ASU required a cross-reference to other disclosures that provide additional detail about those amounts. This ASU did not change the current requirements for reporting the consolidated statement of earnings or other comprehensive income in the financial statements. The Company adopted the required financial reporting presentation effective January 1, 2013.
	Recently Issued Accounting Standards—In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830), clarifying the applicable guidance for the release of the cumulative translation adjustment. ASU 2013-05 is effective for the Company in the period beginning January 1, 2014. The Company does not expect the adoption of this update to have a material impact on the consolidated financial statements.
	In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or Tax Credit Carryforward Exists. ASU 2013-11 requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. ASU 2013-11 is effective for the Company in the period beginning January 1, 2014 and the Company does not anticipate that the adoption of this standard to have a material impact on its consolidated financial statements.

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	The following table presents the calculation of basic and diluted earnings per share:
		Years Ended December 31,
	(In millions, except per share data)	2013			2012			2011
	Basic earnings per share:
	Weighted-average shares outstanding	202.4			203.6			204.3
	Net earnings attributable to shareholders	$	683.8		$	580.4		$	456.7
	Dividends and undistributed earnings attributable to unvested shares	(1.3		)	(1.3		)	(1.3		)
	Net earnings attributable to shareholders used for basic earnings per share calculation	$	682.5		$	579.1		$	455.4
	Net earnings attributable to shareholders per share	$	3.37		$	2.84		$	2.23
	Diluted earnings per share:
	Weighted-average shares outstanding	202.4			203.6			204.3
	Incremental shares outstanding assuming the exercise/vesting of dilutive stock options/performance shares	0.7			0.7			0.7
	Weighted-average shares — diluted	203.1			204.3			205
	Net earnings attributable to shareholders	$	683.8		$	580.4		$	456.7
	Dividends and undistributed earnings attributable to unvested shares	(1.3		)	(1.3		)	(1.3		)
	Net earnings attributable to shareholders used for diluted earnings per share calculation	$	682.5		$	579.1		$	455.4
	Net earnings attributable to shareholders per share	$	3.36		$	2.83		$	2.22

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of components of earnings before income taxes	'
	The components of earnings before income taxes were:
		Years Ended December 31,
	(In millions)	2013			2012				2011
	U.S.	$	141.9		$	105.9			$	85
	Non-U.S.	782.4			664.4				561
	Total	$	924.3		$	770.3			$	646
	The above amounts are categorized based on the applicable taxing authorities.
Summary of components of provision (benefit) for income taxes attributable to operations	'
	The provision (benefit) for income taxes consisted of:
		Years Ended December 31,
	(In millions)	2013			2012				2011
	Current:
	U.S. federal	$	79.1		$	37.1			$	81.3
	U.S. states	2.4			(1.3		)		10.7
	Non-U.S.	130.6			139.7				144.2
	Total current income tax expense	212.1			175.5				236.2
	Deferred:
	U.S. federal	(6.4		)	7.9				(27.3		)
	U.S. states	1.9			(4.0		)		(6.2		)
	Non-U.S.	27.5			2.6				(23.9		)
	Total deferred income tax expense	23			6.5				(57.4		)
	Total	$	235.1		$	182			$	178.8
Schedule of effective income tax rate reconciliation	'
	Effective Tax Rate—MJN’s provision for income taxes in the years ended December 31, 2013, 2012 and 2011 was different from the amount computed by applying the statutory U.S. federal income tax rate to earnings before income taxes as a result of the following:
	(Dollars in millions)	2013						2012						2011
	U.S. statutory rate	$	323.5		35	%		$	269.6			35	%	$	226.1		35	%
	State and local taxes	1.3			0.1			0.8				0.1		3.7			0.6
	Foreign income taxed at different rates	(25.6		)	(2.8	)		(67.7		)		(8.8	)	(42.1		)	(6.5	)
	Repatriation of foreign income	9.4			1			21.6				2.8		21.8			3.4
	Tax rulings and agreements	(121.9		)	(13.2	)		(46.4		)		(6.0	)	(51.9		)	(8.0	)
	Reversal of deferred tax on prior years' unremitted foreign earnings due to a permanent reinvestment assertion	(8.2		)	(0.9	)		(8.7		)		(1.1	)	—			—
	Administrative penalty related to China antitrust review	8.3			0.9			—				—		—			—
	Unrecognized tax benefits and related interest/penalties	38.1			4.1			13.1				1.7		7.3			1.1
	Other	10.2			1.2			(0.3		)		(0.1	)	13.9			2.1
	Total provision / effective tax rate	$	235.1		25.4	%		$	182			23.6	%	$	178.8		27.7	%
	The Company negotiated a tax ruling effective from January 1, 2010, under which certain profits in the Netherlands are exempt from taxation through the year ending December 31, 2019. This ruling was superseded by a subsequent tax agreement effective July 26, 2012, whereby the Company and the Dutch tax authorities agreed to the appropriate remuneration attributable to Dutch manufacturing activities through the year ending December 31, 2019.
Summary of components of current and noncurrent deferred income tax assets (liabilities)	'
	Deferred Taxes and Valuation Allowance—The components of current and noncurrent deferred income tax assets (liabilities) were:
		December 31,
	(In millions)	2013			2012
	Deferred tax assets:
	Accrued expenses	$	33.5		$	28
	Accrued rebates and returns	42.2			44.5
	Pension, post-retirement and post employment liabilities	58.1			65.3
	Stock-based compensation	20.2			18.3
	Obsolescence reserves and other inventory items	7.9			6.3
	Net operating loss carryforwards	13.5			17.2
	Other—net	6.7			23.2
	Valuation allowance	(7.3		)	(6.1		)
	Total deferred tax assets	174.8			196.7
	Deferred tax liabilities:
	Depreciation and amortization	(68.5		)	(76.5		)
	Unremitted earnings and cumulative foreign currency translation adjustments	(9.7		)	(26.1		)
	Total deferred tax liabilities	(78.2		)	(102.6		)
	Deferred tax assets—net	$	96.6		$	94.1
	Recognized as:
	Net deferred income taxes—current	74.9			85.5
	Net deferred income taxes—noncurrent	21.7			8.6
	Total	$	96.6		$	94.1
	As of December 31, 2013, the Company had definite-lived and indefinite-lived gross foreign net operating loss (“NOL”) carryforwards of $49.0 million. Indefinite-lived NOL carryforwards totaled $22.3 million with the remainder being definite-lived. An immaterial amount of these definite-lived NOL carryforwards will begin to expire in 2014, with the remainder of the definite-lived NOL carryforwards to expire no later than 2031. The valuation allowance recorded for NOL carryforwards is $5.0 million as of December 31, 2013.
	As of December 31, 2013, the Company had various definite-lived U.S. state tax credit carryforwards of $6.9 million net of federal benefit. An immaterial amount of these state tax credit carryforwards will begin to expire in 2016, with the remainder of the state tax credit carryforwards to expire no later than 2023. The valuation allowance recorded for state tax credit carryforwards is $2.3 million, net of federal benefit as of December 31, 2013.
	Income taxes paid net of refunds were $159.3 million, $226.8 million, and $174.3 million in the years ended December 31, 2013, 2012, and 2011, respectively. The income taxes were paid to federal, state and foreign taxing authorities and BMS pursuant to the terms of the Amended and Restated Tax Matters Agreement.
	As of December 31, 2013, U.S. taxes have not been provided on approximately $1.4 billion of foreign earnings as these undistributed earnings have been permanently invested offshore. If, in the future, these earnings were to be repatriated to the U.S. additional tax provisions would be required. It is impracticable to determine a precise estimate of the additional provision required. However, the maximum potential estimated U.S. tax liability would be $494 million if these earnings were to be repatriated to the United States in such a manner that the entire amount of foreign earnings would be subject to the U.S. statutory tax rate with no U.S. tax relief for foreign taxes already paid.  However, the Company has no plans to repatriate these foreign earnings.
	The Company’s tax returns are routinely audited by federal, state and foreign tax authorities and these tax audits are at various stages of completion at any given time. The Internal Revenue Service (“IRS”) has completed examinations of the Company’s U.S. income tax filings through December 31, 2007. At December 31, 2013, the Company’s 2011 income tax return was under IRS examination. At December 31, 2013, tax years remaining open to examination outside the U.S. include 2003 and forward.
Schedule of reconciliation of changes in uncertain tax positions	'
	A reconciliation of the Company’s changes in gross uncertain tax positions is as follows:
		Years Ended
		December 31,
	(In millions)	2013			2012				2011
	Balance at January 1:	$	64.7		$	29.7			$	13.6
	Increases based on current year tax positions	23.8			17.8				14.6
	Decreases based on current year tax positions	—			—				—
	Increases based on prior year tax positions	18.9			21.4				1.7
	Decreases based on prior year tax positions	—			—				(0.3		)
	Settlements	—			—				(0.1		)
	Lapse of statute of limitations	(3.8		)	(5.2		)		—
	Cumulative translation adjustment	(1.0		)	1				0.2
	Balance at December 31:	$	102.6		$	64.7			$	29.7
	Uncertain tax positions have been recorded as part of other liabilities with a reversal of up to $10 million reasonably possible in the next 12 months due to the expiration of statutes of limitations. The amounts of uncertain tax positions that, if recognized, would impact the effective tax rate were $48.6 million, $18.9 million, and $10.9 million as of December 31, 2013, 2012 and 2011, respectively. The Company believes that it has provided adequately for all uncertain tax positions. It is reasonably possible that new issues may be raised by tax authorities and that these issues may require increases in the balance of uncertain tax positions.
	Interest and penalties related to uncertain tax positions were $14.8 million and $11.2 million, as of December 31, 2013, and 2012, respectively, and are included as a component of other liabilities. The Company classifies interest and penalties related to uncertain tax positions as a component of provision for income taxes. The amount of interest and penalties included as a component of provision for income taxes was $3.0 million, $5.0 million and $0.6 million for the years ended December 31, 2013, 2012 and 2011, respectively.
	On December 18, 2009, the Company and Bristol-Myers Squibb Company (“BMS”) entered into an Amended and Restated Tax Matters Agreement in anticipation of the separation from BMS. Under the Amended and Restated Tax Matters Agreement, BMS agreed to indemnify the Company for (i) any tax attributable to a MJN legal entity for any taxable period ending on or before December 31, 2008, (ii) any tax arising solely as a result of MJN’s 2009 initial public offering (“IPO”) and the restructuring preceding the IPO, and (iii) any transaction tax associated with the separation transaction. The Company agreed to indemnify BMS for (i) any tax payable with respect to any separate return that the Company is required to file or cause to be filed, (ii) any tax incurred as a result of any gain which may be recognized by a member of the BMS affiliated group with respect to a transfer of certain foreign affiliates by the Company in preparation for the IPO, and (iii) any tax arising from the failure or breach of any representation or covenant made by the Company which failure or breach results in the intended tax consequences of the separation transaction not being achieved. Additionally, under the Amended and Restated Tax Matters Agreement, the Company continues to maintain responsibility for any tax positions which may exist for any taxable period ending after December 31, 2008.

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Schedule of net sales and earnings before interest and income taxes for by reportable segments	'
	(In millions)	Net Sales		Earnings			Year-End		Payments for				Depreciation
				Before			Assets		Capital				and
				Interest and					Expenditures				Amortization
				Income Taxes
	Year ended December 31, 2013
	Asia	$	2,179.30	$	796.2		$	1,390.70	$	168.1			$	19.4
	Latin America	861.4		207.2			716.9		33.3				10.5
	North America/Europe	1,160.00		255			798.5		31.6				29.1
	Total operating segments	4,200.70		1,258.40			2,906.10		233				59
	Corporate and Other	—		(283.5		)	568		7.4				24.1
	Total	$	4,200.70	$	974.9		$	3,474.10	$	240.4			$	83.1
	Year ended December 31, 2012
	Asia	$	1,967.00	$	725.4		$	1,097.30	$	87.4			$	16.9
	Latin America	752.5		177.2			712.8		10.7				8.9
	North America/Europe	1,181.80		251.9			740.5		22.3				27.4
	Total operating segments	3,901.30		1,154.50			2,550.60		120.4				53.2
	Corporate and Other	—		(319.2		)	707.6		4				23.7
	Total	$	3,901.30	$	835.3		$	3,258.20	$	124.4			$	76.9
	Year ended December 31, 2011
	Asia	$	1,827.80	$	672.5		$	1,008.60	$	34			$	17.2
	Latin America	619.4		139.2			467.4		12				7.6
	North America/Europe	1,229.80		312.7			764		33.4				30.7
	Total operating segments	3,677.00		1,124.40			2,240.00		79.4				55.5
	Corporate and Other	—		(426.2		)	526.8		30.1				19.8
	Total	$	3,677.00	$	698.2		$	2,766.80	$	109.5			$	75.3
Schedule of net sales by product line	'
	Net Sales (in millions)	Infant		Children’s			Other		Total
		Formula		Nutrition
	Year ended December 31, 2013	$	2,459.70	$	1,653.30		$	87.7	$	4,200.70
	Year ended December 31, 2012	$	2,295.50	$	1,487.00		$	118.8	$	3,901.30
	Year ended December 31, 2011	$	2,188.70	$	1,394.40		$	93.9	$	3,677.00
Schedule of net sales and long-lived assets by geographic region	'
	Geographic (in millions)	United		China/			Mexico		Singapore		Other				Total
		States		Hong Kong
	Year ended December 31, 2013
	Net Sales	$	948.2	$	1,315.80		$	328.2	28		$	1,580.50			$	4,200.70
	Long-Lived Assets	446.6		64.7			134.8		245.9		427				1,319.00
	Year ended December 31, 2012
	Net Sales	$	990.1	$	1,160.10		$	317.2	22.5		$	1,411.40			$	3,901.30
	Long-Lived Assets	456		65.1			180.1		104.9		437.1				1,243.20
	Year ended December 31, 2011
	Net Sales	$	1,019.70	$	1,083.50		$	321	20.8		$	1,232.00			$	3,677.00
	Long-Lived Assets	457.3		60.7			171.6		1.3		169.7				860.6

EMPLOYEE_STOCK_BENEFIT_PLANS_T

EMPLOYEE STOCK BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of assumptions used in the valuations of stock options	'
			2013			2012			2011
			Black-Scholes			Black-Scholes			Black-Scholes
			Model			Model			Model
	Expected volatility		27	%		26.9	%		26.7	%
	Risk-free interest rate		0.9	%		1.2	%		2.6	%
	Dividend yield		1.9	%		1.6	%		1.7	%
	Expected life		5.3 years			6.0 years			6.0 years
Schedule of stock option activity	'
		Shares		Weighted				Average		Aggregate
		(in thousands)		Average				Remaining		Intrinsic
				Exercise				Contractual		Value
				Price of				Term		(in millions)
				Shares				(in years)
	Balance—January 1, 2011	1,404		$	34.36			8.6		$	48.2
	Granted	558		59.18
	Exercised	-140		31.65						$	5.2
	Forfeited or expired	-33		45.03
	Balance—December 31, 2011	1,789		42.12				8.1		$	47.6
	Granted	491		78.12
	Exercised	-325		35.6						$	11.6
	Forfeited or expired	-53		57.5
	Balance—December 31, 2012	1,902		52.11				7.7		$	99.2
	Granted	485		74.76
	Exercised	-377		36.06						$	17.6
	Forfeited or expired	-51		73.57
	Balance—December 31, 2013	1,959		60.12				7.4		$	46.3
	Vested—December 31, 2013	1,119		50.24				6.5		$	37.5
	Vested and expected to vest—December 31, 2013	1,940		59.98				7.4		$	46.1
Summary of performance share awards activity	'
	Grant Date		Performance Cycle		Shares Granted		Weighted-				Performance
			Measurement Date		and Earned		Average Grant-				Shares
					(in thousands)		Date Fair				Outstanding at
							Value				December 31, 2013
	27-Feb-13		Annually on 12/31		203		$	72.3			143
	March 2, 2012		Annually on 12/31		418		$	67.22			197
	March 2, 2011		Annually on 12/31		275		$	57.03			79
Summary of restricted stock unit activity	'
		Shares			Weighted-
		(in thousands)			Average Grant
					Date Fair
					Value
	Nonvested restricted stock units—January 1, 2011	588			$	35.15
	Granted	134			59.4
	Vested	(170	)		44.44
	Forfeited	(19	)		40.39
	Nonvested restricted stock units—December 31, 2011	533			38.09
	Granted	146			76.98
	Vested	(146	)		32.28
	Forfeited	(19	)		47.57
	Nonvested restricted stock units—December 31, 2012	514			50.24
	Granted	133			74.85
	Vested	(189	)		39.14
	Forfeited	(35	)		62.68
	Nonvested restricted stock units—December 31, 2013	423			61.59
Summary of stock-based compensation expense by award type	'
		Years Ended December 31,
	(In millions)	2013				2012				2011
	Stock options	$	6.5			$	7.5			$	5.9
	Performance share awards	16.1				16.1				22.8
	Restricted stock units	10				8.6				11.2
	Total pre-tax stock-based compensation expense	$	32.6			$	32.2			$	39.9
	Net tax benefit related to stock-based compensation expense	$	(11.4	)		$	(9.8	)		$	(14.1	)
Schedule of stock-based compensation expense recognized in the consolidated statements of earnings	'
		Years Ended December 31,
	(Dollars in millions)	2013				2012				2011
	Cost of products sold	$	3			$	3			$	4
	Selling, general and administrative	26.6				26.2				31.9
	Research and development	3				3				4
	Total stock-based compensation expense	$	32.6			$	32.2			$	39.9

PENSION_AND_OTHER_POSTEMPLOYME1

PENSION AND OTHER POST-EMPLOYMENT BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2013
General Discussion of Pension and Other Postretirement Benefits [Abstract]	'
Schedule of changes in benefit obligations, plan assets, funded status and amounts recognized in the balance sheet	'
		Pension Benefits								Other Benefits
	(In millions)	2013				2012				2013			2012
	Beginning benefit obligations	$	463.6			$	402.7			$	35.1		$	30.2
	Service cost—benefits earned during the year	5.2				3.9				1.1			1
	Interest cost on projected benefit obligations	14.4				15.6				1.3			1.3
	Actuarial assumptions (gains) losses	(25.7		)		72.2				(3.8		)	2.6
	Settlements and curtailments	(50.4		)		(30.9		)		—			—
	Benefits paid	(2.8		)		(2.2		)		(1.3		)	(0.1		)
	Exchange rate changes	(0.3		)		2.3				0.2			0.1
	Benefit obligations at end of year	$	404			$	463.6			$	32.6		$	35.1
	Beginning fair value of plan assets	$	312.1			$	280.7			$	—		$	—
	Actual return on plan assets	(1.4		)		32.8				—			—
	Employer contributions	18.5				28.2				0.9			0.1
	Settlements	(50.4		)		(29.3		)		—			—
	Benefits paid	(2.8		)		(2.2		)		(1.3		)	(0.1		)
	Exchange rate changes	0.1				1.9				0.4			—
	Fair value of plan assets at end of year	$	276.1			$	312.1			$	—		$	—
	Underfunded status at end of year	$	(127.9	)		$	(151.5	)		$	(32.6	)	$	(35.1	)
	Amounts in the consolidated balance sheets include:
	Other assets	$	1.3			$	2.2			$	—		$	—
	Pension, post-retirement and post employment liabilities	(129.2		)		(153.7		)		(32.6		)	(35.1		)
	Balance in the consolidated balance sheet at end of year	$	(127.9	)		$	(151.5	)		$	(32.6	)	$	(35.1	)
	Amounts in accumulated other comprehensive loss include:
	Prior service (benefit)	1.2				—				(0.3		)	(0.5		)
	Transition obligation	0.1				0.2				—			—
	Balance in accumulated other comprehensive loss at end of year	$	1.3			$	0.2			$	(0.3	)	$	(0.5	)
	Accumulated benefit obligation	$	375.7			$	428			$	32.6		$	35.1
Schedule of accumulated benefit obligation in excess of plan assets	'
		Years Ended
		December 31,
	(In millions)	2013				2012
	Projected benefit obligation	$	366.3			$	449.3
	Accumulated benefit obligation	356.1				430.2
	Fair value of pension plan assets	210.8				263.1
Schedule of net periodic benefit cost	'
		Pension Benefits											Other Benefits
		Years Ended											Years Ended
		December 31,											December 31,
	(In millions)	2013				2012				2011			2013				2012			2011
	Service cost — benefits earned during the period	$	5.2			$	3.9			$	3.5		$	1.1			$	1		$	0.9
	Interest cost on projected benefit obligations	14.4				15.6				17			1.3				1.3			1.3
	Expected return on pension plan assets	$	(17.1	)		$	(16.6	)		$	(19.1	)	$	—			$	—		$	—
	Amortization of prior service (benefit)	—				—				—			(0.2		)		(0.2		)	(0.2		)
	Amortization of transition cost	0.1				0.1				0.1			—				—			—
	Sub-total	$	2.6			$	3			$	1.5		$	2.2			$	2.1		$	2
	Net actuarial (gains) losses	(8.2		)		56.3				87.5			(3.8		)		2.6			4
	Curtailments	—				(1.4		)		—			—				—			—
	Total Pension and Other Post-Employment Benefit costs:	$	(5.6	)		$	57.9			$	89		$	(1.6	)		$	4.7		$	6
Schedule of weighted-average assumptions used to determine benefit obligations and net periodic benefit cost	'
		Pension Benefits						Other Benefits
		December 31,						December 31,
		2013			2012			2013			2012
	Discount rate	4.08	%		3.21	%		4.98	%		3.75	%
	Rate of compensation increase	3.22	%		3.58	%		3.08	%		3.48	%
	The discount rate was determined based on the yield to maturity of high-quality corporate bonds and considering the duration of the pension plan obligations. The Citigroup Pension Discount Curve is used in developing the discount rate for the U.S. Pension Plan.
	Weighted-average assumptions used to determine net periodic benefit cost are established at the beginning of the plan year and were as follows:
		Pension Benefits									Other Benefits
		Years Ended									Years Ended
		December 31,									December 31,
		2013			2012			2011			2013		2012			2011
	Discount rate	3.26	%		4.03	%		5.59	%		3.75	%	4.29	%		5.28	%
	Expected long term return on pension plan assets	5.22	%		5.65	%		6.91	%		—	%	—	%		—	%
	Rate of compensation increase	3.59	%		4	%		4.02	%		3.48	%	3.94	%		3.94	%
Schedule of assumed health care cost trend rates	'
		December 31,
		2013			2012			2011
	Health care cost trend rate assumed for next year	6.9	%		7.8	%		7.4	%
	Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	4.9	%		4.9	%		5	%
	Year that the rate reaches the ultimate trend rate	2023			2023			2017
Schedule of effect of one-percentage-point change in assumed health care cost trend rates	'
	(In millions)	1-Percentage-Point				1-Percentage-Point
		Increase				Decrease
	Effect on total of service and interest cost	$	—			$	—
	Increase/(decrease) in post-employment benefit obligation	0.2				0.3
Schedule of fair values of the pension plan assets by asset category	'
		December 31, 2013											December 31, 2012
	(In millions)	Total				Level 1				Level 2			Total				Level 1			Level 2
	Cash and cash equivalents	$	13			$	13			$	—		$	11.4			$	11.4		$	—
	Equity securities:
	U.S. large-cap	16.3				—				16.3			13.6				—			13.6
	U.S. mid-cap growth	3.1				—				3.1			2.8				—			2.8
	U.S. small-cap growth	0.1				—				0.1			1.5				—			1.5
	Emerging markets	2.8				—				2.8			3.1				—			3.1
	Real estate investment trusts	5.6				—				5.6			13.4				—			13.4
	International large-cap value	37				8.5				28.5			28.3				—			28.3
	Hedge fund	17.4				—				17.4			15.7				—			15.7
	Fixed income securities:
	Government bonds	72.8				—				72.8			83.5				—			83.5
	Corporate bonds	101.7				—				101.7			138.8				—			138.8
	Emerging markets	6.3				—				6.3			—				—			—
	Total	$	276.1			$	21.5			$	254.6		$	312.1			$	11.4		$	300.7
Schedule of estimated future benefit payments expected to be paid	'
	(In millions)	Pension				Other
		Benefits				Benefits
	2014	$	29.3			$	0.8
	2015	29.5				1
	2016	29.5				1.1
	2017	30.8				1.1
	2018	29.7				1.3
	Years 2019 - 2023	147.8				6.5

OTHER_EXPENSESNET_Tables

OTHER EXPENSES-NET (Tables)	12 Months Ended
	Dec. 31, 2013
Other Income and Expenses [Abstract]	'
Components of other expenses/(income) net	'
	The components of other expenses—net were:
		Years Ended December 31,
	(In millions)	2013			2012			2011
	Foreign exchange (gains)/losses—net	$	9.3		$	(3.1	)	$	(9.7	)
	Administrative penalty (China)	33.4			—			—
	Severance and other costs	2.2			8			9.9
	Gain on sale of non-core intangible assets	—			(6.5		)	—
	Legal settlements	7			—			—
	Other—net	(3.4		)	6.4			9.7
	Other expenses—net	$	48.5		$	4.8		$	9.9

RECEIVABLES_Tables

RECEIVABLES (Tables)	12 Months Ended
	Dec. 31, 2013
Receivables Abstract [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
		December 31,
	(In millions)	2013			2012
	Trade receivables	$	335.7		$	330
	Miscellaneous receivables	55.2			42.2
	Less allowances	(6.5		)	(7.6		)
	Receivables—net	$	384.4		$	364.6

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Major categories of inventories	'
	(In millions)	December 31, 2013		December 31, 2012
	Finished goods	$	312.7	$	264.6
	Work in process	82.5		56.9
	Raw and packaging materials	139.6		114.4
	Inventories	$	534.8	$	435.9

LONG_LIVED_ASSETS_Tables

LONG LIVED ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
PROPERTY, PLANT AND EQUIPMENT	'
	The major categories of property, plant, and equipment were as follows:
	(In millions)	December 31, 2013			December 31, 2012
	Land	$	12.6		$	6
	Buildings	550.8			506
	Machinery, equipment, and fixtures	650.3			595.7
	Construction in progress	260.9			150.4
	Accumulated depreciation	(607.1		)	(568.2		)
	Property, plant, and equipment—net	$	867.5		$	689.9
Schedule of gross carrying value and accumulated amortization by class of intangible assets	'
	The gross carrying value and accumulated amortization by class of intangible assets were as follows:
		As of December 31, 2013								As of December 31, 2012
	(In millions)	Gross			Accumulated			Net Book		Gross		Accumulated			Net Book
		Carrying			Amortization			Value		Carrying		Amortization			Value
		Amount								Amount
	Indefinite-lived intangible assets
	Trademark(1) .	$	34.5		$	—		$	34.5	$	45.3	$	—		$	45.3
	Non-compete agreement(1) .	6.8			—			6.8		8.9		—			8.9
	Total	41.3			—			41.3		54.2		—			54.2
	Amortizable intangible assets
	Computer software	132.8			(79.3		)	53.5		132.2		(60.2		)	72
	Distributor-customer relationship(2) 10 year life	3.3			(0.6		)	2.7		4.4		(0.7		)	3.7
	Total	136.1			(79.9		)	56.2		136.6		(60.9		)	75.7
	Total other intangible assets	$	177.4		$	(79.9	)	$	97.5	$	190.8	$	(60.9	)	$	129.9
Schedule of Expected Amortization Expense [Table Text Block]	'
	Expected amortization expense related to intangible assets is as follows:
	(In millions)
	Years Ending December 31,
	2014	$	16
	2015	15
	2016	12.3
	2017	9.4
	2018	1.8
	Later years	1.7

GOODWILL_Tables

GOODWILL (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Change in carrying amount of goodwill by reportable segment	'
	For the year ended December 31, 2013 and 2012, the change in the carrying amount of goodwill by reportable segment, including the cumulative impact of the revisions described above, was as follows:
	(In millions)	Asia		Latin America			North America/			Total
							Europe
	Balance as of January 1, 2012	$	—	$	115.8		$	1.7		$	117.5
	Acquisition	—		155.5			17.3			172.8
	Translation adjustments	—		(17.7		)	(2.0		)	(19.7		)
	Balance as of December 31, 2012	—		253.6			17			270.6
	Redenomination	—		(42.5		)	2			(40.5		)
	Translation adjustments	—		(33.3		)	—			(33.3		)
	Balance as of December 31, 2013	$	—	$	177.8		$	19		$	196.8

DEBT_Tables

DEBT (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Components of long-term debt	'
	The components of long-term debt were as follows:
	(Dollars in millions)		December 31, 2013				December 31, 2012
	Principal Value:
	3.50% Notes due 2014		$	500			$	500
	4.90% Notes due 2019		700				700
	5.90% Notes due 2039		300				300
	Subtotal		1,500.00				1,500.00
	Adjustments to Principal Value:
	Unamortized basis adjustment for terminated interest rate swaps		16.7				26
	Unamortized bond discount		(2.0		)		(2.8		)
	Less amount due within one year		505.6				—
	Long-term debt		$	1,009.10			$	1,523.20
Components of interest expense-net	'
	The components of interest expense-net were as follows:
		Years Ended December 31,
	(In millions)	2013				2012				2011
	Interest expense	$59.20				$70.90				$	60.2
	Interest income	(8.6		)		(5.9		)		(8.0		)
	Interest expense-net	$50.60				$65.00				$	52.2
	Interest payments, net of amounts related to interest rate swaps	$	72			$	74.9			$	61.4

DERIVATIVES_AND_OTHER_FINANCIA1

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of fair value of outstanding derivatives	'
				December 31,
	(In millions)	Balance Sheet Location		2013				2012
	Cash flow hedges:
	Foreign exchange contracts	Other assets		$	4.2			$	—
	Interest rate forward swaps	Other assets		19.9				—
	Foreign exchange contracts	Accrued expenses		(0.5		)		(5.1		)
	Net asset/(liability) of derivatives designated as hedging items			$	23.6			$	(5.1	)
Schedule Of Outstanding Foreign Exchange Forward Contracts	'
	(Dollars in millions)		Weighted-average		Notional				Fair Value				Maturity
			Forward Rate		Amount				Asset
	Foreign exchange contracts:
	Cash flow hedges:
	Mexican peso		13.07		84				0.7				2014
	Malaysian ringgit		3.18		55				2				2014
	Philippine peso		43.48		62.4				1				2014
	Total foreign exchange contracts				$	201.4			$	3.7
Schedule of change in accumulated other comprehensive income (loss) and the impact on earnings from foreign exchange contracts	'
	(In millions)	2013				2012
	Balance—January 1	$	(4.1	)		$	4.3
	Derivatives qualifying as cash flow hedges deferred in other comprehensive income	4.8				(12.7		)
	Derivatives qualifying as cash flow hedges reclassified to cost of products sold (effective portion)	5.4				0.8
	Change in deferred taxes	(2.9		)		3.5
	Balance—December 31	$	3.2			$	(4.1	)
Schedule of impact on earnings from interest rate swaps	'
		(Gain) Loss on Marked												(Gain) Loss on Marked
		to Market Swaps												to Market of
														Hedged Items
	(In millions)	2013				2012				2011				2013		2012		2011
	Interest expense—net	$	—			$	—			$	(4.2	)		$	—	$	—	$	4.2
	The impact on earnings from interest rate swaps that qualified as fair value hedges was as follows:
	(In millions)	2013				2012				2011
	Recognized in interest expense	$	—			$	—			$	(6.3	)
	Amortization of basis adjustment for terminated interest rate swaps recognized in interest expense	(9.2		)		(9.3		)		(5.5		)
	Total	$	(9.2	)		$	(9.3	)		$	(11.8	)
	See Note 15 for discussion on the Company’s debt.

EQUITY_Tables

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	Changes in accumulated other comprehensive loss by component were as follows:
	(In millions)		Foreign Currency Translation Adjustments			Deferred Gains/(Losses) on Derivatives Qualifying as Hedges			Pension and Other Post-employment Benefits			Total			Noncontrolling Interest					Redeemable Noncontrolling Interest
	Balance as of January 1, 2013		$	(14.6	)	$	(4.1	)	$	0.3		$	(18.4	)	$	(0.2	)			$	—
	Deferred Gains/(Losses)		(79.4		)	24.2			(1.1		)	(56.3		)	3.3			1		(14.4		)	1
	Reclassification Adjustment for		—			5.4			(0.2		)	5.2			—					—
	(Gains)/Losses Included in Net
	Earnings
	Tax Benefit/(Expense)		10.4			(10.1		)	—			0.3			(1.2		)			—
	Balance as of December 31, 2013		$	(83.6	)	$	15.4		$	(1.0	)	$	(69.2	)	$	1.9				$	(14.4	)
	1 Represents foreign currency translation adjustments.
	Reclassification adjustments out of accumulated other comprehensive loss were as follows:
			31-Dec-13
			Affected Statement of Earnings Lines
	(In millions)		Cost of Products Sold			Selling, General and Administrative			Research and Development			Other Expenses/ (Income) - Net			Tax Benefit/(Expense)				Net
	Deferred Gains/(Losses) on Derivatives Qualifying as Hedges:
	Forward Exchange Contracts		$	(5.4	)										$	1.6			$	(3.8	)
	Pension and Other Post-employment Benefit Plans:
	Prior Service Benefits		0.1			0.1													0.2
	Total Reclassifications		$	(5.3	)	$	0.1		$	—		$	—		$	1.6			$	(3.6	)
Schedule of changes in common shares and treasury stock	'
	Changes in common shares and treasury stock were as follows:
	(In millions)	Common Shares			Treasury Stock		Cost of Treasury
		Issued					Stock
	Balance as of January 1, 2011	204.8			0.1		$	3.2
	Stock-based compensation	0.3			—		4.9
	Treasury stock purchases	—			1.3		81.6
	Balance as of December 31, 2011	205.1			1.4		$	89.7
	Stock-based compensation	0.9			0.2		15.2
	Treasury stock purchases	—			1.9		139.7
	Balance as of December 31, 2012	206			3.5		$	244.6
	Stock-based compensation	0.8			0.2		18.9
	Treasury stock purchases	—			1.1		88.4
	Balance as of December 31, 2013	206.8			4.8		$	351.9

LEASES_Tables

LEASES (Tables)	12 Months Ended
	Dec. 31, 2013
Leases [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	(In millions)
	Years Ending December 31,
	2014	$	36.4
	2015	29.5
	2016	20.8
	2017	15.5
	2018	14.3
	Later Years	22.3
	Total Minimum Payments	$	138.8

SELECTED_QUARTERLY_FINANCIAL_D1

SELECTED QUARTERLY FINANCIAL DATA(UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Schedule of Quarterly Financial Information [Table Text Block]	'
	Dollars in Millions, Except Per Share Data	First		Second		Third		Fourth		Year
		Quarter		Quarter		Quarter		Quarter
	2013:00:00
	Net sales	$	1,037.90	$	1,055.30	$	1,046.80	$	1,060.70	$	4,200.70
	Gross profit	$	652.9	$	673.3	$	684.5	$	661.5	$	2,672.20
	Net earnings	$	190	$	173.4	$	169.7	$	156.1	$	689.2
	Net earnings attributable to shareholders	$	188	$	172	$	171.3	$	152.5	$	683.8
	Basic earnings per share	$	0.93	$	0.85	$	0.85	$	0.75	$	3.37
	Diluted earnings per share	$	0.92	$	0.84	$	0.84	$	0.75	$	3.36
	2012:00:00
	Net sales	$	986.6	$	1,012.30	$	921.3	$	981.1	$	3,901.30
	Gross profit	$	613.8	$	635.6	$	565.6	$	582.5	$	2,397.50
	Net earnings	$	172.6	$	168.9	$	145.2	$	101.6	$	588.3
	Net earnings attributable to shareholders	$	167	$	163.6	$	146.3	$	103.5	$	580.4
	Basic earnings per share	$	0.82	$	0.8	$	0.72	$	0.51	$	2.84
	Diluted earnings per share	$	0.81	$	0.8	$	0.71	$	0.51	$	2.83

ACCOUNTING_POLICIES_Details

ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenue Recognition	'	'	'
WIC rebate accruals	$199.70	$206.50	'
Reduction in revenue due to rebates under the WIC program	702.3	730	700.7
Sales return accruals	44.8	46.4	'
Reduction in sales due to sales returns	81	82.5	81.8
Cash and Cash Equivalents	'	'	'
Maximum Term of Original Maturity to Classify Instruments as Cash and Cash Equivalents(months)	'3 months	'	'
Money market funds, classified as Level Two	$447.80	$520.70	'

ACCOUNTING_POLICIES_Details_2

ACCOUNTING POLICIES (Details 2)	12 Months Ended
	Dec. 31, 2013
Buildings	'
Capital Assets and Depreciation	'
Estimated useful life, property, plant and equipment (in years)	'50 years
Lower limit	'
Finite-Lived Intangible Assets, Net [Abstract]	'
Estimated useful life, capitalized software (in years)	'3 years
Lower limit | Machinery, equipment, and fixtures	'
Capital Assets and Depreciation	'
Estimated useful life, property, plant and equipment (in years)	'3 years
Upper limit	'
Finite-Lived Intangible Assets, Net [Abstract]	'
Estimated useful life, capitalized software (in years)	'7 years
Upper limit | Machinery, equipment, and fixtures	'
Capital Assets and Depreciation	'
Estimated useful life, property, plant and equipment (in years)	'40 years

ACCOUNTING_POLICIES_Details_3

ACCOUNTING POLICIES (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accounting Policies [Abstract]	'	'	'
Cash-flow hedge discontinuation number of days from original forecasted transaction date	'60 days	'	'
Shipping and handling costs	'	'	'
Shipping and handling costs, including warehousing expenses	$119.10	$115.60	$104.30
Advertising Costs	'	'	'
Advertising costs	$226.70	$180.30	$180.60

ACCOUNTING_POLICIES_Accounting

ACCOUNTING POLICIES Accounting change table (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
												Scenario, Previously Reported [Member]	Scenario, Previously Reported [Member]	Scenario, Previously Reported [Member]	Scenario, Adjustment [Member]	Scenario, Adjustment [Member]	Scenario, Adjustment [Member]	Scenario, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'
Annual recognition of actuarial gains/(losses)	'	'	'	'	'	'	'	'	($12)	$58.90	$91.50	'	'	'	'	'	'	'
Cost of Goods Sold	'	'	'	'	'	'	'	'	1,528.50	1,503.80	1,391	1,532.80	1,485.30	1,362.30	-4.3	18.5	28.7	'
Selling, General and Administrative Expense	'	'	'	'	'	'	'	'	903.5	904.5	975.4	918	877.8	926.8	-14.5	26.7	48.6	'
Research and Development Expense	'	'	'	'	'	'	'	'	100.2	100.1	100.8	102.4	95.4	92.5	-2.2	4.7	8.3	'
Other Expensesbnet	'	'	'	'	'	'	'	'	48.5	4.8	9.9	77.8	20	19.6	-29.3	-15.2	-9.7	'
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	974.9	835.3	698.2	924.6	870	774.1	50.3	-34.7	-75.9	'
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest	'	'	'	'	'	'	'	'	924.3	770.3	646	874	805	721.9	50.3	-34.7	-75.9	'
Provision for Income Taxes	'	'	'	'	'	'	'	'	235.1	182	178.8	219.1	192.6	202.9	16	-10.6	-24.1	'
NET EARNINGS	156.1	169.7	173.4	190	101.6	145.2	168.9	172.6	689.2	588.3	467.2	654.9	612.4	519	34.3	-24.1	-51.8	'
Net earnings attributable to shareholders	152.5	171.3	172	188	103.5	146.3	163.6	167	683.8	580.4	456.7	649.5	604.5	508.5	34.3	-24.1	-51.8	'
Net Earnings Attributable to Shareholders (in dollars per share)	$0.75	$0.85	$0.85	$0.93	$0.51	$0.72	$0.80	$0.82	$3.37	$2.84	$2.23	$3.20	$2.96	$2.48	$0.17	($0.12)	($0.25)	'
Net Earnings Attributable to Shareholders (in dollars per share - diluted)	$0.75	$0.84	$0.84	$0.92	$0.51	$0.71	$0.80	$0.81	$3.36	$2.83	$2.22	$3.19	$2.95	$2.47	$0.17	($0.12)	($0.25)	'
Deferred Gains/(Losses) on Pension and Other Postemployment Benefits	'	'	'	'	'	'	'	'	-1.1	0	0	11.6	-58.5	-90.7	-12.7	58.5	90.7	'
Reclassification Adjustment for Losses Included in Net Earnings	'	'	'	'	'	'	'	'	-0.2	0	-0.2	37.5	23.8	14.6	-37.7	-23.8	-14.8	'
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax	'	'	'	'	'	'	'	'	0	0	0	-16.1	10.6	24.1	16.1	-10.6	-24.1	'
AdditionalPaidinDistributedCapital	-721.5	'	'	'	-772.8	'	'	'	-721.5	-772.8	'	-625.3	-676.6	'	-96.2	-96.2	'	96.2
Retained Earnings	1,432.30	'	'	'	1,052.40	'	'	'	1,432.30	1,052.40	'	1,470.40	1,124.80	'	-38.1	-72.4	'	3.5
Accumulated Other Comprehensive Loss	-69.2	'	'	'	-18.4	'	'	'	-69.2	-18.4	'	-203.5	-187	'	134.3	168.6	'	'
Deferred Income Tax	'	'	'	'	'	'	'	'	23	6.5	-57.4	7	17.1	-33.3	16	-10.6	-24.1	'
Pension and Other Post Retirement Benefits Expense	'	'	'	'	'	'	'	'	($7.20)	$62.60	$95	$43.10	$27.90	$19.10	($50.30)	$34.70	$75.90	'

EARNINGS_PER_SHARE_Details

EARNINGS PER SHARE (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Basic earnings per share:	'	'	'	'	'	'	'	'	'	'	'
Weighted-average shares outstanding	'	'	'	'	'	'	'	'	202.4	203.6	204.3
Net earnings attributable to shareholders	$152.50	$171.30	$172	$188	$103.50	$146.30	$163.60	$167	$683.80	$580.40	$456.70
Dividends and undistributed earnings attributable to unvested shares	'	'	'	'	'	'	'	'	-1.3	-1.3	-1.3
Net earnings attributable to shareholders used for basic earnings per share calculation	'	'	'	'	'	'	'	'	682.5	579.1	455.4
Net Earnings Attributable to Shareholders (in dollars per share)	$0.75	$0.85	$0.85	$0.93	$0.51	$0.72	$0.80	$0.82	$3.37	$2.84	$2.23
Diluted earnings per share:	'	'	'	'	'	'	'	'	'	'	'
Weighted-average shares outstanding	'	'	'	'	'	'	'	'	202.4	203.6	204.3
Incremental shares outstanding assuming the exercise/vesting of dilutive stock options/performance shares	'	'	'	'	'	'	'	'	0.7	0.7	0.7
Weighted-average shares - diluted	'	'	'	'	'	'	'	'	203.1	204.3	205
Net earnings attributable to shareholders	152.5	171.3	172	188	103.5	146.3	163.6	167	683.8	580.4	456.7
Dividends and undistributed earnings attributable to unvested shares	'	'	'	'	'	'	'	'	-1.3	-1.3	-1.3
Net earnings attributable to shareholders used for diluted earnings per share calculation	'	'	'	'	'	'	'	'	$682.50	$579.10	$455.40
Net Earnings Attributable to Shareholders (in dollars per share - diluted)	$0.75	$0.84	$0.84	$0.92	$0.51	$0.71	$0.80	$0.81	$3.36	$2.83	$2.22
Potential shares outstanding	2.8	'	'	'	2.7	'	'	'	2.8	2.7	2.9
Potential shares outstanding, not included in the diluted earnings per share calculation	'	'	'	'	'	'	'	'	2.1	2	2.2

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Components of earnings before income taxes	'	'	'
U.S	$141.90	$105.90	$85
Non-U.S.	782.4	664.4	561
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest	924.3	770.3	646
U.S. federal	79.1	37.1	81.3
U.S. states	2.4	-1.3	10.7
Non-U.S.	130.6	139.7	144.2
Current Income Tax Expense (Benefit)	212.1	175.5	236.2
U.S. federal	-6.4	7.9	-27.3
U.S. states	1.9	-4	-6.2
Non-U.S.	27.5	2.6	-23.9
Deferred Income Tax Expense (Benefit)	23	6.5	-57.4
Income Tax Expense (Benefit)	235.1	182	178.8
Provision for income taxes	'	'	'
U.S. statutory rate	323.5	269.6	226.1
State and local taxes	1.3	0.8	3.7
Foreign income taxed at different rates	-25.6	-67.7	-42.1
Repatriation of foreign income	9.4	21.6	21.8
Tax rulings	-121.9	-46.4	-51.9
Reversal of deferred tax on prior years' unremitted earnings due to reinvestment assertion	-8.2	-8.7	0
Administrative penalty related to China antitrust review	8.3	0	0
Unrecognized taxbenefits and related interest penalties	38.1	13.1	7.3
Other	$10.20	($0.30)	$13.90
Effective income tax rate reconciliation	'	'	'
U.S. statutory rate (as a percent)	35.00%	35.00%	35.00%
State and local taxes (as a percent)	0.10%	0.10%	0.60%
Foreign income taxed at different rates (as a percent)	-2.80%	-8.80%	-6.50%
Repatriation of foreign income (as a percent)	1.00%	2.80%	3.40%
Tax rulings (as a percent)	-13.20%	-6.00%	-8.00%
Reversal of deferred tax on prior years' due to reinvestmt assertion (as a percent)	-0.90%	-1.10%	0.00%
Effective Income Tax Rate Reconciliation change admin penalty China	0.90%	0.00%	0.00%
Effective Income Tax Rate Reconciliation Unrecognized tax benefits and related interest penalties	4.10%	1.70%	1.10%
Other (as a percent)	1.20%	-0.10%	2.10%
Effective tax rate (as a percent)	25.40%	23.60%	27.70%

INCOME_TAXES_Details_2

INCOME TAXES (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Deferred tax assets:	'	'	'
Accrued expenses	$33,500,000	$28,000,000	'
Accrued rebates and returns	42,200,000	44,500,000	'
Pension, post retirement and post employment liabilities	58,100,000	65,300,000	'
Stock-based compensation	20,200,000	18,300,000	'
Obsolescence reserves and other inventory items	7,900,000	6,300,000	'
Net operating loss carryforwards	13,500,000	17,200,000	'
Other-net	6,700,000	23,200,000	'
Valuation allowance	-7,300,000	-6,100,000	'
Deferred Tax Assets, Net of Valuation Allowance	174,800,000	196,700,000	'
Deferred tax liabilities:	'	'	'
Depreciation and amortization	-68,500,000	-76,500,000	'
Unremitted earnings and cumulative foreign currency translation adjustments	-9,700,000	-26,100,000	'
Deferred Tax Liabilities, Net	78,200,000	102,600,000	'
Deferred Tax Assets, Net	96,600,000	94,100,000	'
Recognized as:	'	'	'
Deferred income taxes-current-net	74,900,000	85,500,000	'
Deferred income taxes-noncurrent-net	21,700,000	8,600,000	'
Deferred Tax Assets, Net	96,600,000	94,100,000	'
Gross net operating loss (NOL) carryforwards	49,000,000	'	'
Operating Loss Carryforwards - indefinite lived	22,300,000	'	'
Increase (decrease) in valuation allowance recorded for NOL carryforwards	5,000,000	'	'
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	6,900,000	'	'
State tax credit carryforwards valuation allowance	2,300,000	'	'
Income taxes paid	159,300,000	226,800,000	174,300,000
Undistributed Earnings of Foreign Subsidiaries	1,400,000,000	'	'
Deferred tax liability not recognized on undistributed foreign earnings	$494,000,000	'	'

INCOME_TAXES_Details_3

INCOME TAXES (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Reconciliation of the Company's changes in gross uncertain tax positions	'	'	'	'
Gross reserve for uncertain tax positions related to foreign and domestic matters, including penalties and interest	$102.60	$64.70	$29.70	$13.60
Increases based on current year tax positions	23.8	17.8	14.6	'
Decreases based on current year tax positions	0	0	0	'
Increases based on prior year tax positions	18.9	21.4	1.7	'
Decreases based on prior year tax positions	0	0	-0.3	'
Settlements	0	0	-0.1	'
Lapse of statute of limitations	-3.8	-5.2	0	'
Cumulative translation adjustment	-1	1	0.2	'
Unrecognized Tax Benefits reversing within 12 months	10	'	'	'
Amounts of uncertain tax positions that, if recognized, would impact effective tax rate	48.6	18.9	10.9	'
Interest and penalties related to uncertain tax positions, included in other liabilities	14.8	11.2	'	'
Amount of interest and penalties included as a component of provision for income taxes	$3	$5	$0.60	'

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
									Segment
Segment Reporting [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Number of geographic operating segments	'	'	'	'	'	'	'	'	4	'	'
Number of reportable segments	'	'	'	'	'	'	'	'	3	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Net Sales	$1,060.70	$1,046.80	$1,055.30	$1,037.90	$981.10	$921.30	$1,012.30	$986.60	$4,200.70	$3,901.30	$3,677
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	974.9	835.3	698.2
Assets	3,474.10	'	'	'	3,258.20	'	'	'	3,474.10	3,258.20	2,766.80
Payments for Capital Expenditures	'	'	'	'	'	'	'	'	240.4	124.4	109.5
Depreciation and Amortization	'	'	'	'	'	'	'	'	83.1	76.9	75.3
North America Europe and Latin America [Member] [Member] | Customer one	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Percentage of the entity's gross sales	'	'	'	'	'	'	'	'	10.00%	11.00%	12.00%
North America/Europe	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Net Sales	'	'	'	'	'	'	'	'	1,160	1,181.80	1,229.80
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	255	251.9	312.7
Assets	798.5	'	'	'	740.5	'	'	'	798.5	740.5	764
Payments for Capital Expenditures	'	'	'	'	'	'	'	'	31.6	22.3	33.4
Depreciation and Amortization	'	'	'	'	'	'	'	'	29.1	27.4	30.7
Total operating segments	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Net Sales	'	'	'	'	'	'	'	'	4,200.70	3,901.30	3,677
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	1,258.40	1,154.50	1,124.40
Assets	2,906.10	'	'	'	2,550.60	'	'	'	2,906.10	2,550.60	2,240
Payments for Capital Expenditures	'	'	'	'	'	'	'	'	233	120.4	79.4
Depreciation and Amortization	'	'	'	'	'	'	'	'	59	53.2	55.5
Corporate And Other	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Net Sales	'	'	'	'	'	'	'	'	0	0	0
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	-283.5	-319.2	-426.2
Assets	568	'	'	'	707.6	'	'	'	568	707.6	526.8
Payments for Capital Expenditures	'	'	'	'	'	'	'	'	7.4	4	30.1
Depreciation and Amortization	'	'	'	'	'	'	'	'	24.1	23.7	19.8
Asia [Member]	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Net Sales	'	'	'	'	'	'	'	'	2,179.30	1,967	1,827.80
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	796.2	725.4	672.5
Assets	1,390.70	'	'	'	1,097.30	'	'	'	1,390.70	1,097.30	1,008.60
Payments for Capital Expenditures	'	'	'	'	'	'	'	'	168.1	87.4	34
Depreciation and Amortization	'	'	'	'	'	'	'	'	19.4	16.9	17.2
Asia [Member] | Customer two	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Percentage of the entity's gross sales	'	'	'	'	'	'	'	'	16.00%	15.00%	14.00%
Latin America	'	'	'	'	'	'	'	'	'	'	'
Concentration Risk	'	'	'	'	'	'	'	'	'	'	'
Net Sales	'	'	'	'	'	'	'	'	861.4	752.5	619.4
EARNINGS BEFORE INTEREST AND INCOME TAXES	'	'	'	'	'	'	'	'	207.2	177.2	139.2
Assets	716.9	'	'	'	712.8	'	'	'	716.9	712.8	467.4
Payments for Capital Expenditures	'	'	'	'	'	'	'	'	33.3	10.7	12
Depreciation and Amortization	'	'	'	'	'	'	'	'	$10.50	$8.90	$7.60

SEGMENT_INFORMATION_Details_2

SEGMENT INFORMATION (Details 2) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	$1,060.70	$1,046.80	$1,055.30	$1,037.90	$981.10	$921.30	$1,012.30	$986.60	$4,200.70	$3,901.30	$3,677
Infant Formula	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	2,459.70	2,295.50	2,188.70
Children's Nutrition	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	1,653.30	1,487	1,394.40
Other.	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	$87.70	$118.80	$93.90

SEGMENT_INFORMATION_Details_3

SEGMENT INFORMATION (Details 3) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	$1,060.70	$1,046.80	$1,055.30	$1,037.90	$981.10	$921.30	$1,012.30	$986.60	$4,200.70	$3,901.30	$3,677
Long-Lived Assets	1,319	'	'	'	1,243.20	'	'	'	1,319	1,243.20	860.6
United States	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	948.2	990.1	1,019.70
Long-Lived Assets	446.6	'	'	'	456	'	'	'	446.6	456	457.3
China / Hong Kong	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	1,315.80	1,160.10	1,083.50
Long-Lived Assets	64.7	'	'	'	65.1	'	'	'	64.7	65.1	60.7
Mexico	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	328.2	317.2	321
Long-Lived Assets	134.8	'	'	'	180.1	'	'	'	134.8	180.1	171.6
SINGAPORE	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	28	22.5	20.8
Long-Lived Assets	245.9	'	'	'	104.9	'	'	'	245.9	104.9	1.3
Other	'	'	'	'	'	'	'	'	'	'	'
SEGMENT INFORMATION	'	'	'	'	'	'	'	'	'	'	'
NET SALES	'	'	'	'	'	'	'	'	1,580.50	1,411.40	1,232
Long-Lived Assets	$427	'	'	'	$437.10	'	'	'	$427	$437.10	$169.70

EMPLOYEE_STOCK_BENEFIT_PLANS_D

EMPLOYEE STOCK BENEFIT PLANS (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of shares approved	25,000,000	'	'	'
Percentage of market price at which executive officers and key employees may be granted options to purchase common stock	100.00%	'	'	'
Term of awards	'3 years	'	'	'
Assumptions used to calculate fair value of stock options	'	'	'	'
Expected volatility (as a percent)	27.00%	26.90%	26.70%	'
Risk-free interest rate (as a percent)	0.90%	1.20%	2.60%	'
Dividend yield (as a percent)	1.90%	1.60%	1.70%	'
Expected life (in years)	'5 years 3 months 20 days	'6 years	'6 years	'
Stock option, Shares	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,959,000	1,902,000	1,789,000	1,404,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	485,000	491,000	558,000	'
Exercised (in shares)	-377,000	-325,000	-140,000	'
Forfeited or expired (in shares)	-51,000	-53,000	-33,000	'
Vested (in shares)	1,119,000	'	'	'
Vested and expected to vest (in shares)	1,940,000	'	'	'
Stock option, Weighted Average Exercise Price of Shares	'	'	'	'
Balance at the beginning of the period (in dollars per share)	$52.11	$42.12	$34.36	'
Granted (in dollars per share)	$74.76	$78.12	$59.18	'
Exercised (in dollars per share)	$36.06	$35.60	$31.65	'
Forfeited or expired (in dollars per share)	$73.57	$57.50	$45.03	'
Balance at the end of the period (in dollars per share)	$60.12	$52.11	$42.12	$34.36
Vested (in dollars per share)	$50.24	'	'	'
Vested and expected to vest (in dollars per share)	$59.98	'	'	'
Stock option, Average Remaining Contractual Term (in years)	'	'	'	'
Balance at the end of the period (in years)	'7 years 4 months 24 days	'7 years 8 months 15 days	'8 years 1 month 6 days	'8 years 7 months 9 days
Vested (in years)	'6 years 6 months	'	'	'
Vested and expected to vest (in years)	'7 years 4 months 24 days	'	'	'
Stock option, Aggregate Intrinsic Value	'	'	'	'
Outstanding options	$46.30	$99.20	$47.60	$48.20
Exercised options	17.6	11.6	5.2	'
Vested options	37.5	'	'	'
Vested and expected to vest options	46.1	'	'	'
Weighted-Average Grant Date Fair Value (in dollars per share)	$15.08	$17.55	$14.73	'
Cash proceeds received from options exercised	13.6	11.6	4.5	'
Tax benefit realized from stock options exercised	5.9	4.8	1.8	'
Performance Share Awards	'	'	'	'
Shares Granted and Earned	203,000	418,000	275,000	'
Weighted-Average Grant- Date Fair Value (in dollars per share)	$72.30	$67.22	$57.03	'
Shares outstanding at period end	143,000	197,000	79,000	'
Percentage of plan performance assumed	100.00%	'	'	'
Nonvested restricted stock units, Shares	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	423,000	514,000	533,000	588,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	133,000	146,000	134,000	'
Vested (in shares)	-189,000	-146,000	-170,000	'
Forfeited (in shares)	-35,000	-19,000	-19,000	'
Nonvested restricted stock units, Weighted-Average Grant Date Fair Value	'	'	'	'
Nonvested at the beginning of the period (in dollars per share)	$50.24	$38.09	$35.15	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	$74.85	$76.98	$59.40	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$39.14	$32.28	$44.44	'
Forfeited (in dollars per share)	$62.68	$47.57	$40.39	'
Nonvested at the end of the period (in dollars per share)	$61.59	$50.24	$38.09	$35.15
Allocated Share-based Compensation Expense (pre-tax)	32.6	32.2	39.9	'
Stock-based compensation expense	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	32.6	32.2	39.9	'
Net tax benefit related to stock-based compensation expense	-11.4	-9.8	-14.1	'
Upper limit	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Term of awards	'5 years	'	'	'
Percentage payout based on targets met	200.00%	'	'	'
Lower limit	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Term of awards	'1 year	'	'	'
Percentage payout based on targets met	0.00%	'	'	'
Stock options	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Under one of the company's vesting schedules, percentage of stock options exercisable on each of the first through the fourth anniversaries of the grant date	25.00%	'	'	'
Under the second of two vesting schedules, percentage of stock options exercisable on each of the first through the third anniversaries of the grant date	33.00%	'	'	'
Term of awards	'10 years	'	'	'
Stock option, Aggregate Intrinsic Value	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	7.4	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'1 year 9 months 18 days	'	'	'
Nonvested restricted stock units, Weighted-Average Grant Date Fair Value	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	6.5	7.5	5.9	'
Stock-based compensation expense	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	6.5	7.5	5.9	'
Performance share awards	'	'	'	'
Stock option, Aggregate Intrinsic Value	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	6.5	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'1 year 6 months	'	'	'
Nonvested restricted stock units, Weighted-Average Grant Date Fair Value	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	16.1	16.1	22.8	'
Stock-based compensation expense	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	16.1	16.1	22.8	'
Restricted stock units	'	'	'	'
Stock option, Aggregate Intrinsic Value	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	12.8	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'2 years 6 months	'	'	'
Nonvested restricted stock units, Weighted-Average Grant Date Fair Value	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	10	8.6	11.2	'
Stock-based compensation expense	'	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	$10	$8.60	$11.20	'

EMPLOYEE_STOCK_BENEFIT_PLANS_D1

EMPLOYEE STOCK BENEFIT PLANS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock-based compensation expense	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	$32.60	$32.20	$39.90
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount	0	'	'
Cost of products sold	'	'	'
Stock-based compensation expense	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	3	3	4
Selling, general and administrative	'	'	'
Stock-based compensation expense	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	26.6	26.2	31.9
Research and Development Expense [Member]	'	'	'
Stock-based compensation expense	'	'	'
Allocated Share-based Compensation Expense (pre-tax)	$3	$3	$4

PENSION_AND_OTHER_POSTEMPLOYME2

PENSION AND OTHER POST-EMPLOYMENT BENEFIT PLANS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Changes in net periodic benefit cost	'	'	'
Percentage in total pension assets and obligations	75.00%	'	'
Change in fair value of plan assets:	'	'	'
Beginning fair value of plan assets	$312.10	'	'
Fair value of plan assets at end of year	276.1	312.1	'
Amounts in the consolidated balance sheets include:	'	'	'
Pension, Post Retirement and Post Employment Liabilities	-161.8	-188.8	'
Accumulated benefit obligation in excess of plan assets	'	'	'
Projected benefit obligation	366.3	449.3	'
Accumulated benefit obligation	356.1	430.2	'
Fair value of plan assets	210.8	263.1	'
Weighted-average assumptions used to determine net periodic benefit cost	'	'	'
Expected long term return on plan assets in next fiscal year (as a percent)	7.00%	'	'
Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]	'	'	'
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	6.90%	7.80%	7.40%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate	4.90%	4.90%	5.00%
Defined Benefit Plan, Year that Rate Reaches Ultimate Trend Rate	'2023	'2023	'2017
Defined Benefit Plan, Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rates [Abstract]	'	'	'
Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components	0	'	'
Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components	0	'	'
Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation	0.2	'	'
Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation	0.3	'	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	276.1	312.1	'
Period of notice for quarterly redemption of diversified hedge	'60 days	'	'
DefinedContributionBenefits [Abstract]	'	'	'
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year	0	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]	'	'	'
Defined Contribution Plan, Cost Recognized	19.9	21.3	19.3
Cash and Cash Equivalents [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	13	11.4	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	13	11.4	'
US large cap equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	16.3	13.6	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	16.3	13.6	'
US mid cap growth equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	3.1	2.8	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	3.1	2.8	'
US small cap growth equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0.1	1.5	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0.1	1.5	'
Emerging market equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	2.8	3.1	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	2.8	3.1	'
Real estate investment trusts [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	5.6	13.4	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	5.6	13.4	'
International large cap value equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	37	28.3	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	37	28.3	'
Hedge Funds [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	17.4	15.7	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	17.4	15.7	'
Municipal Bonds [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	72.8	83.5	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	72.8	83.5	'
Corporate Bond Securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	101.7	138.8	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	101.7	138.8	'
Emerging markets Fixed Income [Domain]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	6.3	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	6.3	0	'
Pension Benefits	'	'	'
Changes in benefit obligations	'	'	'
Beginning benefit obligations	463.6	402.7	'
Service cost - benefits earned during the period	5.2	3.9	3.5
Interest cost on projected benefit obligations	14.4	15.6	17
Actuarial assumptions (gains) losses	-25.7	72.2	'
Settlements and curtailments	-50.4	-30.9	'
Benefits paid	-2.8	-2.2	'
Exchange rate changes	-0.3	2.3	'
Benefit obligations at end of year	404	463.6	402.7
Change in fair value of plan assets:	'	'	'
Beginning fair value of plan assets	312.1	280.7	'
Actual return on plan assets	-1.4	32.8	'
Employer contributions	18.5	28.2	9.5
Settlements	-50.4	-29.3	'
Benefits paid	-2.8	-2.2	'
Exchange rate changes	0.1	1.9	'
Fair value of plan assets at end of year	276.1	312.1	280.7
Underfunded status at end of year	-127.9	-151.5	'
Amounts in the consolidated balance sheets include:	'	'	'
Other assets	1.3	2.2	'
Pension, Post Retirement and Post Employment Liabilities	-129.2	-153.7	'
Defined Benefit Plan, Amounts Recognized in Balance Sheet	-127.9	-151.5	'
Amounts in accumulated other comprehensive loss include:	'	'	'
Prior service (benefit)	1.2	0	'
Transition obligation	0.1	0.2	'
Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax	1.3	0.2	'
Accumulated benefit obligation	375.7	428	'
Accumulated benefit obligation in excess of plan assets	'	'	'
Service cost - benefits earned during the period	5.2	3.9	3.5
Interest cost on projected benefit obligations	14.4	15.6	17
Expected return on plan assets	-17.1	-16.6	-19.1
Amortization of prior service (benefit)	0	0	0
Amortization of transition cost	0.1	0.1	0.1
Net periodic benefit cost	2.6	3	1.5
Settlements and curtailments	-8.2	56.3	87.5
Defined Benefit Plan, Curtailments	0	-1.4	0
Total net periodic benefit cost	-5.6	57.9	89
Weighted-average assumptions used to determine benefit obligations	'	'	'
Discount rate (as a percent)	4.08%	3.21%	'
Rate of compensation increase (as a percent)	3.22%	3.58%	'
Weighted-average assumptions used to determine net periodic benefit cost	'	'	'
Discount rate (as a percent)	3.26%	4.03%	5.59%
Expected long term return on plan assets (as a percent)	5.22%	5.65%	6.91%
Rate of compensation increase (as a percent)	3.59%	4.00%	4.02%
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	276.1	312.1	280.7
DefinedContributionBenefits [Abstract]	'	'	'
Employer contributions	18.5	28.2	9.5
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]	'	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months	29.3	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Two	29.5	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Three	29.5	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Four	30.8	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Five	29.7	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Five Fiscal Years Thereafter	147.8	'	'
Other Benefits	'	'	'
Changes in benefit obligations	'	'	'
Beginning benefit obligations	35.1	30.2	'
Service cost - benefits earned during the period	1.1	1	0.9
Interest cost on projected benefit obligations	1.3	1.3	1.3
Actuarial assumptions (gains) losses	-3.8	2.6	'
Settlements and curtailments	0	0	'
Benefits paid	-1.3	-0.1	'
Exchange rate changes	0.2	0.1	'
Benefit obligations at end of year	32.6	35.1	30.2
Change in fair value of plan assets:	'	'	'
Beginning fair value of plan assets	0	0	'
Actual return on plan assets	0	0	'
Employer contributions	0.9	0.1	'
Settlements	0	0	'
Benefits paid	-1.3	-0.1	'
Exchange rate changes	0.4	0	'
Fair value of plan assets at end of year	0	0	0
Underfunded status at end of year	-32.6	-35.1	'
Amounts in the consolidated balance sheets include:	'	'	'
Other assets	0	0	'
Pension, Post Retirement and Post Employment Liabilities	-32.6	-35.1	'
Defined Benefit Plan, Amounts Recognized in Balance Sheet	-32.6	-35.1	'
Amounts in accumulated other comprehensive loss include:	'	'	'
Prior service (benefit)	-0.3	-0.5	'
Transition obligation	0	0	'
Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax	-0.3	-0.5	'
Accumulated benefit obligation	32.6	35.1	'
Accumulated benefit obligation in excess of plan assets	'	'	'
Service cost - benefits earned during the period	1.1	1	0.9
Interest cost on projected benefit obligations	1.3	1.3	1.3
Expected return on plan assets	0	0	0
Amortization of prior service (benefit)	-0.2	-0.2	-0.2
Amortization of transition cost	0	0	0
Net periodic benefit cost	2.2	2.1	2
Settlements and curtailments	-3.8	2.6	4
Defined Benefit Plan, Curtailments	0	0	0
Total net periodic benefit cost	-1.6	4.7	6
Weighted-average assumptions used to determine benefit obligations	'	'	'
Discount rate (as a percent)	4.98%	3.75%	'
Rate of compensation increase (as a percent)	3.08%	3.48%	'
Weighted-average assumptions used to determine net periodic benefit cost	'	'	'
Discount rate (as a percent)	3.75%	4.29%	5.28%
Expected long term return on plan assets (as a percent)	0.00%	0.00%	0.00%
Rate of compensation increase (as a percent)	3.48%	3.94%	3.94%
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	0
DefinedContributionBenefits [Abstract]	'	'	'
Employer contributions	0.9	0.1	'
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]	'	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months	0.8	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Two	1	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Three	1.1	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Four	1.1	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Year Five	1.3	'	'
Defined Benefit Plan, Expected Future Benefit Payments, Five Fiscal Years Thereafter	6.5	'	'
U.S. Pension Plan | Equity Securities [Member]	'	'	'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'	'	'
Defined Benefit Plan, Target Allocation Percentage	'.4	'	'
U.S. Pension Plan | Fixed Income [Member]	'	'	'
Defined Benefit Plan, Assets, Target Allocations [Abstract]	'	'	'
Defined Benefit Plan, Target Allocation Percentage	'.6	'	'
Fair Value, Inputs, Level 1 [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	21.5	11.4	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	21.5	11.4	'
Fair Value, Inputs, Level 1 [Member] | Cash and Cash Equivalents [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	13	11.4	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	13	11.4	'
Fair Value, Inputs, Level 1 [Member] | US large cap equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | US mid cap growth equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | US small cap growth equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | Emerging market equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | Real estate investment trusts [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | International large cap value equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	8.5	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	8.5	0	'
Fair Value, Inputs, Level 1 [Member] | Hedge Funds [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | Municipal Bonds [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | Corporate Bond Securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 1 [Member] | Emerging markets Fixed Income [Domain]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	'	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	'	'
Fair Value, Inputs, Level 2 [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	254.6	300.7	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	254.6	300.7	'
Fair Value, Inputs, Level 2 [Member] | Cash and Cash Equivalents [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0	0	'
Fair Value, Inputs, Level 2 [Member] | US large cap equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	16.3	13.6	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	16.3	13.6	'
Fair Value, Inputs, Level 2 [Member] | US mid cap growth equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	3.1	2.8	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	3.1	2.8	'
Fair Value, Inputs, Level 2 [Member] | US small cap growth equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	0.1	1.5	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	0.1	1.5	'
Fair Value, Inputs, Level 2 [Member] | Emerging market equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	2.8	3.1	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	2.8	3.1	'
Fair Value, Inputs, Level 2 [Member] | Real estate investment trusts [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	5.6	13.4	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	5.6	13.4	'
Fair Value, Inputs, Level 2 [Member] | International large cap value equity securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	28.5	28.3	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	28.5	28.3	'
Fair Value, Inputs, Level 2 [Member] | Hedge Funds [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	17.4	15.7	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	17.4	15.7	'
Fair Value, Inputs, Level 2 [Member] | Municipal Bonds [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	72.8	83.5	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	72.8	83.5	'
Fair Value, Inputs, Level 2 [Member] | Corporate Bond Securities [Member]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	101.7	138.8	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	101.7	138.8	'
Fair Value, Inputs, Level 2 [Member] | Emerging markets Fixed Income [Domain]	'	'	'
Change in fair value of plan assets:	'	'	'
Fair value of plan assets at end of year	6.3	0	'
DefinedBenefitPlanFairValueofPlanAssets [Abstract]	'	'	'
Defined Benefit Plan, Fair Value of Plan Assets	$6.30	$0	'

REDEEMABLE_NONCONTROLLING_INTE1

REDEEMABLE NONCONTROLLING INTEREST (Details)	Mar. 15, 2012	Dec. 31, 2013	Dec. 31, 2013
	Nutricion para el Conosur S.A.	Put Option [Member]	Call Option [Member]
Business Acquisition [Line Items]	'	'	'
Percentage of outstanding shares of capital stock acquired	80.00%	'	'
Noncontrolling interests (as a percent)	'	20.00%	20.00%

NONCONTROLLING_INTERESTS_Detai

NONCONTROLLING INTERESTS (Details)	Dec. 31, 2013
Argentina	'
Noncontrolling interest disclosures	'
Noncontrolling interests (as a percent)	20.00%
China	'
Noncontrolling interest disclosures	'
Noncontrolling interests (as a percent)	11.00%
Indonesia	'
Noncontrolling interest disclosures	'
Noncontrolling interests (as a percent)	10.00%

OTHER_EXPENSESNET_Details

OTHER EXPENSES-NET (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
ScheduleOfOtherIncomeAndOtherExpenseNet [Line Items]	'	'	'
Foreign exchange (gains)/losses-net	$9.30	($3.10)	($9.70)
Administrative penalty (China)	33.4	0	0
Severance and other costs	2.2	8	9.9
Gain on sale of non-strategic intangible asset	'	-6.5	0
Legal Fees	7	0	0
Other net	-3.4	6.4	9.7
Other Expenses/(Income)bnet	48.5	4.8	9.9
Total operating segments	'	'	'
ScheduleOfOtherIncomeAndOtherExpenseNet [Line Items]	'	'	'
Gain on sale of non-strategic intangible asset	$0	'	'

RECEIVABLES_Details

RECEIVABLES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Receivables Abstract [Abstract]	'	'
Trade receivables	$335.70	$330
Miscellaneous receivables	55.2	42.2
Less allowances	-6.5	-7.6
Receivables, Net	$384.40	$364.60

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Finished goods	$312.70	$264.60
Work in process	82.5	56.9
Raw and packaging materials	139.6	114.4
Inventories	$534.80	$435.90

LONG_LIVED_ASSETS_Details

LONG LIVED ASSETS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Property, plant and equipment disclosures	'	'	'
Accumulated depreciation	($607.10)	($568.20)	'
Property, plant, and equipment-net	867.5	689.9	'
Depreciation expense	63.7	55.8	57.2
Interest capitalized	5.7	0.6	0.2
Asset Retirement Obligations, Noncurrent	3.6	3.3	'
Expected amortization expense related to intangible assets	'	'	'
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	16	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Two	15	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Three	12.3	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Four	9.4	'	'
Finite-Lived Intangible Assets, Amortization Expense, Year Five	1.8	'	'
Finite-Lived Intangible Assets, Amortization Expense, after Year Five	1.7	'	'
Land	'	'	'
Property, plant and equipment disclosures	'	'	'
Property, Plant and Equipment, Gross	12.6	6	'
Buildings	'	'	'
Property, plant and equipment disclosures	'	'	'
Property, Plant and Equipment, Gross	550.8	506	'
Machinery, equipment and fixtures	'	'	'
Property, plant and equipment disclosures	'	'	'
Property, Plant and Equipment, Gross	650.3	595.7	'
Construction in progress	'	'	'
Property, plant and equipment disclosures	'	'	'
Property, Plant and Equipment, Gross	$260.90	$150.40	'

OTHER_INTANGIBLE_ASSETS_Detail

OTHER INTANGIBLE ASSETS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Other intangible assets	'	'	'
Total	$41.30	$54.20	'
Indefinite-lived intangible assets zero amortization	0	0	'
Finite-Lived Intangible Assets, Net [Abstract]	'	'	'
Gross Carrying Amount	136.1	136.6	'
Accumulated Amortization	-79.9	-60.9	'
Net Book Value	56.2	75.7	'
Total other intangible assets, Gross Carrying Amount	177.4	190.8	'
Total other intangible assets, Net Book Value	97.5	129.9	'
Amortization expense for other intangible assets	19.4	21.1	18.1
Computer software	'	'	'
Finite-Lived Intangible Assets, Net [Abstract]	'	'	'
Gross Carrying Amount	132.8	132.2	'
Accumulated Amortization	-79.3	-60.2	'
Net Book Value	53.5	72	'
Distributor-customer relationship	'	'	'
Finite-Lived Intangible Assets, Net [Abstract]	'	'	'
Gross Carrying Amount	3.3	4.4	'
Accumulated Amortization	-0.6	-0.7	'
Net Book Value	2.7	3.7	'
Trademark	'	'	'
Other intangible assets	'	'	'
Total	34.5	45.3	'
Indefinite-lived intangible assets zero amortization	0	0	'
Non-compete agreement	'	'	'
Other intangible assets	'	'	'
Total	6.8	8.9	'
Indefinite-lived intangible assets zero amortization	$0	$0	'

LONG_LIVED_ASSETS_Noncash_acti

LONG LIVED ASSETS Non-cash activity (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Noncash activity [Abstract]	'	'	'
Capital Expenditures Incurred but Not yet Paid	$89.50	$78.70	$32.80

GOODWILL_Details

GOODWILL (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Details of goodwill	'	'
Goodwill at the beginning of the period	$270.60	$117.50
Acquisition	'	172.8
Goodwill, Other Changes	-40.5	'
Translation adjustments	-33.3	-19.7
Goodwill at the end of the period	196.8	270.6
Latin America	'	'
Details of goodwill	'	'
Goodwill at the beginning of the period	253.6	115.8
Acquisition	'	155.5
Goodwill, Other Changes	-42.5	'
Translation adjustments	-33.3	-17.7
Goodwill at the end of the period	177.8	253.6
North America/Europe	'	'
Details of goodwill	'	'
Goodwill at the beginning of the period	17	1.7
Acquisition	'	17.3
Goodwill, Other Changes	2	'
Translation adjustments	0	-2
Goodwill at the end of the period	19	17
Asia [Member]	'	'
Details of goodwill	'	'
Goodwill at the beginning of the period	0	0
Acquisition	'	0
Goodwill, Other Changes	0	'
Translation adjustments	0	0
Goodwill at the end of the period	$0	$0

DEBT_Details

DEBT (Details)	3 Months Ended	12 Months Ended		1 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Mar. 15, 2012	Dec. 31, 2013	Dec. 31, 2013
	USD ($)	USD ($)	USD ($)	Nutricion para el Conosur S.A.	Nutricion para el Conosur S.A.	Lower limit	Upper limit
				ARS	ARS
Line of credit facility disclosures	'	'	'	'	'	'	'
Short-term borrowings	$2	$2	$161	'	'	'	'
Short term borrowings interest rate at end of period	22.00%	22.00%	'	'	'	'	'
Term of credit facility	'5	'	'	'	'	'	'
Line of Credit Facility, Expiration Date	'	30-Jun-16	'	'	'	'	'
Line of credit, maximum amount of outstanding borrowings and letters of credit permitted at any one time	500	500	'	'	'	'	'
Line of credit, potential maximum with Company's request and lender consent	750	750	'	'	'	'	'
Credit Facility covenant, consolidated total debt to consolidated EBITDA ratio, numerator(cannot exceed)	'	3.25	'	'	'	'	'
Credit Facility covenant, consolidated total debt to consolidated EBITDA ratio, denominator	'	1	'	'	'	'	'
Credit Facility covenant, consolidated EBITDA to consolidated interest expense ratio, numerator (cannot be less)	'	3	'	'	'	'	'
Credit Facility covenant, consolidated EBITDA to consolidated interest expense ratio, denominator	'	1	'	'	'	'	'
Description of interest rate basis	'	'LIBOR	'	'	'	'	'
Range of margin added to base rate (as a percent)	'	'	'	'	'	0.08%	1.45%
Credit facility, commitment fee percentage	'	0.20%	'	'	'	'	'
Credit facility weighted average interest rate (as a percent)	'	1.52%	'	'	'	'	'
Percentage of outstanding shares of capital stock acquired	'	'	'	'	80.00%	'	'
Purchase price allocation, Total consideration transferred	'	'	'	850.7	'	'	'
Note payable, acquisition date	'	'	'	'	377.6	'	'

DEBT_Details_2

DEBT (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Long-Term Debt	'	'	'
Principal value of long-term debt obligations	$1,500	$1,500	'
Unamortized basis adjustment for terminated interest rate swaps	16.7	26	'
Unamortized bond discount	-2	-2.8	'
Long-term Debt Current Portion	505.6	0	'
Long-term debt	1,009.10	1,523.20	'
Long-term debt - fair value	1,611.10	'	'
Interest expense	59.2	70.9	60.2
Interest income	-8.6	-5.9	-8
Interest expense-net	50.6	65	52.2
Interest payments, net of amounts related to interest rate swaps	72	74.9	61.4
3.50% Notes due 2014	'	'	'
Long-Term Debt	'	'	'
Principal value of long-term debt obligations	500	500	'
Stated rate (as a percent)	3.50%	'	'
4.90% Notes due 2019	'	'	'
Long-Term Debt	'	'	'
Principal value of long-term debt obligations	700	700	'
Stated rate (as a percent)	4.90%	'	'
5.90% Notes due 2039	'	'	'
Long-Term Debt	'	'	'
Principal value of long-term debt obligations	$300	$300	'
Stated rate (as a percent)	5.90%	'	'

DERIVATIVES_AND_OTHER_FINANCIA2

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Details) (USD $)

12 Months Ended

12 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Nov. 30, 2009

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Commodity Option [Member]

Mexican peso

Malaysia, Ringgits

Philippine peso

Interest Rate Swaps

Interest Rate Swaps

Cash flow hedges

Cash flow hedges

Designated as hedging instruments

Designated as hedging instruments

Designated as hedging instruments

Designated as hedging instruments

Designated as hedging instruments

Designated as hedging instruments

Lower limit

Upper limit

lb

D

Foreign Currency Forward Contract

Cash flow hedges

Cash flow hedges

Cash flow hedges

Cash flow hedges

Interest Rate Swaps

Interest Rate Swaps

Interest Rate Swaps

Interest Rate Swaps

Other assets

Other assets

Accrued expenses

Accrued expenses

Other assets

Other assets

Derivative disclosures

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

No transfers between levels in fair value hierarchy

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Nonmonetary Notional Amount, Mass

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Amount of Hedged Item

'

'

'

'

'

'

500

700

'

'

'

'

'

'

'

'

'

'

Cash flow hedges

'

'

'

'

'

'

'

'

'

'

4.2

0

-0.5

-5.1

19.9

0

'

'

Net asset/(liability) of derivatives designated as hedging instruments

23.6

-5.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of days from originally forecasted transaction date to discontinue cash flow hedge accounting

'

'

'

'

'

'

'

'

60

'

'

'

'

'

'

'

'

'

Maximum duration of foreign exchange contracts used to hedge intercompany purchases (in months)

'

'

'

'

'

'

'

'

'

'1 year 6 months

'

'

'

'

'

'

'

'

Weighted average Forward Rate (in foreign currency)

'

'

'

13.07

3.18

43.48

'

'

'

'

'

'

'

'

'

'

'

'

Notional value

201.4

'

0.3

84

55

62.4

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Fair Value, Gross Asset

$3.70

'

'

$0.70

$2

$1

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Maturity Date

'

'

'

31-Dec-14

31-Dec-14

31-Dec-14

'

'

'

'

'

'

'

'

'

'

'

'

Derivative, Forward Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.79%

3.94%

DERIVATIVES_AND_OTHER_FINANCIA3

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Interest rate swap fair value hedges	'	'	'
Beginning balance	($4.10)	$4.30	'
Derivatives qualifying as cash flow hedges deferred in other comprehensive income	24.2	-12.7	5.8
Reclassification Adjustment for Losses Included in Net Earnings	5.4	0.8	2.9
Change in deferred taxes	-2.9	3.5	'
Ending balance	3.2	-4.1	4.3
Cash flow hedge included within accumulated other comprehensive income (loss) expected to be reclassified within the next twelve months	3.2	'	'
Foreign Exchange Contracts	'	'	'
Interest rate swap fair value hedges	'	'	'
Derivatives qualifying as cash flow hedges deferred in other comprehensive income	4.8	-12.7	'
Interest Rate Swaps	'	'	'
Interest rate swap fair value hedges	'	'	'
Derivatives qualifying as cash flow hedges deferred in other comprehensive income	$19.40	'	'

DERIVATIVES_AND_OTHER_FINANCIA4

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Details 3) (USD $)

12 Months Ended

1 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Nov. 30, 2009

Jul. 31, 2011

Nov. 30, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Interest Rate Swaps

Interest Rate Swaps

Interest Rate Swaps

Interest Rate Swaps

Fair value hedges

Fair value hedges

Fair value hedges

Fair value hedges

Fair value hedges

Fair value hedges

Terminated contracts

Terminated contracts

Interest Rate Swaps

Interest Rate Swaps

Interest Rate Swaps

Interest rate swap fair value hedges

'

'

'

'

'

'

'

'

'

'

'

'

'

Notional Amount of Underlying Debt

'

'

'

$500

$700

'

'

'

'

'

'

'

'

Notional amount

201.4

'

'

'

'

500

200

'

'

'

'

'

'

Cash received

'

'

'

'

'

23.5

15.6

'

'

'

'

'

'

(Gain) loss on marked to market of swaps

'

'

'

'

'

'

'

0

0

-4.2

'

'

'

(Gain) loss on marked to market of hedged items

0

0

4.2

'

'

'

'

'

'

'

'

'

'

Derivative, Gain on Derivative

'

'

'

'

'

'

'

'

'

'

0

0

6.3

Amortization of basis adjustment for terminated interest rate swaps recognized in interest expense

'

'

'

'

'

'

'

'

'

'

-9.2

-9.3

-5.5

Recognized in interest expense

'

'

'

'

'

'

'

'

'

'

9.2

9.3

11.8

Money market funds, classified as Level Two

$447.80

$520.70

'

'

'

'

'

'

'

'

'

'

'

EQUITY_Details

EQUITY (Details) (USD $)

3 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

46 Months Ended

4 Months Ended

12 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Redeemable Noncontrolling Interest

Redeemable Noncontrolling Interest

Accumulated Translation Adjustment [Member]

Accumulated Translation Adjustment [Member]

Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]

Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]

Accumulated Defined Benefit Plans Adjustment [Member]

Accumulated Defined Benefit Plans Adjustment [Member]

Noncontrolling Interests

Noncontrolling Interests

Common Stock

Common Stock

Common Stock

Treasury Stock

Treasury Stock

Treasury Stock

March Two Thousand Ten Repurchase [Member]

September Two Thousand Thirteen Repurchase [Member]

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Foreign Exchange [Member]

Cost of products sold

Cost of products sold

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Research and Development Expense [Member]

Other expenses - net [Member]

Treasury Stock

Treasury Stock

Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]

Accumulated Defined Benefit Plans Adjustment [Member]

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Accumulated Defined Benefit Plans Adjustment [Member]

Selling, General and Administrative Expenses [Member]

Selling, General and Administrative Expenses [Member]

Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]

Accumulated Defined Benefit Plans Adjustment [Member]

Changes in common shares and treasury stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued, balance at beginning of period

'

'

'

206

'

'

'

'

206

'

'

'

'

'

'

'

'

'

'

'

'

206

205.1

204.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury stock balance at beginning of period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.5

1.4

0.1

'

'

'

'

'

'

'

'

'

'

'

'

Stock-based compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.8

0.9

0.3

0.2

0.2

0

'

'

'

'

'

'

'

'

'

'

'

'

Treasury stock purchases

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

1.1

1.9

1.3

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued, balance at end of period

206.8

'

'

'

206

'

'

'

206.8

206

'

'

'

'

'

'

'

'

'

'

'

206.8

206

205.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury stock balance at end of period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.8

3.5

1.4

'

'

'

'

'

'

'

'

'

'

'

'

Balance, beginning of period (in dollars )

'

'

'

$244.60

'

'

'

'

$244.60

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$244.60

$89.70

$3.20

'

'

'

'

'

'

'

'

'

'

'

'

Stock-based compensation (in dollars )

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18.9

15.2

4.9

'

'

'

'

'

'

'

'

'

'

'

'

Treasury stock purchases (in dollars )

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

88.4

139.7

81.6

'

'

'

'

'

'

'

'

'

'

'

'

Balance, end of period (in dollars )

351.9

'

'

'

244.6

'

'

'

351.9

244.6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

351.9

244.6

89.7

'

'

'

'

'

'

'

'

'

'

'

'

Shares authorized to be repurchased (in dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300

500

'

'

'

'

'

'

'

'

'

'

Shares repurchased, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.2

0.1

'

'

'

'

'

'

'

'

'

'

Shares repurchased, average cost per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$71.21

$84.06

'

'

'

'

'

'

'

'

'

'

Remaining repurchased available under the authorization (in dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

490.3

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Loss

-69.2

'

'

'

-18.4

'

'

'

-69.2

-18.4

'

'

'

-83.6

-14.6

15.4

-4.1

-1

0.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders Equity Noncontrolling Interest Accumulated Other Comprehensive Income

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.9

-0.2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redeemable noncontrolling interest accumlated other comprehensive income loss

'

'

'

'

'

'

'

'

'

'

'

-14.4

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive Income (Loss), before Reclassifications, before Tax

'

'

'

'

'

'

'

'

-56.3

'

'

-14.4

'

-79.4

'

24.2

'

-1.1

'

3.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost of Goods Sold

'

'

'

'

'

'

'

'

5.2

'

'

0

'

0

'

5.4

'

-0.2

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Tax Benefit/(Expense)

'

'

'

'

'

'

'

'

9.2

-13

4.7

0

'

10.4

'

'

'

'

'

-1.2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax

'

'

'

'

'

'

'

'

2.9

-3.5

'

'

'

'

'

10.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax

'

'

'

'

'

'

'

'

0

0

0

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive Income (Loss), Tax

'

'

'

'

'

'

'

'

0.3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reclassification Adjustment for Losses Included in Net Earnings

'

'

'

'

'

'

'

'

-1,528.50

-1,503.80

-1,391

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-5.4

5.3

'

'

'

'

'

Income Tax Expense (Benefit)

'

'

'

'

'

'

'

'

235.1

182

178.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.6

1.6

'

'

'

'

'

'

'

'

NET EARNINGS

156.1

169.7

173.4

190

101.6

145.2

168.9

172.6

689.2

588.3

467.2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-3.6

-3.8

'

'

'

'

'

'

'

'

Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax

'

'

'

'

'

'

'

'

0.2

0

0.2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.1

'

0.1

'

'

Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Net of Tax

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.2

'

'

'

'

'

'

'

Selling, General and Administrative Expense

'

'

'

'

'

'

'

'

903.5

904.5

975.4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.1

'

'

'

Research and Development Expense

'

'

'

'

'

'

'

'

100.2

100.1

100.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

Other Expensesbnet

'

'

'

'

'

'

'

'

$48.50

$4.80

$9.90

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0

Common Stock, Dividends, Per Share, Declared

'

'

'

'

'

'

'

'

$1.36

$1.20

$1.04

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

LEASES_Details

LEASES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Leases [Abstract]	'	'	'
Operating Leases, Future Minimum Payments Due, Next Twelve Months	$36.40	'	'
Operating Leases, Future Minimum Payments, Due in Two Years	29.5	'	'
Operating Leases, Future Minimum Payments, Due in Three Years	20.8	'	'
Operating Leases, Future Minimum Payments, Due in Four Years	15.5	'	'
Operating Leases, Future Minimum Payments, Due in Five Years	14.3	'	'
Operating Leases, Future Minimum Payments, Due Thereafter	22.3	'	'
Operating Leases, Future Minimum Payments Due	138.8	'	'
Operating Leases, Rent Expense, Net	39.7	37.4	35.5
Capital Lease Obligations	$2.90	$2.70	'

CONTINGENCIES_Details

CONTINGENCIES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Proceeding
Commitments and Contingencies Disclosure [Abstract]	'	'	'
Administrative penalty (China)	$33.40	$0	$0
Minimum number of proceedings that could have a material impact	1	'	'

SELECTED_QUARTERLY_FINANCIAL_D2

SELECTED QUARTERLY FINANCIAL DATA(UNAUDITED) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Financial Information Disclosure [Abstract]	'	'	'	'	'	'	'	'	'	'	'
NET SALES	$1,060.70	$1,046.80	$1,055.30	$1,037.90	$981.10	$921.30	$1,012.30	$986.60	$4,200.70	$3,901.30	$3,677
Gross Profit	661.5	684.5	673.3	652.9	582.5	565.6	635.6	613.8	2,672.20	2,397.50	2,286
Net Earnings	156.1	169.7	173.4	190	101.6	145.2	168.9	172.6	689.2	588.3	467.2
Net earnings attributable to shareholders	$152.50	$171.30	$172	$188	$103.50	$146.30	$163.60	$167	$683.80	$580.40	$456.70
Net Earnings Attributable to Shareholders (in dollars per share)	$0.75	$0.85	$0.85	$0.93	$0.51	$0.72	$0.80	$0.82	$3.37	$2.84	$2.23
Net Earnings Attributable to Shareholders (in dollars per share - diluted)	$0.75	$0.84	$0.84	$0.92	$0.51	$0.71	$0.80	$0.81	$3.36	$2.83	$2.22

Schedule_II_Valuation_and_Qual1

Schedule II Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Valuation Allowance of Deferred Tax Assets [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Valuation Allowances and Reserves, Balance	$6.10	$7	$3.30
Valuation Allowances and Reserves, Charged to Cost and Expense	3.8	1.1	3.7
Valuation Allowances and Reserves, Adjustments	-2.6	-2	0
Valuation Allowances and Reserves, Balance	7.3	6.1	7
Allowance for Doubtful Accounts [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Valuation Allowances and Reserves, Balance	7.6	6.3	8.3
Valuation Allowances and Reserves, Charged to Cost and Expense	0.6	1.5	0.2
Valuation Allowances and Reserves, Deductions	-0.2	-0.4	0
Valuation Allowances and Reserves, Adjustments	-1.5	0.2	-2.2
Valuation Allowances and Reserves, Balance	$6.50	$7.60	$6.30